US20100137178A1 - Perfume systems - Google Patents

Perfume systems Download PDF

Info

Publication number
US20100137178A1
US20100137178A1 US12/628,255 US62825509A US2010137178A1 US 20100137178 A1 US20100137178 A1 US 20100137178A1 US 62825509 A US62825509 A US 62825509A US 2010137178 A1 US2010137178 A1 US 2010137178A1
Authority
US
United States
Prior art keywords
enyl
methyl
methylbut
dimethyl
propan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/628,255
Inventor
Johan Smets
Hugo Robert Germain Denutte
An Pintens
David Thomas Stanton
Koen Van Aken
Inge Helena Hubert Laureyn
Bram Denolf
Freek Annie Camiel Vrielynck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Priority to US12/628,255 priority Critical patent/US20100137178A1/en
Assigned to THE PROCTER & GAMBLE COMPANY reassignment THE PROCTER & GAMBLE COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DENUTTE, HUGO ROBERT GERMAIN, PINTENS, AN (NMN), Smets, Johan (NMN), DENOLF, BRAM (NMN), LAUREYN, INGE HELENA HUBERT, VAN AKEN, KOEN (NMN), VRIELYNCK, FREEK ANNIE CAMIEL, STANTON, DAVID THOMAS
Publication of US20100137178A1 publication Critical patent/US20100137178A1/en
Priority to US13/616,766 priority patent/US8431520B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/50—Perfumes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00—Formulations or additives for perfume preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/06—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms of an acyclic and unsaturated carbon skeleton
    • C07C255/07—Mononitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/33—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring with cyano groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/05—Alcohols containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/05—Alcohols containing rings other than six-membered aromatic rings
    • C07C33/14—Alcohols containing rings other than six-membered aromatic rings containing six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/203—Unsaturated compounds containing keto groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/213—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/213—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C49/217—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/225—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/29—Saturated compounds containing keto groups bound to rings
    • C07C49/293—Saturated compounds containing keto groups bound to rings to a three- or four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/527—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings
    • C07C49/557—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings having unsaturation outside the rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/782—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic
    • C07C49/792—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/794—Ketones containing a keto group bound to a six-membered aromatic ring having unsaturation outside an aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/03—Monocarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/007—Esters of unsaturated alcohols having the esterified hydroxy group bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00—Essential oils; Perfumes
    • C11B9/0026—Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring
    • C11B9/003—Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring the ring containing less than six carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00—Essential oils; Perfumes
    • C11B9/0026—Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring
    • C11B9/0034—Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring the ring containing six carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00—Essential oils; Perfumes
    • C11B9/0061—Essential oils; Perfumes compounds containing a six-membered aromatic ring not condensed with another ring
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00—Essential oils; Perfumes
    • C11B9/0061—Essential oils; Perfumes compounds containing a six-membered aromatic ring not condensed with another ring
    • C11B9/0065—Nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Definitions

  • the present application relates to perfume raw materials, perfume delivery systems and consumer products comprising such perfume raw materials and/or such perfume delivery systems, as well as processes for making and using such perfume raw materials, perfume delivery systems and consumer products.
  • Consumer products may comprise one or more perfumes and/or perfume delivery systems that can provide a desired scent to such product and/or a situs that is contacted with such a product and/or mask an undesirable odor. While current perfumes and perfume delivery systems provide desirable odors, consumers continue to seek products that have scents that may be longer lasting and that are tailored to their individual desires (see for example USPA 2007/0275866 A1 and U.S. patent application Ser. No. 12/133,866)—unfortunately the pool of perfume raw materials and perfume delivery systems that is available is still too limited to completely meet the perfume community's needs. Thus, perfumers need an ever larger pool of perfume raw materials and perfume delivery systems.
  • perfume raw materials and compositions including the delivery systems, disclosed herein expand the perfume community's options, as such perfume raw materials can provide variations on character and such compositions can provide desired odor profiles.
  • the present application relates to perfume raw materials, perfume systems and consumer products comprising such perfume raw materials and/or such perfume systems, as well as processes for making and using such perfume raw materials, perfume systems and consumer products.
  • consumer product means baby care, beauty care, fabric & home care, family care, feminine care, health care, snack and/or beverage products or devices generally intended to be used or consumed in the form in which it is sold.
  • Such products include but are not limited to diapers, bibs, wipes; products for and/or methods relating to treating hair (human, dog, and/or cat), including, bleaching, coloring, dyeing, conditioning, shampooing, styling; deodorants and antiperspirants; personal cleansing; cosmetics; skin care including application of creams, lotions, and other topically applied products for consumer use including fine fragrances; and shaving products, products for and/or methods relating to treating fabrics, hard surfaces and any other surfaces in the area of fabric and home care, including: air care including air fresheners and scent delivery systems, car care, dishwashing, fabric conditioning (including softening and/or freshing), laundry detergency, laundry and rinse additive and/or care, hard surface cleaning and/or treatment including floor and toilet bowl cleaners, and other cleaning for consumer or institutional use
  • air care including
  • cleaning and/or treatment composition is a subset of consumer products that includes, unless otherwise indicated, beauty care, fabric & home care products.
  • Such products include, but are not limited to, products for treating hair (human, dog, and/or cat), including, bleaching, coloring, dyeing, conditioning, shampooing, styling; deodorants and antiperspirants; personal cleansing; cosmetics; skin care including application of creams, lotions, and other topically applied products for consumer use including fine fragrances; and shaving products, products for treating fabrics, hard surfaces and any other surfaces in the area of fabric and home care, including: air care including air fresheners and scent delivery systems, car care, dishwashing, fabric conditioning (including softening and/or freshing), laundry detergency, laundry and rinse additive and/or care, hard surface cleaning and/or treatment including floor and toilet bowl cleaners, granular or powder-form all-purpose or “heavy-duty” washing agents, especially cleaning detergents; liquid, gel or paste-form all-purpose washing agents, especially the so-called heavy
  • the term “fabric and/or hard surface cleaning and/or treatment composition” is a subset of cleaning and treatment compositions that includes, unless otherwise indicated, granular or powder-form all-purpose or “heavy-duty” washing agents, especially cleaning detergents; liquid, gel or paste-form all-purpose washing agents, especially the so-called heavy-duty liquid types; liquid fine-fabric detergents; hand dishwashing agents or light duty dishwashing agents, especially those of the high-foaming type; machine dishwashing agents, including the various tablet, granular, liquid and rinse-aid types for household and institutional use; liquid cleaning and disinfecting agents, including antibacterial hand-wash types, cleaning bars, car or carpet shampoos, bathroom cleaners including toilet bowl cleaners; and metal cleaners, fabric conditioning products including softening and/or freshing that may be in liquid, solid and/or dryer sheet form; as well as cleaning auxiliaries such as bleach additives and “stain-stick” or pre-treat types, substrate-laden products such as dryer added sheets, dry and wetted
  • solid includes granular, powder, bar and tablet product forms.
  • fluid includes liquid, gel, paste and gas product forms.
  • situs includes paper products, fabrics, garments, hard surfaces, hair and skin.
  • component or composition levels are in reference to the active portion of that component or composition, and are exclusive of impurities, for example, residual solvents or by-products, which may be present in commercially available sources of such components or compositions.
  • PRMs Suitable Perfume Raw Materials
  • Suitable PRMs include the PRMs listed in Table 1 below and stereoisomers thereof.
  • the PRMs disclosed in Table 1 above may provide one or more of the following benefits at a level that Applicants believe is unexpected in view of PRMs in general: neat product odor; wet fabric odor when applied to a fabric; dry fabric odor when applied to a fabric; reduced leakage from an encapsulate, including an encapsulate such as a perfume microcapsule; increased head space versus neat oil in certain perfume delivery technologies; odor when used in a matrix perfume delivery that is applied to a package; neat product odor when applied to a cleaning and/or treatment composition; fine fragrance composition odor when used in a fine fragrance; dry hair odor when a composition comprising such a PRM is applied to hair; PRM bloom from a solution comprising such a PRM and new PRM character when applied to a situs. Confirmation of such benefits can be obtained by applying standard test methodologies.
  • PRMs and stereoisomers of such PRMs also known as molecules in the examples of the present specification
  • Table 1 The PRMs and stereoisomers of such PRMs (also known as molecules in the examples of the present specification) disclosed in Table 1 above can be made in accordance with the respective teachings found, for example in the examples of the present specification.
  • a PRM having the structure of Table 1 PRM 16, 20, 27, 28, 118, 123 and 140 are disclosed.
  • the PRMs disclosed in Table 1 and stereoisomers thereof are suitable for use, as defined by the present specification, in consumer products at levels, based on total consumer product weight of from about 0.0001% to about 25%, from about 0.0005% to about 10%, from about 0.001% to about 5%, from about 0.005% to about 2.5%, or even from 0.01% to about 1%.
  • Such PRMs and stereoisomers thereof may be used in combination in the aforementioned consumer product.
  • a consumer product that may comprise one or more PRMs selected from Table 1 PRMs 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 118, 123, 140 and stereoisomers of such PRMs is disclosed.
  • the PRMs disclosed in Table 1 and stereoisomers thereof are suitable for use, as defined by the present specification, in cleaning and/or treatment composition at levels, based on total cleaning and treatment products weight of from about 0.0001% to about 25%, from about 0.0005% to about 10%, from about 0.001% to about 5%, from about 0.005% to about 2.5%, or even from 0.01% to about 1%.
  • Such PRMs and stereoisomers thereof may be used in combination in the aforementioned cleaning and/treatment compositions.
  • a cleaning and/or treatment composition that may comprise one or more PRMs selected from Table 1 PRMs 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 77, 100, 101, 107, 108, 110, 117, 118, 123, 127, 140 and stereoisomers of such PRMs is disclosed.
  • the PRMs disclosed in Table 1 and stereoisomers thereof are suitable for use, as defined by the present specification, in fabric and/or hard surface cleaning and/or treatment compositions at levels, based on total fabric and/or hard surface cleaning and/or treatment composition weight of from about 0.00001% to about 25%, from 0.00005% to about 10%, from 0.0001% to about 5%, from 0.0005% to about 1.0%, or even from 0.001% to about 0.5%.
  • Such PRMs and stereoisomers thereof may be used in combination in the aforementioned fabric and/or hard surface cleaning and/or treatment compositions.
  • a fabric and/or hard surface cleaning and/or treatment composition that may comprise one or more PRMs selected from Table 1 PRMs 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 33, 34, 35, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 74, 75, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115,
  • a detergent that may comprise the same level of the PRMs as disclosed for the aforementioned fabric and hard surface cleaning and/or treatment compositions is disclosed.
  • a detergent that may comprise one or more PRMs selected from Table 1 PRMs 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 33, 34, 35, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 74, 75, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106
  • the PRMs disclosed in Table 1 and stereoisomers thereof are suitable for use, in highly compacted consumer products, including highly compacted fabric and hard surface cleaning and/or treatment compositions, for example highly compacted detergents that may be solids or fluids, at levels, based on total composition weight, of from about 0.00001% to about 25%, from 0.00005% to about 10%, from 0.0001% to about 5%, from 0.0005% to about 1.0%, or even from 0.001% to about 0.5%.
  • Such PRMs and stereoisomers thereof may be used in combination in the aforementioned highly compacted detergent compositions.
  • Such highly compact detergents typically comprise a higher than normal percentage of active ingredients.
  • a highly compacted detergent that may comprise one or more PRMs selected from Table 1 PRMs and stereoisomers of such PRMs is disclosed.
  • highly compacted a detergent that may comprise one or more PRMs selected from Table 1 PRMs 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95,
  • perfume delivery systems Certain perfume delivery systems, methods of making certain perfume delivery systems and the uses of such perfume delivery systems are disclosed in USPA 2007/0275866 A1. Such perfume delivery systems include:
  • PAD Polymer Assisted Delivery
  • This perfume delivery technology uses polymeric materials to deliver perfume materials.
  • Classical coacervation, water soluble or partly soluble to insoluble charged or neutral polymers, liquid crystals, hot melts, hydrogels, perfumed plastics, microcapsules, nano- and micro-latexes, polymeric film formers, and polymeric absorbents, polymeric adsorbents, etc. are some examples.
  • PAD includes but is not limited to:
  • the PRMs disclosed in Table 1 and stereoisomers thereof are suitable for use in perfume delivery systems at levels, based on total perfume delivery system weight, of from 0.001% to about 50%, from 0.005% to 30%, from 0.01% to about 10%, from 0.025% to about 5%, or even from 0.025% to about 1%.
  • the perfume delivery systems disclosed herein are suitable for use in consumer products, cleaning and treatment compositions and fabric and hard surface cleaning and/or treatment compositions, detergents, and highly compacted consumer products, including highly compacted fabric and hard surface cleaning and/or treatment compositions, for example highly compacted detergents that may be solids or fluids, at levels, based on total consumer product weight, from about 0.001% to about 20%, from about 0.01% to about 10%, from about 0.05% to about 5%, from about 0.1% to about 0.5%.
  • the amount of Table 1 PRMs may be from about 0.1% to about 99%, from 25% to about 95%, from 30 to about 90%, from 45% to about 90%, from 65% to about 90%.
  • microcapsules and/or nanocapsules that may comprise one or more PRMs selected from Table 1 PRMs 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108,
  • PRMs 15, 16, 17, 18, 19, 20, 116, 118, 119, 129, 135 and 141 are alcohols.
  • PRMs 28, 29 and 52 are esters.
  • PRMs 34, 73, 74, 75, 76, 77, 91, 101, 106, 109, 121, 124, 130, 132, 136, 138, 139, 143, 148, 152, 157, 158 and 161 are nitriles.
  • the amount of total perfume based on total weight of starch encapsulates and starch agglomerates ranges from 0.1% to about 99%, from 25% to about 95%, from 30 to about 90%, from 45% to about 90%, from 65% to about 90%.
  • the PRMs disclosed in Table 1 and stereoisomers thereof are suitable for use in such starch encapsulates and starch agglomerates. Such PRMs and stereoisomers thereof may be used in combination in such starch encapsulates and starch agglomerates.
  • the amount of total perfume based on total weight of [cyclodextrin-perfume] complexes ranges from 0.1% to about 99%, from 2.5% to about 75%, from 5% to about 60%, from 5% to about 50%, from 5% to about 25%.
  • the PRMs disclosed in Table 1 and stereoisomers thereof are suitable for use in such [cyclodextrin-perfume] complexes. Such PRMs and stereoisomers thereof may be used in combination in such [cyclodextrin-perfume] complexes.
  • the amount of total perfume based on total weight of Polymer Assisted Delivery (PAD) Matrix Systems ranges from 0.1% to about 99%, from 2.5% to about 75%, from 5% to about 60%, from 5% to about 50%, from 5% to about 25%. In one aspect, the amount of total perfume based on total weight of a hot melt perfume delivery system/perfume loaded plastic Matrix System and ranges from 1% to about 99%, from 2.5% to about 75%, from 5% to about 60%, from 5% to about 50%, from 10% to about 50%.
  • the PRMs disclosed in Table 1 and stereoisomers thereof are suitable for use in such Polymer Assisted Delivery (PAD) Matrix Systems, including hot melt perfume delivery system/perfume loaded plastic Matrix Systems.
  • PAD Polymer Assisted Delivery
  • Such PRMs and stereoisomers thereof may be used in combination in such Polymer Assisted Delivery (PAD) Matrix Systems (including hot melt perfume delivery system/perfume loaded plastic Matrix Systems).
  • the amount of total perfume based on total weight of Amine Assisted Delivery (AAD) ranges from 1% to about 99%, from 2.5% to about 75%, from 5% to about 60%, from 5% to about 50%, from 5% to about 25%.
  • the PRMs disclosed in Table 1 and stereoisomers thereof are suitable for use in such Amine Assisted Delivery (AAD) systems. Such PRMs and stereoisomers thereof may be used in combination in such Amine Assisted Delivery (AAD) systems.
  • an Amine Assisted Delivery (AAD) system that may comprise one or more PRMs selected from Table 1 PRMs 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109
  • PRMs 15, 16, 17, 18, 19, 20, 116, 118, 119, 129, 135 and 141 are alcohols.
  • PRMs 34, 73, 74, 75, 76, 77, 91, 101, 106, 109, 121, 124, 130, 132, 136, 138, 139, 143, 148, 152, 157, 158 and 161 are nitriles.
  • a Pro-Perfume (PP) Amine Reaction Product (ARP) system that may comprise one or more PRMs selected from Table 1 PRMs 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 21, 22, 23, 24, 25, 26, 27, 30, 31, 32, 33, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 64, 65, 66, 67, 68, 69, 70, 71, 72, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 92, 93, 94, 95, 96, 97, 98, 99, 100, 102, 103, 104, 105, 107, 108, 110, 111, 112, 113, 114, 115, 117, 120, 122, 123,
  • PRMs are ketones.
  • the amount of total perfume based on total weight of Pro-Perfume (PP) Amine Reaction Product (ARP) system ranges from 0.1% to about 99%, from about 1% to about 99%, from 5% to about 90%, from 10% to about 75%, from 20% to about 75%, from 25% to about 60%.
  • perfume delivery technologies also known as perfume delivery systems that are disclosed in the present specification may be used in any combination in any type of consumer product, cleaning and/or treatment composition, fabric and hard surface cleaning and/or treatment composition, detergent, and highly compact detergent.
  • the PRMs disclosed in Table 1 may be used to formulate perfumes. Such perfumes are combinations of PRMs that may comprise a combination of Table 1 PRMs, or one or Table 1 PRMs and one or more additional PRMs. When used in a perfume, the Table 1 PRMs may used, based on total perfume weight, at levels of from about 0.01% to about 50%, from about 0.1% to about 15%, from about 0.1% to about 10% or even from about 0.5% to about 10%. Such perfumes may be used in multiple applications including being applied neat to a situs or used in a consumer product, cleaning and/or treatment composition, fabric and hard surface cleaning and/or treatment composition, detergent, and/or a highly compact detergent.
  • adjuncts are suitable for use in the instant compositions and may be desirably incorporated in certain embodiments of the invention, for example to assist or enhance performance, for treatment of the substrate to be cleaned, or to modify the aesthetics of the composition as is the case with perfumes, colorants, dyes or the like. It is understood that such adjuncts are in addition to the components that are supplied via Applicants' perfumes and/or perfume systems. The precise nature of these additional components, and levels of incorporation thereof, will depend on the physical form of the composition and the nature of the operation for which it is to be used.
  • Suitable adjunct materials include, but are not limited to, surfactants, builders, chelating agents, dye transfer inhibiting agents, dispersants, enzymes, and enzyme stabilizers, catalytic materials, bleach activators, polymeric dispersing agents, clay soil removal/anti-redeposition agents, brighteners, suds suppressors, dyes, additional perfume and perfume delivery systems, structure elasticizing agents, fabric softeners, carriers, hydrotropes, processing aids and/or pigments.
  • suitable examples of such other adjuncts and levels of use are found in U.S. Pat. Nos. 5,576,282, 6,306,812 B1 and 6,326,348 B1 that are incorporated by reference.
  • adjunct ingredient is not essential to Applicants' compositions.
  • certain embodiments of Applicants' compositions do not contain one or more of the following adjuncts materials: bleach activators, surfactants, builders, chelating agents, dye transfer inhibiting agents, dispersants, enzymes, and enzyme stabilizers, catalytic metal complexes, polymeric dispersing agents, clay and soil removal/anti-redeposition agents, brighteners, suds suppressors, dyes, additional perfumes and perfume delivery systems, structure elasticizing agents, fabric softeners, carriers, hydrotropes, processing aids and/or pigments.
  • one or more adjuncts may be present as detailed below:
  • compositions according to the present invention can comprise a surfactant or surfactant system wherein the surfactant can be selected from nonionic and/or anionic and/or cationic surfactants and/or ampholytic and/or zwitterionic and/or semi-polar nonionic surfactants.
  • the surfactant is typically present at a level of from about 0.1%, from about 1%, or even from about 5% by weight of the cleaning compositions to about 99.9%, to about 80%, to about 35%, or even to about 30% by weight of the cleaning compositions.
  • compositions of the present invention can comprise one or more detergent builders or builder systems. When present, the compositions will typically comprise at least about 1% builder, or from about 5% or 10% to about 80%, 50%, or even 30% by weight, of said builder.
  • Builders include, but are not limited to, the alkali metal, ammonium and alkanolammonium salts of polyphosphates, alkali metal silicates, alkaline earth and alkali metal carbonates, aluminosilicate builders polycarboxylate compounds.
  • ether hydroxypolycarboxylates copolymers of maleic anhydride with ethylene or vinyl methyl ether, 1,3,5-trihydroxybenzene-2,4,6-trisulphonic acid, and carboxymethyl-oxysuccinic acid
  • the various alkali metal, ammonium and substituted ammonium salts of polyacetic acids such as ethylenediamine tetraacetic acid and nitrilotriacetic acid
  • polycarboxylates such as mellitic acid, succinic acid, oxydisuccinic acid, polymaleic acid, benzene 1,3,5-tricarboxylic acid, carboxymethyloxysuccinic acid, and soluble salts thereof.
  • compositions herein may also optionally contain one or more copper, iron and/or manganese chelating agents. If utilized, chelating agents will generally comprise from about 0.1% by weight of the compositions herein to about 15%, or even from about 3.0% to about 15% by weight of the compositions herein.
  • compositions of the present invention may also include one or more dye transfer inhibiting agents.
  • Suitable polymeric dye transfer inhibiting agents include, but are not limited to, polyvinylpyrrolidone polymers, polyamine N-oxide polymers, copolymers of N-vinylpyrrolidone and N-vinylimidazole, polyvinyloxazolidones and polyvinylimidazoles or mixtures thereof.
  • the dye transfer inhibiting agents are present at levels from about 0.0001%, from about 0.01%, from about 0.05% by weight of the cleaning compositions to about 10%, about 2%, or even about 1% by weight of the cleaning compositions.
  • compositions of the present invention can also contain dispersants.
  • Suitable water-soluble organic materials are the homo- or co-polymeric acids or their salts, in which the polycarboxylic acid may comprise at least two carboxyl radicals separated from each other by not more than two carbon atoms.
  • Enzymes The compositions can comprise one or more detergent enzymes which provide cleaning performance and/or fabric care benefits.
  • suitable enzymes include, but are not limited to, hemicellulases, peroxidases, proteases, cellulases, xylanases, lipases, phospholipases, esterases, cutinases, pectinases, keratanases, reductases, oxidases, phenoloxidases, lipoxygenases, ligninases, pullulanases, tannases, pentosanases, malanases, ⁇ -glucanases, arabinosidases, hyaluronidase, chondroitinase, laccase, and amylases, or mixtures thereof.
  • a typical combination is a cocktail of conventional applicable enzymes like protease, lipase, cutinase and/or cellulase in conjunction with amylase.
  • Enzyme Stabilizers Enzymes for use in compositions, for example, detergents can be stabilized by various techniques.
  • the enzymes employed herein can be stabilized by the presence of water-soluble sources of calcium and/or magnesium ions in the finished compositions that provide such ions to the enzymes.
  • compositions may include catalytic metal complexes.
  • One type of metal-containing bleach catalyst is a catalyst system comprising a transition metal cation of defined bleach catalytic activity, such as copper, iron, titanium, ruthenium, tungsten, molybdenum, or manganese cations, an auxiliary metal cation having little or no bleach catalytic activity, such as zinc or aluminum cations, and a sequestrate having defined stability constants for the catalytic and auxiliary metal cations, particularly ethylenediaminetetraacetic acid, ethylenediaminetetra (methyl-enephosphonic acid) and water-soluble salts thereof.
  • a transition metal cation of defined bleach catalytic activity such as copper, iron, titanium, ruthenium, tungsten, molybdenum, or manganese cations
  • an auxiliary metal cation having little or no bleach catalytic activity, such as zinc or aluminum cations
  • a sequestrate having defined stability constants for the catalytic and
  • compositions herein can be catalyzed by means of a manganese compound.
  • a manganese compound Such compounds and levels of use are well known in the art and include, for example, the manganese-based catalysts disclosed in U.S. Pat. No. 5,576,282.
  • Cobalt bleach catalysts useful herein are known, and are described, for example, in U.S. Pat. Nos. 5,597,936 and 5,595,967. Such cobalt catalysts are readily prepared by known procedures, such as taught for example in U.S. Pat. Nos. 5,597,936, and 5,595,967.
  • compositions herein may also suitably include a transition metal complex of a macropolycyclic rigid ligand—abbreviated as “MRL”.
  • MRL macropolycyclic rigid ligand
  • the compositions and cleaning processes herein can be adjusted to provide on the order of at least one part per hundred million of the benefit agent MRL species in the aqueous washing medium, and may provide from about 0.005 ppm to about 25 ppm, from about 0.05 ppm to about 10 ppm, or even from about 0.1 ppm to about 5 ppm, of the MRL in the wash liquor.
  • Suitable transition-metals in the instant transition-metal bleach catalyst include manganese, iron and chromium.
  • Suitable MRL's herein are a special type of ultra-rigid ligand that is cross-bridged such as 5,12-diethyl-1,5,8,12-tetraazabicyclo[6.6.2]hexa-decane.
  • Suitable transition metal MRLs are readily prepared by known procedures, such as taught for example in WO 00/32601, and U.S. Pat. No. 6,225,464.
  • Certain of the consumer products disclosed herein can be used to clean or treat a situs inter alia a surface or fabric.
  • a situs is contacted with an embodiment of Applicants' composition, in neat form or diluted in a liquor, for example, a wash liquor and then the situs may be optionally washed and/or rinsed.
  • a situs is optionally washed and/or rinsed, contacted with a particle according to the present invention or composition comprising said particle and then optionally washed and/or rinsed.
  • washing includes but is not limited to, scrubbing, and mechanical agitation.
  • the fabric may comprise most any fabric capable of being laundered or treated in normal consumer use conditions.
  • Liquors that may comprise the disclosed compositions may have a pH of from about 3 to about 11.5. Such compositions are typically employed at concentrations of from about 500 ppm to about 15,000 ppm in solution.
  • the wash solvent is water
  • the water temperature typically ranges from about 5° C. to about 90° C. and, when the situs comprises a fabric, the water to fabric ratio is typically from about 1:1 to about 30:1.
  • the silica was washed with methyl tert-butyl ether (MTBE; 2*3 mL). The combined organic fractions were mixed with 25 mL of 0.5 M HCl and extracted with MTBE (2*5 mL) and washed with saturated aqueous NaHCO 3 (5 mL) and brine (5 mL). The crude oil was obtained after drying over MgSO 4 , filtration and concentration. Additional flash chromatography was performed to obtain the compound in high purity, with a Biotage PS1: TLC-based method calculated from solvent conditions 80:20-mixture petroleum ether/Ethyl Acetate.
  • Step 2 exemplified for a 24 mmolar scale:
  • the crude oil was obtained after drying over MgSO 4 , filtration and concentration. Then, the crude oil was dissolved again in Et 2 O and kept in the freezer for 16 hours. The white precipitate was filtered of and the filtrate was concentrated. The pure compound was obtained after flash chromatography, performed with a Biotage PS 1: TLC-based method calculated from solvent conditions 9:1-mixture petroleum ether/Ethyl Acetate.
  • the organic layer was extracted with diethyl ether (Et 2 O; 2*15 mL) and washed with aqueous saturated NaHCO 3 (10 mL) and brine (10 mL).
  • the crude oil was obtained after drying over MgSO 4 , filtration and concentration. Then, the crude oil was dissolved again in Et 2 O and kept in the freezer for 16 hours. The white precipitate was filtered of and the filtrate was concentrated at the rotavap.
  • the pure compound was obtained after flash chromatography, performed with a Biotage PS 1: TLC-based method calculated from solvent conditions 85:15-mixture petroleum ether/Ethyl Acetate.
  • R 1 Scale time [h] 22 Me 15 mmol 0° C. rt, 72 h 23 Et 10 mmol 0° C. rt, 16 h 24 i-Pr 10 mmol 0° C. rt, 72 h 26 Allyl 20 mmol 0° C. rt, 16 h 25 n-Pr 1 mmol 0° C. rt, 16 h 21 n-Am 1 mmol 0° C. rt, 16 h 27 t-Bu 20 mmol 0° C. rt, 48 h 1 Flash Chromatography was performed with a Biotage PS1: TLC-based method calculated from solvent conditions 85:15-mixture petroleum ether/Ethyl Acetate.
  • a 2-L flask, dropping funnel, stifling bar and septum were dried in the oven at 80° C. and 20 mbar for 24 h.
  • the glassware was cooled to room temperature under nitrogen atmosphere, before 152 gram of aluminium trichloride (AlCl 3 ; 1.2 equiv) was dissolved in 300 mL of anhydrous benzene.
  • 140 gram of cyclopentylacetyl chloride (1 equiv) were added drop wise and very slowly over a 2 h period to this reaction mixture while the temperature was controlled below 40° C. by the rate of addition of the acid chloride.
  • the reaction start and progress were followed by the gas evolvement.
  • the reaction mixture was continued at 45° C. for 16 h.
  • the reaction mixture was quenched by adding it to a large quantity of crushed ice (1.5 kg). 1 Liter of demineralised water was added, while controlling the temperature with ice. A white suspension was formed.
  • the glassware was washed with 100 mL of methyl tent-butyl ether (MTBE) and the combined organic layers were filtered and extracted with MTBE (2*100 mL). Then the organic layers were washed with aqueous NaHCO 3 solution and brine.
  • the organic fractions were collected, dried over Na 2 SO 4 , filtered and dried in vacuo (70° C. at 15 mbar) to afford a red oil. This oil was mixed with 10 w % of active carbon and stirred at room temperature for 16 h. Then the mixture was filtered over a short Celite path and the glassware and filter were rinsed with 100 mL of ligroin. The organic fractions were combined and dried at the rotavap, affording a yellow oil.
  • MTBE methyl tent-but
  • Biotage 1 chloride rt, 16 h (15 mmol) 9 Cyclopentylacetyl mesitylene 0° C. Biotage 1 chloride rt, 16 h (15 mmol) 1 Flash Chromatography was performed with a Biotage PS1: TLC-based method calculated from solvent conditions 95:5-mixture petroleum ether/Ethyl Acetate.
  • the organic phase was extracted with aqueous saturated bicarbonate (4*750 mL). Each time, the aqueous phase was washed with toluene (2*100 mL). After this washing, all the organic phases were combined and washed once more with aqueous saturated bicarbonate (750 mL) and with brine (3*250 mL).
  • reaction mixture was quenched in demineralised water with 5 ice cubes in it. A white suspension was formed (exothermic; additional ice cubes were added).
  • the glassware was washed with 25 mL of Et 2 O and the combined organic layers were filtered and extracted with ether (2*20 mL). Then the organic layers were treated with 2*25 mL of aqueous NaHCO 3 solution and this aqueous layer was extracted again with diethyl ether (2*10 mL). Then, the organic fractions were collected, dried over Na 2 SO 4 , filtered and dried in vacuum (low pressure; high temperature resulting in a dark oil formed. The compound was placed in the fridge and solidified after some time. It was tried to purify the ketone via re-crystallisation. First it was dissolved in the minimal amount of Et 2 O. Upon cooling it solidified after a few hours. This procedure was repeated two times resulting in colourless crystals.
  • Compound 52 was synthesized starting from 20 mmol 4,4-dimethyl-3-oxopentanoate.
  • the ⁇ -keto-ester (1 eq.) formed in step 1 was solved in MTBE (0.6 M) and sodium t-butoxide (1.1 eq.) and prenyl bromide (1.5 eq.) were added at room temperature. The resulting mixture was stirred for 16 hours at the same temperature and quenched with an aqueous H 2 SO 4 solution (0.5 M). After extracting the mixture with MTBE, the collected organic layers were dried over MgSO 4 and concentrated under reduced pressure. The resulting oil was purified by column chromatography using a petroleum ether-MTBE mixture (95-5) as eluens. Concentration of the eluent under reduced pressure resulted in the compound as a colorless oil.
  • Compound 53 was synthesized starting from 45 mmol 3,3-dimethyl-2-butanone.
  • Compound 63 was synthesized starting from 15 mmol lavandulol.
  • the reaction was quenched with a H 2 SO 4 solution (2M—2 eq.) and stirred at ambient temperature till full hydrolysis of the in situ formed imine was observed.
  • the mixture was then extracted with Et 2 O and washed with a saturated NaHCO 3 aqueous solution.
  • the combined organic phases were dried over MgSO 4 and concentrated under reduced pressure.
  • the resulting oil was purified using a quick filtration over silica gel by eluting with a petroleum ether—Et 2 O mixture (9-1). Concentration of the eluent under reduced pressure resulted in the compound as a colorless oil.
  • the Weinreb amide formed in step 2 was solved in dry THF (0.5 M) and cooled to ⁇ 15° C. A solution of EtMgBr (1 M—1.5 eq.) was added drop wise to the mixture. Complete reaction conversion was observed with GC-MS after 10 minutes stirring at ⁇ 10/ ⁇ 15° C. This reaction mixture was quenched with a saturated aqueous NH 4 Cl solution, extracted with Et 2 O; dried over MgSO 4 and concentrated under reduced pressure. The resulting oil was purified using a quick filtration over silica gel by eluting with a petroleum ether—Et 2 O mixture (9-1). Concentration under reduced pressure resulted in the compound as a colorless oil.
  • Compound 101 was synthesized starting from 100 mmol nitrile [2947-60-6].
  • Compound 125 was synthesized starting from 11 mmol iso-butyronitrile.
  • step 1 The nitrile formed in step 1 was solved in dry THF (0.5 M) and cooled to ⁇ 20° C. A solution of methyllithium (1.3 eq.—1.6 M) was added drop wise. Reaction completion was observed after 10 minutes stifling at ⁇ 20° C. The reaction was quenched with a H 2 SO 4 solution (2M—2 eq.) and stirred at ambient temperature till full hydrolysis of the in situ formed imine was observed (over night ambient temperature). The mixture was then extracted with Et 2 O and washed with a saturated NaHCO 3 aqueous solution. The combined organic phases were dried over MgSO 4 and concentrated under reduced pressure. The resulting oil was purified using a quick filtration over silica gel by eluting with a petroleum ether-Et 2 O mixture (9-1). Concentration of the eluent under reduced pressure resulted in the compound as a colorless oil.
  • Compound 140 was synthesized starting from 24 mmol acid [6120-95-2].
  • the Weinreb amide formed in step 2 was solved in dry THF (0.5 M) and cooled to ⁇ 15° C. A solution of EtMgBr (1 M—1.5 eq.) was added drop wise to the mixture. Complete reaction conversion was observed with GC-MS after 10 minutes stirring at ⁇ 10/ ⁇ 15° C. This reaction mixture was quenched with a saturated aqueous NH 4 Cl solution, extracted with Et 2 O; dried over MgSO 4 and concentrated under reduced pressure. The resulting oil was purified using a quick filtration over silica gel by eluting with a petroleum ether-Et 2 O mixture (9-1). Concentration under reduced pressure resulted in the compound as a colorless oil.
  • Lupasol WF 50% of Lupasol WF (CAS# 09002-98-6) from BASF, is put at 60° C. in warm water bath for 1 hour before use. Mixing of the two ingredients was done by using the Ultra-Turrax T25 Basic equipment (from IKA) during 5 minutes. When the mixing is finished the sample is put in a warm water bath at 60° C. for ⁇ 12 hours. A homogenous, viscous material is obtained. In the same way as described above different ratios between the components can be used:
  • butyl acrylate-acrylic acid copolymer emulsifier (Colloid C351, 25% solids, pka 4.5-4.7, (Kemira Chemicals, Inc. Kennesaw, Georgia U.S.A.) is dissolved and mixed in 200 grams deionized water. The pH of the solution is adjusted to pH of 4.0 with sodium hydroxide solution. 8 grams of partially methylated methylol melamine resin (Cymel 385, 80% solids, (Cytec Industries West Paterson, N.J., U.S.A.)) is added to the emulsifier solution. 200 grams of perfume oil comprising one or more Table 1 PRMs is added to the previous mixture under mechanical agitation and the temperature is raised to 50° C.
  • perfume oil comprising one or more Table 1 PRMs is added to the previous mixture under mechanical agitation and the temperature is raised to 50° C.
  • the second solution and 4 grams of sodium sulfate salt are added to the emulsion.
  • This second solution contains 10 grams of butyl acrylate-acrylic acid copolymer emulsifier (Colloid C351, 25% solids, pka 4.5-4.7, Kemira), 120 grams of distilled water, sodium hydroxide solution to adjust pH to 4.8, 25 grams of partially methylated methylol melamine resin (Cymel 385, 80% solids, Cytec). This mixture is heated to 70° C. and maintained overnight with continuous stirring to complete the encapsulation process. 23 grams of acetoacetamide (Sigma-Aldrich, Saint Louis, Mo., U.S.A.) is added to the suspension. An average capsule size of 30 um is obtained as analyzed by a Model 780 Accusizer.
  • a mixture comprising 50% of a perfume composition comprising one or more Table 1 PRMs, 40% of carboxyl-terminated Hycar®1300 ⁇ 18 (CAS#0068891-50-9) from Noveon, (put at 60° C. in warm water bath for 1 hour before mixing) and 10% of Lupasol® WF(CAS# 09002-98-6) from BASF (put at 60° C. in warm water bath for 1 hour before mixing).
  • Mixing is achieved by mixing for five minutes using a Ultra-Turrax T25 Basic equipment (from IKA). After mixing, the mixture is put in a warm water bath at 60° C. for ⁇ 12 hours. A homogenous, viscous and sticky material is obtained.
  • Weight % Perfume composition 40 50 60 70 80 Lupasol ® WF 12 10 8 6 4 Hycar ® 48 40 32 24 16 CTBN1300X18 Perfume composition 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 50 Lupasol ® WF 2.5 5 7.5 10 12.5 15 17.5 20 Hycar ® CTBN 47.5 45 42.5 40 37.5 35 32.5 30 1300X18
  • Non-limiting examples of product formulations containing PRMs disclosed in the present specification perfume and amines summarized in the following table.
  • Methyl bis(tallow amidoethyl)2-hydroxyethyl ammonium methyl sulfate b Methyl bis(tallow amidoethyl)2-hydroxyethyl ammonium methyl sulfate.
  • c Reaction product of Fatty acid with Methyldiethanolamine in a molar ratio 1.5:1, quaternized with Methylchloride, resulting in a 1:1 molar mixture of N,N-bis(stearoyl-oxy-ethyl) N,N-dimethyl ammonium chloride and N-(stearoyl-oxy-ethyl) N,-hydroxyethyl N,N dimethyl ammonium chloride.
  • d Cationic high amylose maize starch available from National Starch under the trade name CATO ®.
  • e Perfume comprising one or more Table 1 PRMs.
  • f Copolymer of ethylene oxide and terephthalate having the formula described in U.S. Pat. No. 5,574,179 at col.15, lines 1-5, wherein each X is methyl, each n is 40, u is 4, each R1 is essentially 1,4-phenylene moieties, each R2 is essentially ethylene, 1,2-propylene moieties, or mixtures thereof.
  • i KATHON ® CG available from Rohm and Haas Co.
  • PPM is “parts per million.”
  • j Gluteraldehyde k Silicone antifoam agent available from Dow Corning Corp. under the trade name DC2310.
  • l Hydrophobically-modified ethoxylated urethane available from Rohm and Haas under the tradename Aculan 44. *One or more materials comprising an amine moiety as disclosed in the present specification. ⁇ balance
  • HDLs Liquid Laundry Formulations

Abstract

The present application relates to perfume raw materials, perfume delivery systems and consumer products comprising such perfume raw materials and/or such perfume delivery systems, as well as processes for making and using such perfume raw materials, perfume delivery systems and consumer products. Such perfume raw materials and compositions, including the delivery systems, disclosed herein expand the perfume communities options as such perfume raw materials can provide variations on character and such compositions can provide desired odor profiles.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application claims priority under 35 U.S.C. §119(e) to U.S. Provisional Application Ser. No. 61/118,720 filed Dec. 1, 2008.
    • FIELD OF INVENTION
  • The present application relates to perfume raw materials, perfume delivery systems and consumer products comprising such perfume raw materials and/or such perfume delivery systems, as well as processes for making and using such perfume raw materials, perfume delivery systems and consumer products.
    • BACKGROUND OF THE INVENTION
  • Consumer products may comprise one or more perfumes and/or perfume delivery systems that can provide a desired scent to such product and/or a situs that is contacted with such a product and/or mask an undesirable odor. While current perfumes and perfume delivery systems provide desirable odors, consumers continue to seek products that have scents that may be longer lasting and that are tailored to their individual desires (see for example USPA 2007/0275866 A1 and U.S. patent application Ser. No. 12/133,866)—unfortunately the pool of perfume raw materials and perfume delivery systems that is available is still too limited to completely meet the perfume community's needs. Thus, perfumers need an ever larger pool of perfume raw materials and perfume delivery systems.
  • Applicants believe that the perfume raw materials and compositions, including the delivery systems, disclosed herein expand the perfume community's options, as such perfume raw materials can provide variations on character and such compositions can provide desired odor profiles.
    • SUMMARY OF THE INVENTION
  • The present application relates to perfume raw materials, perfume systems and consumer products comprising such perfume raw materials and/or such perfume systems, as well as processes for making and using such perfume raw materials, perfume systems and consumer products.
    • DETAILED DESCRIPTION OF THE INVENTION Definitions
  • As used herein “consumer product” means baby care, beauty care, fabric & home care, family care, feminine care, health care, snack and/or beverage products or devices generally intended to be used or consumed in the form in which it is sold. Such products include but are not limited to diapers, bibs, wipes; products for and/or methods relating to treating hair (human, dog, and/or cat), including, bleaching, coloring, dyeing, conditioning, shampooing, styling; deodorants and antiperspirants; personal cleansing; cosmetics; skin care including application of creams, lotions, and other topically applied products for consumer use including fine fragrances; and shaving products, products for and/or methods relating to treating fabrics, hard surfaces and any other surfaces in the area of fabric and home care, including: air care including air fresheners and scent delivery systems, car care, dishwashing, fabric conditioning (including softening and/or freshing), laundry detergency, laundry and rinse additive and/or care, hard surface cleaning and/or treatment including floor and toilet bowl cleaners, and other cleaning for consumer or institutional use; products and/or methods relating to bath tissue, facial tissue, paper handkerchiefs, and/or paper towels; tampons, feminine napkins; products and/or methods relating to oral care including toothpastes, tooth gels, tooth rinses, denture adhesives, tooth whitening; over-the-counter health care including cough and cold remedies, pain relievers, RX pharmaceuticals, pet health and nutrition; processed food products intended primarily for consumption between customary meals or as a meal accompaniment (non-limiting examples include potato chips, tortilla chips, popcorn, pretzels, corn chips, cereal bars, vegetable chips or crisps, snack mixes, party mixes, multigrain chips, snack crackers, cheese snacks, pork rinds, corn snacks, pellet snacks, extruded snacks and bagel chips); and coffee.
  • As used herein, the term “cleaning and/or treatment composition” is a subset of consumer products that includes, unless otherwise indicated, beauty care, fabric & home care products. Such products include, but are not limited to, products for treating hair (human, dog, and/or cat), including, bleaching, coloring, dyeing, conditioning, shampooing, styling; deodorants and antiperspirants; personal cleansing; cosmetics; skin care including application of creams, lotions, and other topically applied products for consumer use including fine fragrances; and shaving products, products for treating fabrics, hard surfaces and any other surfaces in the area of fabric and home care, including: air care including air fresheners and scent delivery systems, car care, dishwashing, fabric conditioning (including softening and/or freshing), laundry detergency, laundry and rinse additive and/or care, hard surface cleaning and/or treatment including floor and toilet bowl cleaners, granular or powder-form all-purpose or “heavy-duty” washing agents, especially cleaning detergents; liquid, gel or paste-form all-purpose washing agents, especially the so-called heavy-duty liquid types; liquid fine-fabric detergents; hand dishwashing agents or light duty dishwashing agents, especially those of the high-foaming type; machine dishwashing agents, including the various tablet, granular, liquid and rinse-aid types for household and institutional use; liquid cleaning and disinfecting agents, including antibacterial hand-wash types, cleaning bars, mouthwashes, denture cleaners, dentifrice, car or carpet shampoos, bathroom cleaners including toilet bowl cleaners; hair shampoos and hair-rinses; shower gels, fine fragrances and foam baths and metal cleaners; as well as cleaning auxiliaries such as bleach additives and “stain-stick” or pre-treat types, substrate-laden products such as dryer added sheets, dry and wetted wipes and pads, nonwoven substrates, and sponges; as well as sprays and mists all for consumer or/and institutional use; and/or methods relating to oral care including toothpastes, tooth gels, tooth rinses, denture adhesives, tooth whitening.
  • As used herein, the term “fabric and/or hard surface cleaning and/or treatment composition” is a subset of cleaning and treatment compositions that includes, unless otherwise indicated, granular or powder-form all-purpose or “heavy-duty” washing agents, especially cleaning detergents; liquid, gel or paste-form all-purpose washing agents, especially the so-called heavy-duty liquid types; liquid fine-fabric detergents; hand dishwashing agents or light duty dishwashing agents, especially those of the high-foaming type; machine dishwashing agents, including the various tablet, granular, liquid and rinse-aid types for household and institutional use; liquid cleaning and disinfecting agents, including antibacterial hand-wash types, cleaning bars, car or carpet shampoos, bathroom cleaners including toilet bowl cleaners; and metal cleaners, fabric conditioning products including softening and/or freshing that may be in liquid, solid and/or dryer sheet form; as well as cleaning auxiliaries such as bleach additives and “stain-stick” or pre-treat types, substrate-laden products such as dryer added sheets, dry and wetted wipes and pads, nonwoven substrates, and sponges; as well as sprays and mists. All of such products which were applicable may be in standard, concentrated or even highly concentrated form even to the extent that such products may in certain aspect be non-aqueous.
  • As used herein, articles such as “a” and “an” when used in a claim, are understood to mean one or more of what is claimed or described.
  • As used herein, the terms “include”, “includes” and “including” are meant to be non-limiting.
  • As used herein, the term “solid” includes granular, powder, bar and tablet product forms.
  • As used herein, the term “fluid” includes liquid, gel, paste and gas product forms.
  • As used herein, the term “situs” includes paper products, fabrics, garments, hard surfaces, hair and skin.
  • Unless otherwise noted, all component or composition levels are in reference to the active portion of that component or composition, and are exclusive of impurities, for example, residual solvents or by-products, which may be present in commercially available sources of such components or compositions.
  • All percentages and ratios are calculated by weight unless otherwise indicated. All percentages and ratios are calculated based on the total composition unless otherwise indicated.
  • It should be understood that every maximum numerical limitation given throughout this specification includes every lower numerical limitation, as if such lower numerical limitations were expressly written herein. Every minimum numerical limitation given throughout this specification will include every higher numerical limitation, as if such higher numerical limitations were expressly written herein. Every numerical range given throughout this specification will include every narrower numerical range that falls within such broader numerical range, as if such narrower numerical ranges were all expressly written herein.
  • Suitable Perfume Raw Materials (herein after “PRMs”)
  • Suitable PRMs include the PRMs listed in Table 1 below and stereoisomers thereof.
  • Chemical structure IUPAC Names Molecules Characteristics
     1
    Figure US20100137178A1-20100603-C00001
         		2-cyclohexyl-1-phenylethanone Honey, pineapple, fruity, powerful (lingers)
     2
    Figure US20100137178A1-20100603-C00002
         		2-methyl-4-phenyloctan-3-one Spicy, Celery, green, basil
     3
    Figure US20100137178A1-20100603-C00003
         		2,5-dimethyl-4-phenylhexan-3-one Honey, tea, aromatic, hay
     4
    Figure US20100137178A1-20100603-C00004
         		2-methyl-4-phenylhexan-3-one Rose, fruity
     5
    Figure US20100137178A1-20100603-C00005
         		2-cyclohexyl-1-(4- methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone Floral, petrol/rubbery (styrene)
     6
    Figure US20100137178A1-20100603-C00006
         		2-cycloheptyl-1-phenylethanone Almond, sweet, anisic, spicy
     7
    Figure US20100137178A1-20100603-C00007
         		2-cyclopentyl-1-p-tolylethanone sweet, fruity (almond), floral (rose - geranium)
     8
    Figure US20100137178A1-20100603-C00008
         		2-cyclopentyl-1-(4- ethylphenyl)ethanone musty, cheesy
     9
    Figure US20100137178A1-20100603-C00009
         		2-cyclopentyl-1-(2,4,6- trimethylphenyl)ethanone clean nice character
    10
    Figure US20100137178A1-20100603-C00010
         		2-cyclopentyl-1-phenylethanone cheesy, rose, floral, fruity ester, pineapple, acidic
    11
    Figure US20100137178A1-20100603-C00011
         		3-cyclohexyl-1-phenylpropan-1-one Almond, floral, fruity (apple)
    12
    Figure US20100137178A1-20100603-C00012
         		3-cyclohexyl-1-(4- ethylphenyl)propan-1-one Animalic, Metallic
    13
    Figure US20100137178A1-20100603-C00013
         		3-cyclohexyl-1-(4- methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one jasmin, ylang, animalic note
    14
    Figure US20100137178A1-20100603-C00014
         		3-cyclohexyl-1-(2,4,6- trimethylphenyl)propan-1-one floral (muguet), green, fresh, sweet
    15
    Figure US20100137178A1-20100603-C00015
         		4-(4-methylcyclohex-3-enyl)pentan- 2-ol Green, citrus, hay, cut grass
    16
    Figure US20100137178A1-20100603-C00016
         		5-(4-methylcyclohex-3-enyl)hexan- 3-ol Citrus, aldehydic, floral, muguet, unique in character
    17
    Figure US20100137178A1-20100603-C00017
         		2-methyl-4-(4-methylcyclohex-3- enyl)pentan-2-ol Citrus, root, camphor
    18
    Figure US20100137178A1-20100603-C00018
         		6-(4-methylcyclohex-3-enyl)hept-1- en-4-ol Geranium, floral
    19
    Figure US20100137178A1-20100603-C00019
         		2-methyl-5-(4-methylcyclohex-3- enyl)hexan-3-ol Aldehydic, citrus, spicy
    20
    Figure US20100137178A1-20100603-C00020
         		2,2-dimethyl-5-(4-methylcyclohex-3- enyl)hexan-3-ol Fruity (apple), diffusive, floral
    21
    Figure US20100137178A1-20100603-C00021
         		2-(4-methylcyclohex-3-enyl)nonan-4- one Woody, cedar
    22
    Figure US20100137178A1-20100603-C00022
         		4-(4-methylcyclohex-3-enyl)pentan- 2-one Fruity, Vertenex (woody), sour note, acrylic, very diffusive
    23
    Figure US20100137178A1-20100603-C00023
         		5-(4-methylcyclohex-3-enyl)hexan-3- one Smokey, oily/buttery, ozonic, sour
    24
    Figure US20100137178A1-20100603-C00024
         		2-methyl-5-(4-methylcyclohex-3- enyl)hexan-3-one Jasmin, lactonic, floral
    25
    Figure US20100137178A1-20100603-C00025
         		2-(4-methylcyclohex-3-enyl)heptan- 4-one Floral, lactonic
    26
    Figure US20100137178A1-20100603-C00026
         		6-(4-methylcyclohex-3-enyl)hept-1- en-4-one Fatty, aldehydic, frutene
    27
    Figure US20100137178A1-20100603-C00027
         		2,2-dimethyl-5-(4-methylcyclohex-3- enyl)hexan-3-one Herbal, Tea, Terpentine
    28
    Figure US20100137178A1-20100603-C00028
         		2,2-dimethyl-5-(4-methylcyclohex-3- enyl)hexan-3-yl acetate Floral, fruity
    29
    Figure US20100137178A1-20100603-C00029
         		5-(4-methylcyclohex-3-enyl)hexan-3- yl acetate Fruity, Cassis
    30
    Figure US20100137178A1-20100603-C00030
         		3-methyl-4-phenylbut-3-en-2-one floral (rose), citrus, nitrilic, very diffusive
    31
    Figure US20100137178A1-20100603-C00031
         		4-(4-methylphenyl)butan-2-one, 4-p-tolylbutan-2-one Floral, Sweet, Anisic
    32
    Figure US20100137178A1-20100603-C00032
         		1-(3-methylphenyl)pent-1-en-3-one 1-m-tolylpent-1-en-3-one Chlorinated (bleach), honey, almond
    33
    Figure US20100137178A1-20100603-C00033
         		3-methyl-4-(4-methylphenyl)but-3- en-2-one 3-methyl-4-p-tolylbut-3-en-2-one buttery
    34
    Figure US20100137178A1-20100603-C00034
         		4-(2-methyl-3-oxobut-1- enyl)benzonitrile Sweet (honey), fruity
    35
    Figure US20100137178A1-20100603-C00035
         		1-phenylhex-1-en-3-one Almond, sweet, candy
    36
    Figure US20100137178A1-20100603-C00036
         		1-(2-methylphenyl)pent-1-en-3-one 1-o-tolylpent-1-en-3-one Floral, fruity, almond, saffron, anisic, diffusive
    37
    Figure US20100137178A1-20100603-C00037
         		3-methyl-4-(2-methylphenyl)but-3- en-2-one 3-methyl-4-o-tolylbut-3-en-2-one rose, buttery, ionone
    38
    Figure US20100137178A1-20100603-C00038
         		3-methyl-4-(3-methylphenyl)but-3- en-2-one 3-methyl-4-m-tolylbut-3-en-2-one nice, sweet, caramel, nutty
    39
    Figure US20100137178A1-20100603-C00039
         		4-(4-methoxyphenyl)-3-methylbut-3- en-2-one sweet, burnt caramel
    40
    Figure US20100137178A1-20100603-C00040
         		3-(4-methylbenzylidene)pentan-2-one floral, mimosa
    41
    Figure US20100137178A1-20100603-C00041
         		1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one Sweet, anisic, almond
    42
    Figure US20100137178A1-20100603-C00042
         		1-(2,4,6-trimethylphenyl)hex-1-en-3- one Spicy, violet, rosy
    43
    Figure US20100137178A1-20100603-C00043
         		1-(2,4,6-trimethylphenyl)pent-1-en-3- one Saffron, floral, animalic
    44
    Figure US20100137178A1-20100603-C00044
         		3-methyl-4-(2,4,6- trimethylphenyl)but-3-en-2-one Aromatic, herbal, anisic
    45
    Figure US20100137178A1-20100603-C00045
         		1-(2,6-dimethylphenyl)hex-1-en-3- one Floral, violet
    46
    Figure US20100137178A1-20100603-C00046
         		1-(2,6-dimethylphenyl)pent-1-en-3- one Spicy, floral, saffron
    47
    Figure US20100137178A1-20100603-C00047
         		1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one Sweet, fruity, almond
    48
    Figure US20100137178A1-20100603-C00048
         		1-cyclohexyl-2-phenylpropan-1-one Glue, rose, fruity
    49
    Figure US20100137178A1-20100603-C00049
         		2,2,4,7-tetramethyloct-6-en-3-one citrus, herbal (lavender ketone hint)
    50
    Figure US20100137178A1-20100603-C00050
         		2,4(R,S),7-trimethyloct-6-en-3-one grapefruit, green
    51
    Figure US20100137178A1-20100603-C00051
         		2,2,4,4,7-pentamethyloct-6-en-3-one lime, spicy, herbal, diffusive, citrus, citronella,
    52
    Figure US20100137178A1-20100603-C00052
         		Ethyl 2(R,S),5-dimethyl-2- (pivaloyl)hex-4-enoate
    53
    Figure US20100137178A1-20100603-C00053
         		2,2,7-Trimethyl-4-(3-methylbut-2- enyl)oct-6-en-3-one
    54
    Figure US20100137178A1-20100603-C00054
         		1-(1-(3-methylbut-2- enyl)cyclohexyl)ethanone rose, citrus, grapefruit
    55
    Figure US20100137178A1-20100603-C00055
         		1-(1-(3-methylbut-2- enyl)cyclohexyl)propan-1-one chemical
    56
    Figure US20100137178A1-20100603-C00056
         		2-methyl-1-(1-(3-methylbut-2- enyl)cyclohexyl)propan-1-one weak (gun powder)
    57
    Figure US20100137178A1-20100603-C00057
         		4,4,7-trimethyloct-6-en-3-one rosey - geranium, grapefruit
    58
    Figure US20100137178A1-20100603-C00058
         		1-(1-(3-methylbut-2- enyl)cyclopentyl)ethanone Grapefruit
    59
    Figure US20100137178A1-20100603-C00059
         		1-(1-(3-methylbut-2- enyl)cyclopentyl)propan-1-one rose, fruity
    60
    Figure US20100137178A1-20100603-C00060
         		3,6-dimethyl-3-(3-methylbut-2- enyl)hept-5-en-2-one Rose
    61
    Figure US20100137178A1-20100603-C00061
         		3(R,S),6-dimethylhept-5-en-2-one
    62
    Figure US20100137178A1-20100603-C00062
         		1-(1-(3-hydroxy-3- methylbutyl)cyclohexyl)-2- methylpropan-1-one chemical, acid
    63
    Figure US20100137178A1-20100603-C00063
         		5-methyl-2(R,S)-(prop-1-en-2-yl)- hex-4-enoic acid
    64
    Figure US20100137178A1-20100603-C00064
         		2-methyl-1-(1-(3-methylbut-2- enyl)cyclopentyl)propan-1-one fruity, chemical
    65
    Figure US20100137178A1-20100603-C00065
         		4,7-dimethyl-4-(3-methylbut-2- enyl)oct-6-en-3-one Rose
    66
    Figure US20100137178A1-20100603-C00066
         		2,4,7-trimethyl-4-(3-methylbut-2- enyl)oct-6-en-3-one Bleach
    67
    Figure US20100137178A1-20100603-C00067
         		3(R,S),5,5,8-tetramethylnon-7-en-4- one fruity, grapefruit
    68
    Figure US20100137178A1-20100603-C00068
         		1-(1-(3-methylbut-2- enyl)cyclopropyl)ethanone Fruity, ethereal
    69
    Figure US20100137178A1-20100603-C00069
         		2-methyl-1-(1-(3-(R,S )-methylbut-2- enyl)cyclopropyl)butan-1-one fruity (grapefruit-plum)
    70
    Figure US20100137178A1-20100603-C00070
         		2-methyl-1-(1-(3-methylbut-2- enyl)cyclopropyl)propan-1-one citrus, grapefruit
    71
    Figure US20100137178A1-20100603-C00071
         		1-(1-(3-methylbut-2- enyl)cyclopropyl)pentan-1-one fruity - spicy (garpaccio) - metallic
    72
    Figure US20100137178A1-20100603-C00072
         		9-methyldec-8-en-3 one waxy, fruity, clean (→ green, violet)
    73
    Figure US20100137178A1-20100603-C00073
         		2,5-dimethyl-2-(3-methylbut-2- enyl)hex-4-enenitrile geranium, rose, terpenic
    74
    Figure US20100137178A1-20100603-C00074
         		1-(3-methylbut-2- enyl)cyclopentanecarbonitrile spicy, nutty, rubbery
    75
    Figure US20100137178A1-20100603-C00075
         		1-(3-methylbut-2- enyl)cyclohexanecarbonitrile herbal - aromatic, floral-green
    76
    Figure US20100137178A1-20100603-C00076
         		1-(3-methylbut-2- enyl)cyclopropanecarbonitrile minty, nutty
    77
    Figure US20100137178A1-20100603-C00077
         		1-(3-methylbut-2- enyl)cyclobutanecarbonitrile celery, diffusive
    78
    Figure US20100137178A1-20100603-C00078
         		2-methyl-1-(1-(3-(R,S )-methylbut-2- enyl)cyclobutyl)butan-1-one fruity, herbal (menthol)
    79
    Figure US20100137178A1-20100603-C00079
         		1-(1-(3-methylbut-2- enyl)cyclobutyl)ethanone citrus, aromatic, diffusive
    80
    Figure US20100137178A1-20100603-C00080
         		2-(R,S)-methyl-1-(1- phenylcyclopropyl)butan-1-one woody, earthy
    81
    Figure US20100137178A1-20100603-C00081
         		1-(1-(3-methylbut-2- enyl)cyclobutyl)pentan-1-one Spearmint
    82
    Figure US20100137178A1-20100603-C00082
         		2-methyl-1-(1-(3-methylbut-2- enyl)cyclobutyl)propan-1-one pine, terpenic
    83
    Figure US20100137178A1-20100603-C00083
         		1-(1-phenylcyclopropyl)propan-1-one woody, earthy, orange (over- ripe),
    84
    Figure US20100137178A1-20100603-C00084
         		2-methyl-1-(1- phenylcyclopropyl)propan-1-one woody, gunpowder, (fougere)
    85
    Figure US20100137178A1-20100603-C00085
         		1-(1-(3-methylbut-2- enyl)cyclopropyl)propan-1-one terpenic, herbal
    86
    Figure US20100137178A1-20100603-C00086
         		3-methyl-1-(1-(3-methylbut-2- enyl)cyclopropyl)butan-1-one metallic, fruity
    87
    Figure US20100137178A1-20100603-C00087
         		1-(1-p-tolylcyclopropyl)propan-1-one oily, solventy, nutty
    88
    Figure US20100137178A1-20100603-C00088
         		2-(R,S)-methyl-1-(1-p- tolylcyclopropyl)butan-1-one woody, weak
    89
    Figure US20100137178A1-20100603-C00089
         		1-(1-(3-methylbut-2-enyl)-3- methylenecyclobutyl)ethanone herbal (edible - oxo)
    90
    Figure US20100137178A1-20100603-C00090
         		1-(1-phenylcyclobutyl)pentan-1-one styrene, oily
    91
    Figure US20100137178A1-20100603-C00091
         		2,2,5-trimethylhex-4-enenitrile earthy, ozonic, vetyver
    92
    Figure US20100137178A1-20100603-C00092
         		6,6,9-trimethyldec-8-en-5-one floral, intense
    93
    Figure US20100137178A1-20100603-C00093
         		2,5,5,8-tetramethylnon-7-en-4-one floral, valerianic
    94
    Figure US20100137178A1-20100603-C00094
         		1-(1-(3-methylbut-2- enyl)cyclopentyl)pentan-1-one floral, valerianic
    95
    Figure US20100137178A1-20100603-C00095
         		3-methyl-1-(1-(3-methylbut-2- enyl)cyclopentyl)butan-1-one floral, valerianic
    96
    Figure US20100137178A1-20100603-C00096
         		2,2-dimethyl-1-(1-(3-methylbut-2- enyl)cyclopropyl)propan-1-one citrus, fresh, diffusive
    97
    Figure US20100137178A1-20100603-C00097
         		2-methyl-1-(1-p- tolylcyclopropyl)propan-1-one almond, chemical
    98
    Figure US20100137178A1-20100603-C00098
         		1-(1-((E)-3,7-dimethylocta-2,6- dienyl)cyclopropyl)ethanone Spicy
    99
    Figure US20100137178A1-20100603-C00099
         		2-methyl-1-(1-((E)-3,7-dimethylocta- 2,6-dienyl)cyclopropyl)butan-1-one herbal, green, fruity (natural)
    100 
    Figure US20100137178A1-20100603-C00100
         		2,4-dimethyl-2-m-tolylpentan-3-one intense, tobacco (sweet), earthy
    101 
    Figure US20100137178A1-20100603-C00101
         		2-methyl-2-m-tolylpropanenitrile intense, root, vetyver
    102 
    Figure US20100137178A1-20100603-C00102
         		3-methyl-3-m-tolylbutan-2-one burnt, caramelized
    103 
    Figure US20100137178A1-20100603-C00103
         		2-methyl-2-m-tolylpentan-3-one diffusive, orange flower
    104 
    Figure US20100137178A1-20100603-C00104
         		1-(1-p-tolylcyclopentyl)ethanone spicy, vegetable
    105 
    Figure US20100137178A1-20100603-C00105
         		7-methyl-1-phenyloct-6-en-1-one truffle, oriental bouillon
    106 
    Figure US20100137178A1-20100603-C00106
         		2,2-dimethyl-3-o-tolylpropanenitrile saffras, earthy, woody
    107 
    Figure US20100137178A1-20100603-C00107
         		3,3-dimethyl-4-o-tolylbutan-2-one Cedarwood
    108 
    Figure US20100137178A1-20100603-C00108
         		2,2-dimethyl-1-o-tolylpentan-3-one woody, citrus, medicinal
    109 
    Figure US20100137178A1-20100603-C00109
         		o-methyl- benzylcyclopropanecarbonitrile woody, spicy, chemical
    110 
    Figure US20100137178A1-20100603-C00110
         		2,2,4-trimethyl-1-o-tolylhexan-3-one floral, terpineol, camomile, green
    111 
    Figure US20100137178A1-20100603-C00111
         		1-(1-(2-methylbenzyl)- cyclopropyl)propanone rose, violet, woody
    112 
    Figure US20100137178A1-20100603-C00112
         		1-(1-(2- methylbenzyl)cyclopropyl)ethanone leathery, powdery
    113 
    Figure US20100137178A1-20100603-C00113
         		2-(R,S)-methyl-1-(1-(2- methylbenzyl)cyclopropyl)butan-1- one fruity, tutti-frutti, citrus
    114 
    Figure US20100137178A1-20100603-C00114
         		2-methyl-1-(1-(2- methylbenzyl)cyclopropyl)propan-1- one citrus, fruity (apple)
    115 
    Figure US20100137178A1-20100603-C00115
         		2,2,5-trimethyl-1-phenylhexan-3-one intense, woody, celery, anima
    116 
    Figure US20100137178A1-20100603-C00116
         		2-(1-(3-methylbut-2- enyl)cyclopropyl)propan-2-ol intense, floral, lilac, terpineol
    117 
    Figure US20100137178A1-20100603-C00117
         		1-(1-(3-methylbut-2- enyl)cyclopropyl)propan-1-one woody, camphor, costus
    118 
    Figure US20100137178A1-20100603-C00118
         		2-(R,S)-(1-(3-methylbut-2- enyl)cyclobutyl)butan-2-ol citrus, herbal, bleach
    119 
    Figure US20100137178A1-20100603-C00119
         		1-(R,S)-(1-(3-methylbut-2- enyl)cyclobutyl)propan-1-ol Weak
    120 
    Figure US20100137178A1-20100603-C00120
         		9-methyldec-1,8-dien-3-one diffusive, very intense, metallic, smoky (gun powder)
    121 
    Figure US20100137178A1-20100603-C00121
         		2,2-dimethyl-3-(R,S)- phenylbutanenitrile tobacco, floral (violet)
    122 
    Figure US20100137178A1-20100603-C00122
         		4,4-dimethyl-5-(R,S)-phenylhexan-3- one herbal (green, chamomile)
    123 
    Figure US20100137178A1-20100603-C00123
         		1-cyclopentyl-7-methyloct-6-en-1- one very intense, nutty, spicy, green (galbanum)
    124 
    Figure US20100137178A1-20100603-C00124
         		2,2-dimethyl-3-p-tolylpropanenitrile chervil, fennel, celery, mint
    125 
    Figure US20100137178A1-20100603-C00125
         		3-(4-methoxy-3-methylphenyl)-3- methylbutan-2-one leatherym, quinone
    126 
    Figure US20100137178A1-20100603-C00126
         		2,2,4-(R,S)-trimethyl-1-p-tolylhexan- 3-one weak, chocolate, nutty
    127 
    Figure US20100137178A1-20100603-C00127
         		3,3-dimethyl-4-(R,S)-phenylpentan- 2-one diffusive, herbal, citrus
    128 
    Figure US20100137178A1-20100603-C00128
         		2,2-dimethyl-1-p-tolylpentan-3-one fennel, herbal
    129 
    Figure US20100137178A1-20100603-C00129
         		3-(R,S)-(1-(3-methylbut-2- enyl)cyclobutyl)heptan-3-ol citrus, amber
    130 
    Figure US20100137178A1-20100603-C00130
         		3-cyclohexyl-2,2- dimethylpropanenitrile intense, mint, marine, spicy
    131 
    Figure US20100137178A1-20100603-C00131
         		1-cyclohexyl-2,2,4-trimethylpentan- 3-one Peppery
    132 
    Figure US20100137178A1-20100603-C00132
         		1-(R,S)-(1-phenylethyl)- cyclobutanecarbonitrile chemical, solventy
    133 
    Figure US20100137178A1-20100603-C00133
         		1-(1-(R,S)-(1-phenylethyl)- cyclobutyl)ethanone chemical, solventy, animalic
    134 
    Figure US20100137178A1-20100603-C00134
         		2-methyl-1-(1-(R,S)-(1- phenylethyl)cyclobutyl)propan-1-one chemical, orange flower
    135 
    Figure US20100137178A1-20100603-C00135
         		2-methyl-1-(R,S)-(1-(1-(R,s)- phenylethyl)cyclobutyl)propan-1-ol Chemical
    136 
    Figure US20100137178A1-20100603-C00136
         		1-(1-(R,S)- phenylethyl)cyclopropanecarbonitrile Petrol
    137 
    Figure US20100137178A1-20100603-C00137
         		1-(1-(1-(R,S)- phenylethyl)cyclopropyl)ethanone green, floral, chemical
    138 
    Figure US20100137178A1-20100603-C00138
         		2,2-dimethyl-3-m-tolylpropanenitrile orange crystals
    139 
    Figure US20100137178A1-20100603-C00139
         		3-(4-tert-butylphenyl)-2,2- dimethylpropanenitrile woody, floral
    140 
    Figure US20100137178A1-20100603-C00140
         		1-(1-phenylcyclopropyl)but-3-en-1- one fruity (berries), green
    141 
    Figure US20100137178A1-20100603-C00141
         		1-(1-phenylcyclopropyl)but-3-en-1- (R,s)-ol floral, chemical
    142 
    Figure US20100137178A1-20100603-C00142
         		4-(4-tert-butylphenyl)-3,3- dimethylbutan-2-one Sulphuric
    143 
    Figure US20100137178A1-20100603-C00143
         		2,2-dimethyl-4-phenylbutanenitrile Chemical
    144 
    Figure US20100137178A1-20100603-C00144
         		11-methyldodec-10-en-5-one Seafood
    145 
    Figure US20100137178A1-20100603-C00145
         		2,9-dimethyldec-8-en-3-one intense, fruity, oily, clean
    146 
    Figure US20100137178A1-20100603-C00146
         		2,10-dimethylundec-9-en-4-one intense, waxy, aldehydic, floral, fruity (melon)
    147 
    Figure US20100137178A1-20100603-C00147
         		2,2,9-trimethyldec-8-en-3-one intense, woody, waxy
    148 
    Figure US20100137178A1-20100603-C00148
         		2,2,3-(R,S),7-tetramethyloct-6- enenitrile citrus, waxy, bleach
    149 
    Figure US20100137178A1-20100603-C00149
         		4,4,5-(R,S),9-tetramethyldec-8-en-3- one intense, floral, waxy
    150 
    Figure US20100137178A1-20100603-C00150
         		6,6,7-(R,S),11-tetramethyldodec-10- en-5-one celery, green, floral
    151 
    Figure US20100137178A1-20100603-C00151
         		3,3-dimethyl-5-phenylpentan-s-one glue, sweet
    152 
    Figure US20100137178A1-20100603-C00152
         		2-((R,S)-cyclohex-2-enyl)-2- methylpropanenitrile intense, woody, camphoraceous
    153 
    Figure US20100137178A1-20100603-C00153
         		2-((R,S)-cyclohex-2-enyl)-2,5- dimethylhexan-3-one citrus, herbal
    154 
    Figure US20100137178A1-20100603-C00154
         		3,3-dimethyl-1-phenyloctan-4-one Chemical
    155 
    Figure US20100137178A1-20100603-C00155
         		2-((R,S)-cyclohex-2-enyl)-2- methylpentan-3-one intense, fruity, floral, woody, spicy
    156 
    Figure US20100137178A1-20100603-C00156
         		4,4-dimethyl-6-phenylhexan-3-one Floral, woody
    157 
    Figure US20100137178A1-20100603-C00157
         		2,2-dimethyl-5-phenylpentanenitrile citrus, nitrile, chemical, clean
    158 
    Figure US20100137178A1-20100603-C00158
         		2,2-dimethylhept-6-enenitrile intense, floral, celery
    159 
    Figure US20100137178A1-20100603-C00159
         		6,6-dimethylundec-10-en-5-one Waxy, clean
    160 
    Figure US20100137178A1-20100603-C00160
         		3,3-dimethyl-6-phenylhexan-2-one citrus, herbal
    161 
    Figure US20100137178A1-20100603-C00161
         		2,2-dimethyl-4-((1R,5S)-6,6- dimethylbicyclo[3.1.1]hept-2-en-2- yl)butanenitrile floral, spicy (peppery), woody
  • The PRMs disclosed in Table 1 above may provide one or more of the following benefits at a level that Applicants believe is unexpected in view of PRMs in general: neat product odor; wet fabric odor when applied to a fabric; dry fabric odor when applied to a fabric; reduced leakage from an encapsulate, including an encapsulate such as a perfume microcapsule; increased head space versus neat oil in certain perfume delivery technologies; odor when used in a matrix perfume delivery that is applied to a package; neat product odor when applied to a cleaning and/or treatment composition; fine fragrance composition odor when used in a fine fragrance; dry hair odor when a composition comprising such a PRM is applied to hair; PRM bloom from a solution comprising such a PRM and new PRM character when applied to a situs. Confirmation of such benefits can be obtained by applying standard test methodologies.
  • The PRMs and stereoisomers of such PRMs (also known as molecules in the examples of the present specification) disclosed in Table 1 above can be made in accordance with the respective teachings found, for example in the examples of the present specification.
  • In one aspect, a PRM having the structure of Table 1 PRM 16, 20, 27, 28, 118, 123 and 140 are disclosed.
  • In one aspect, the PRMs disclosed in Table 1 and stereoisomers thereof are suitable for use, as defined by the present specification, in consumer products at levels, based on total consumer product weight of from about 0.0001% to about 25%, from about 0.0005% to about 10%, from about 0.001% to about 5%, from about 0.005% to about 2.5%, or even from 0.01% to about 1%. Such PRMs and stereoisomers thereof may be used in combination in the aforementioned consumer product. In one aspect, a consumer product that may comprise one or more PRMs selected from Table 1 PRMs 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 118, 123, 140 and stereoisomers of such PRMs is disclosed.
  • In one aspect, the PRMs disclosed in Table 1 and stereoisomers thereof are suitable for use, as defined by the present specification, in cleaning and/or treatment composition at levels, based on total cleaning and treatment products weight of from about 0.0001% to about 25%, from about 0.0005% to about 10%, from about 0.001% to about 5%, from about 0.005% to about 2.5%, or even from 0.01% to about 1%. Such PRMs and stereoisomers thereof may be used in combination in the aforementioned cleaning and/treatment compositions. In one aspect, a cleaning and/or treatment composition that may comprise one or more PRMs selected from Table 1 PRMs 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 77, 100, 101, 107, 108, 110, 117, 118, 123, 127, 140 and stereoisomers of such PRMs is disclosed.
  • In one aspect, the PRMs disclosed in Table 1 and stereoisomers thereof are suitable for use, as defined by the present specification, in fabric and/or hard surface cleaning and/or treatment compositions at levels, based on total fabric and/or hard surface cleaning and/or treatment composition weight of from about 0.00001% to about 25%, from 0.00005% to about 10%, from 0.0001% to about 5%, from 0.0005% to about 1.0%, or even from 0.001% to about 0.5%. Such PRMs and stereoisomers thereof may be used in combination in the aforementioned fabric and/or hard surface cleaning and/or treatment compositions. In one aspect, a fabric and/or hard surface cleaning and/or treatment composition that may comprise one or more PRMs selected from Table 1 PRMs 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 33, 34, 35, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 74, 75, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 117, 118, 119, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161 and stereoisomers of such PRMs is disclosed.
  • In one aspect, a detergent that may comprise the same level of the PRMs as disclosed for the aforementioned fabric and hard surface cleaning and/or treatment compositions is disclosed. In one aspect, a detergent that may comprise one or more PRMs selected from Table 1 PRMs 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 33, 34, 35, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 74, 75, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 117, 118, 119, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161 and stereoisomers of such PRMs is disclosed.
  • In one aspect, the PRMs disclosed in Table 1 and stereoisomers thereof are suitable for use, in highly compacted consumer products, including highly compacted fabric and hard surface cleaning and/or treatment compositions, for example highly compacted detergents that may be solids or fluids, at levels, based on total composition weight, of from about 0.00001% to about 25%, from 0.00005% to about 10%, from 0.0001% to about 5%, from 0.0005% to about 1.0%, or even from 0.001% to about 0.5%. Such PRMs and stereoisomers thereof may be used in combination in the aforementioned highly compacted detergent compositions. Such highly compact detergents typically comprise a higher than normal percentage of active ingredients. In one aspect, a highly compacted detergent that may comprise one or more PRMs selected from Table 1 PRMs and stereoisomers of such PRMs is disclosed. In another aspect, highly compacted a detergent that may comprise one or more PRMs selected from Table 1 PRMs 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161 and stereoisomers of such PRMs is disclosed.
    • Perfume Delivery Systems
  • Certain perfume delivery systems, methods of making certain perfume delivery systems and the uses of such perfume delivery systems are disclosed in USPA 2007/0275866 A1. Such perfume delivery systems include:
  • I. Polymer Assisted Delivery (PAD): This perfume delivery technology uses polymeric materials to deliver perfume materials. Classical coacervation, water soluble or partly soluble to insoluble charged or neutral polymers, liquid crystals, hot melts, hydrogels, perfumed plastics, microcapsules, nano- and micro-latexes, polymeric film formers, and polymeric absorbents, polymeric adsorbents, etc. are some examples. PAD includes but is not limited to:
      • a.) Matrix Systems: The fragrance is dissolved or dispersed in a polymer matrix or particle. Perfumes, for example, may be 1) dispersed into the polymer prior to formulating into the product or 2) added separately from the polymer during or after formulation of the product. Diffusion of perfume from the polymer is a common trigger that allows or increases the rate of perfume release from a polymeric matrix system that is deposited or applied to the desired surface (situs), although many other triggers are know that may control perfume release. Absorption and/or adsorption into or onto polymeric particles, films, solutions, and the like are aspects of this technology. Nano- or micro-particles composed of organic materials (e.g., latexes) are examples. Suitable particles include a wide range of materials including, but not limited to polyacetal, polyacrylate, polyacrylic, polyacrylonitrile, polyamide, polyaryletherketone, polybutadiene, polybutylene, polybutylene terephthalate, polychloroprene, poly ethylene, polyethylene terephthalate, polycyclohexylene dimethylene terephthalate, polycarbonate, polychloroprene, polyhydroxyalkanoate, polyketone, polyester, polyethylene, polyetherimide, polyethersulfone, polyethylenechlorinates, polyimide, polyisoprene, polylactic acid, polymethylpentene, polyphenylene oxide, polyphenylene sulfide, polyphthalamide, polypropylene, polystyrene, polysulfone, polyvinyl acetate, polyvinyl chloride, as well as polymers or copolymers based on acrylonitrile-butadiene, cellulose acetate, ethylene-vinyl acetate, ethylene vinyl alcohol, styrene-butadiene, vinyl acetate-ethylene, and mixtures thereof.
        • “Standard” systems refer to those that are “pre-loaded” with the intent of keeping the pre-loaded perfume associated with the polymer until the moment or moments of perfume release. Such polymers may also suppress the neat product odor and provide a bloom and/or longevity benefit depending on the rate of perfume release. One challenge with such systems is to achieve the ideal balance between 1) in-product stability (keeping perfume inside carrier until you need it) and 2) timely release (during use or from dry situs). Achieving such stability is particularly important during in-product storage and product aging. This challenge is particularly apparent for aqueous-based, surfactant-containing products, such as heavy duty liquid laundry detergents. Many “Standard” matrix systems available effectively become “Equilibrium” systems when formulated into aqueous-based products. One may select an “Equilibrium” system or a Reservoir system, which has acceptable in-product diffusion stability and available triggers for release (e.g., friction). “Equilibrium” systems are those in which the perfume and polymer may be added separately to the product, and the equilibrium interaction between perfume and polymer leads to a benefit at one or more consumer touch points (versus a free perfume control that has no polymer-assisted delivery technology). The polymer may also be pre-loaded with perfume; however, part or all of the perfume may diffuse during in-product storage reaching an equilibrium that includes having desired perfume raw materials (PRMs) associated with the polymer. The polymer then carries the perfume to the surface, and release is typically via perfume diffusion. The use of such equilibrium system polymers has the potential to decrease the neat product odor intensity of the neat product (usually more so in the case of pre-loaded standard system). Deposition of such polymers may serve to “flatten” the release profile and provide increased longevity. As indicated above, such longevity would be achieved by suppressing the initial intensity and may enable the formulator to use more high impact or low odor detection threshold (ODT) or low Kovats Index (KI) PRMs to achieve FMOT benefits without initial intensity that is too strong or distorted. It is important that perfume release occurs within the time frame of the application to impact the desired consumer touch point or touch points. Suitable micro-particles and micro-latexes as well as methods of making same may be found in USPA 2005/0003980 A1. Matrix systems also include hot melt adhesives and perfume plastics. In addition, hydrophobically modified polysaccharides may be formulated into the perfumed product to increase perfume deposition and/or modify perfume release. All such matrix systems, including for example polysaccarides and nanolatexes may be combined with other PDTs, including other PAD systems such as PAD reservoir systems in the form of a perfume microcapsule (PMC). Polymer Assisted Delivery (PAD) matrix systems may include those described in the following references: US Patent Applications 2004/0110648 A1; 2004/0092414 A1; 2004/0091445 A1 and 2004/0087476 A1; and U.S. Pat. Nos. 6,531,444; 6,024,943; 6,042,792; 6,051,540; 4,540,721 and 4,973,422.
        • Silicones are also examples of polymers that may be used as PDT, and can provide perfume benefits in a manner similar to the polymer-assisted delivery “matrix system”. Such a PDT is referred to as silicone-assisted delivery (SAD). One may pre-load silicones with perfume, or use them as an equilibrium system as described for PAD. Suitable silicones as well as making same may be found in WO 2005/102261; USPA 20050124530A1; USPA 20050143282A1; and WO 2003/015736. Functionalized silicones may also be used as described in USPA 2006/003913 A1. Examples of silicones include polydimethylsiloxane and polyalkyldimethylsiloxanes. Other examples include those with amine functionality, which may be used to provide benefits associated with amine-assisted delivery (AAD) and/or polymer-assisted delivery (PAD) and/or amine-reaction products (ARP). Other such examples may be found in U.S. Pat. No. 4,911,852; USPA 2004/0058845 A1; USPA 2004/0092425 A1 and USPA 2005/0003980 A1.
      • b.) Reservoir Systems: Reservoir systems are also known as a core-shell type technology, or one in which the fragrance is surrounded by a perfume release controlling membrane, which may serve as a protective shell. The material inside the microcapsule is referred to as the core, internal phase, or fill, whereas the wall is sometimes called a shell, coating, or membrane. Microparticles or pressure sensitive capsules or microcapsules are examples of this technology. Microcapsules of the current invention are formed by a variety of procedures that include, but are not limited to, coating, extrusion, spray-drying, interfacial, in-situ and matrix polymerization. The possible shell materials vary widely in their stability toward water. Among the most stable are polyoxymethyleneurea (PMU)-based materials, which may hold certain PRMs for even long periods of time in aqueous solution (or product). Such systems include but are not limited to urea-formaldehyde and/or melamine-formaldehyde. Gelatin-based microcapsules may be prepared so that they dissolve quickly or slowly in water, depending for example on the degree of cross-linking. Many other capsule wall materials are available and vary in the degree of perfume diffusion stability observed. Without wishing to be bound by theory, the rate of release of perfume from a capsule, for example, once deposited on a surface is typically in reverse order of in-product perfume diffusion stability. As such, urea-formaldehyde and melamine-formaldehyde microcapsules for example, typically require a release mechanism other than, or in addition to, diffusion for release, such as mechanical force (e.g., friction, pressure, shear stress) that serves to break the capsule and increase the rate of perfume (fragrance) release. Other triggers include melting, dissolution, hydrolysis or other chemical reaction, electromagnetic radiation, and the like. The use of pre-loaded microcapsules requires the proper ratio of in-product stability and in-use and/or on-surface (on-situs) release, as well as proper selection of PRMs. Microcapsules that are based on urea-formaldehyde and/or melamine-formaldehyde are relatively stable, especially in near neutral aqueous-based solutions. These materials may require a friction trigger which may not be applicable to all product applications. Other microcapsule materials (e.g., gelatin) may be unstable in aqueous-based products and may even provide reduced benefit (versus free perfume control) when in-product aged. Scratch and sniff technologies are yet another example of PAD. Perfume microcapsules (PMC) may include those described in the following references: US Patent Applications: 2003/0125222 A1; 2003/215417 A1; 2003/216488 A1; 2003/158344 A1; 2003/165692 A1; 2004/071742 A1; 2004/071746 A1; 2004/072719 A1; 2004/072720 A1; 2006/0039934 A1; 2003/203829 A1; 2003/195133 A1; 2004/087477 A1; 2004/0106536 A1; and U.S. Pat. Nos. 6,645,479 B1; 6,200,949 B1; 4,882,220; 4,917,920; 4,514,461; 6,106,875 and 4,234,627, 3,594,328 and US RE 32713.
        II. Molecule-Assisted Delivery (MAD): Non-polymer materials or molecules may also serve to improve the delivery of perfume. Without wishing to be bound by theory, perfume may non-covalently interact with organic materials, resulting in altered deposition and/or release. Non-limiting examples of such organic materials include but are not limited to hydrophobic materials such as organic oils, waxes, mineral oils, petrolatum, fatty acids or esters, sugars, surfactants, liposomes and even other perfume raw material (perfume oils), as well as natural oils, including body and/or other soils. Perfume fixatives are yet another example. In one aspect, non-polymeric materials or molecules have a CLogP greater than about 2. Molecule-Assisted Delivery (MAD) may also include those described in U.S. Pat. No. 7,119,060 and U.S. Pat. No. 5,506,201.
        III. Fiber-Assisted Delivery (FAD): The choice or use of a situs itself may serve to improve the delivery of perfume. In fact, the situs itself may be a perfume delivery technology. For example, different fabric types such as cotton or polyester will have different properties with respect to ability to attract and/or retain and/or release perfume. The amount of perfume deposited on or in fibers may be altered by the choice of fiber, and also by the history or treatment of the fiber, as well as by any fiber coatings or treatments. Fibers may be woven and non-woven as well as natural or synthetic. Natural fibers include those produced by plants, animals, and geological processes, and include but are not limited to cellulose materials such as cotton, linen, hemp jute, flax, ramie, and sisal, and fibers used to manufacture paper and cloth. Fiber-Assisted Delivery may consist of the use of wood fiber, such as thermomechanical pulp and bleached or unbleached kraft or sulfite pulps. Animal fibers consist largely of particular proteins, such as silk, sinew, catgut and hair (including wool). Polymer fibers based on synthetic chemicals include but are not limited to polyamide nylon, PET or PBT polyester, phenol-formaldehyde (PF), polyvinyl alcohol fiber (PVOH), polyvinyl chloride fiber (PVC), polyolefins (PP and PE), and acrylic polymers. All such fibers may be pre-loaded with a perfume, and then added to a product that may or may not contain free perfume and/or one or more perfume delivery technologies. In one aspect, the fibers may be added to a product prior to being loaded with a perfume, and then loaded with a perfume by adding a perfume that may diffuse into the fiber, to the product. Without wishing to be bound by theory, the perfume may absorb onto or be adsorbed into the fiber, for example, during product storage, and then be released at one or more moments of truth or consumer touch points.
        IV. Amine Assisted Delivery (AAD): The amine-assisted delivery technology approach utilizes materials that contain an amine group to increase perfume deposition or modify perfume release during product use. There is no requirement in this approach to pre-complex or pre-react the perfume raw material(s) and amine prior to addition to the product. In one aspect, amine-containing AAD materials suitable for use herein may be non-aromatic; for example, polyalkylimine, such as polyethyleneimine (PEI), or polyvinylamine (PVAm), or aromatic, for example, anthranilates. Such materials may also be polymeric or non-polymeric. In one aspect, such materials contain at least one primary amine. This technology will allow increased longevity and controlled release also of low ODT perfume notes (e.g., aldehydes, ketones, enones) via amine functionality, and delivery of other PRMs, without being bound by theory, via polymer-assisted delivery for polymeric amines. Without technology, volatile top notes can be lost too quickly, leaving a higher ratio of middle and base notes to top notes. The use of a polymeric amine allows higher levels of top notes and other PRMS to be used to obtain freshness longevity without causing neat product odor to be more intense than desired, or allows top notes and other PRMs to be used more efficiently. In one aspect, AAD systems are effective at delivering PRMs at pH greater than about neutral. Without wishing to be bound by theory, conditions in which more of the amines of the AAD system are deprotonated may result in an increased affinity of the deprotonated amines for PRMs such as aldehydes and ketones, including unsaturated ketones and enones such as damascone. In another aspect, polymeric amines are effective at delivering PRMs at pH less than about neutral. Without wishing to be bound by theory, conditions in which more of the amines of the AAD system are protonated may result in a decreased affinity of the protonated amines for PRMs such as aldehydes and ketones, and a strong affinity of the polymer framework for a broad range of PRMs. In such an aspect, polymer-assisted delivery may be delivering more of the perfume benefit; such systems are a subspecies of AAD and may be referred to as Amine-Polymer-Assisted Delivery or APAD. In some cases when the APAD is employed in a composition that has a pH of less than seven, such APAD systems may also be considered Polymer-Assisted Delivery (PAD). In yet another aspect, AAD and PAD systems may interact with other materials, such as anionic surfactants or polymers to form coacervate and/or coacervates-like systems. In another aspect, a material that contains a heteroatom other than nitrogen, for example sulfur, phosphorus or selenium, may be used as an alternative to amine compounds. In yet another aspect, the aforementioned alternative compounds can be used in combination with amine compounds. In yet another aspect, a single molecule may comprise an amine moiety and one or more of the alternative heteroatom moieties, for example, thiols, phosphines and selenols. Suitable AAD systems as well as methods of making same may be found in US Patent Applications 2005/0003980 A1; 2003/0199422 A1; 2003/0036489 A1; 2004/0220074 A1 and U.S. Pat. No. 6,103,678.
        V. Cyclodextrin Delivery System (CD): This technology approach uses a cyclic oligosaccharide or cyclodextrin to improve the delivery of perfume. Typically a perfume and cyclodextrin (CD) complex is formed. Such complexes may be preformed, formed in-situ, or formed on or in the situs. Without wishing to be bound by theory, loss of water may serve to shift the equilibrium toward the CD-Perfume complex, especially if other adjunct ingredients (e.g., surfactant) are not present at high concentration to compete with the perfume for the cyclodextrin cavity. A bloom benefit may be achieved if water exposure or an increase in moisture content occurs at a later time point. In addition, cyclodextrin allows the perfume formulator increased flexibility in selection of PRMs. Cyclodextrin may be pre-loaded with perfume or added separately from perfume to obtain the desired perfume stability, deposition or release benefit. Suitable CDs as well as methods of making same may be found in USPA 2005/0003980 A1 and 2006/0263313 A1 and U.S. Pat. Nos. 5,552,378; 3,812,011; 4,317,881; 4,418,144 and 4,378,923.
        VI. Starch Encapsulated Accord (SEA): The use of a starch encapsulated accord (SEA) technology allows one to modify the properties of the perfume, for example, by converting a liquid perfume into a solid by adding ingredients such as starch. The benefit includes increased perfume retention during product storage, especially under non-aqueous conditions. Upon exposure to moisture, a perfume bloom may be triggered. Benefits at other moments of truth may also be achieved because the starch allows the product formulator to select PRMs or PRM concentrations that normally cannot be used without the presence of SEA. Another technology example includes the use of other organic and inorganic materials, such as silica to convert perfume from liquid to solid. Suitable SEAs as well as methods of making same may be found in USPA 2005/0003980 A1 and U.S. Pat. No. 6,458,754 B1.
        VII. Inorganic Carrier Delivery System (ZIC): This technology relates to the use of porous zeolites or other inorganic materials to deliver perfumes. Perfume-loaded zeolite may be used with or without adjunct ingredients used for example to coat the perfume-loaded zeolite (PLZ) to change its perfume release properties during product storage or during use or from the dry situs. Suitable zeolite and inorganic carriers as well as methods of making same may be found in USPA 2005/0003980 A1 and U.S. Pat. Nos. 5,858,959; 6,245,732 B1; 6,048,830 and 4,539,135. Silica is another form of ZIC. Another example of a suitable inorganic carrier includes inorganic tubules, where the perfume or other active material is contained within the lumen of the nano- or micro-tubules. In one aspect, the perfume-loaded inorganic tubule (or Perfume-Loaded Tubule or PLT) is a mineral nano- or micro-tubule, such as halloysite or mixtures of halloysite with other inorganic materials, including other clays. The PLT technology may also comprise additional ingredients on the inside and/or outside of the tubule for the purpose of improving in-product diffusion stability, deposition on the desired situs or for controlling the release rate of the loaded perfume. Monomeric and/or polymeric materials, including starch encapsulation, may be used to coat, plug, cap, or otherwise encapsulate the PLT. Suitable PLT systems as well as methods of making same may be found in U.S. Pat. No. 5,651,976.
        VIII. Pro-Perfume (PP): This technology refers to perfume technologies that result from the reaction of perfume materials with other substrates or chemicals to form materials that have a covalent bond between one or more PRMs and one or more carriers. The PRM is converted into a new material called a pro-PRM (i.e., pro-perfume), which then may release the original PRM upon exposure to a trigger such as water or light. Pro-perfumes may provide enhanced perfume delivery properties such as increased perfume deposition, longevity, stability, retention, and the like. Pro-perfumes include those that are monomeric (non-polymeric) or polymeric, and may be pre-formed or may be formed in-situ under equilibrium conditions, such as those that may be present during in-product storage or on the wet or dry situs. Nonlimiting examples of pro-perfumes include Michael adducts (e.g., beta-amino ketones), aromatic or non-aromatic imines (Schiff bases), oxazolidines, beta-keto esters, and orthoesters. Another aspect includes compounds comprising one or more beta-oxy or beta-thio carbonyl moieties capable of releasing a PRM, for example, an alpha, beta-unsaturated ketone, aldehyde or carboxylic ester. The typical trigger for perfume release is exposure to water; although other triggers may include enzymes, heat, light, pH change, autoxidation, a shift of equilibrium, change in concentration or ionic strength and others. For aqueous-based products, light-triggered pro-perfumes are particularly suited. Such photo-pro-perfumes (PPPs) include but are not limited to those that release coumarin derivatives and perfumes and/or pro-perfumes upon being triggered. The released pro-perfume may release one or more PRMs by means of any of the above mentioned triggers. In one aspect, the photo-pro-perfume releases a nitrogen-based pro-perfume when exposed to a light and/or moisture trigger. In another aspect, the nitrogen-based pro-perfume, released from the photo-pro-perfume, releases one or more PRMs selected, for example, from aldehydes, ketones (including enones) and alcohols. In still another aspect, the PPP releases a dihydroxy coumarin derivative. The light-triggered pro-perfume may also be an ester that releases a coumarin derivative and a perfume alcohol. In one aspect the pro-perfume is a dimethoxybenzoin derivative as described in USPA 2006/0020459 A1. In another aspect the pro-perfume is a 3′, 5′-dimethoxybenzoin (DMB) derivative that releases an alcohol upon exposure to electromagnetic radiation. In yet another aspect, the pro-perfume releases one or more low ODT PRMs, including tertiary alcohols such as linalool, tetrahydrolinalool, or dihydromyrcenol. Suitable pro-perfumes and methods of making same can be found in U.S. Pat. Nos. 7,018,978 B2; 6,987,084 B2; 6,956,013 B2; 6,861,402 B1; 6,544,945 B1; 6,093,691; 6,277,796 B1; 6,165,953; 6,316,397 B1; 6,437,150 B1; 6,479,682 B1; 6,096,918; 6,218,355 B1; 6,133,228; 6,147,037; 7,109,153 B2; 7,071,151 B2; 6,987,084 B2; 6,610,646 B2 and 5,958,870, as well as can be found in USPA 2005/0003980 A1 and USPA 2006/0223726 A1.
      • Amine Reaction Product (ARP): For purposes of the present application, ARP is a subclass or species of PP. One may also use “reactive” polymeric amines in which the amine functionality is pre-reacted with one or more PRMs to form an amine reaction product (ARP). Typically the reactive amines are primary and/or secondary amines, and may be part of a polymer or a monomer (non-polymer). Such ARPs may also be mixed with additional PRMs to provide benefits of polymer-assisted delivery and/or amine-assisted delivery. Nonlimiting examples of polymeric amines include polymers based on polyalkylimines, such as polyethyleneimine (PEI), or polyvinylamine (PVAm). Nonlimiting examples of monomeric (non-polymeric) amines include hydroxylamines, such as 2-aminoethanol and its alkyl substituted derivatives, and aromatic amines such as anthranilates. The ARPs may be premixed with perfume or added separately in leave-on or rinse-off applications. In another aspect, a material that contains a heteroatom other than nitrogen, for example oxygen, sulfur, phosphorus or selenium, may be used as an alternative to amine compounds. In yet another aspect, the aforementioned alternative compounds can be used in combination with amine compounds. In yet another aspect, a single molecule may comprise an amine moiety and one or more of the alternative heteroatom moieties, for example, thiols, phosphines and selenols. The benefit may include improved delivery of perfume as well as controlled perfume release. Suitable ARPs as well as methods of making same can be found in USPA 2005/0003980 A1 and U.S. Pat. No. 6,413,920 B1.
  • In one aspect, the PRMs disclosed in Table 1 and stereoisomers thereof are suitable for use in perfume delivery systems at levels, based on total perfume delivery system weight, of from 0.001% to about 50%, from 0.005% to 30%, from 0.01% to about 10%, from 0.025% to about 5%, or even from 0.025% to about 1%.
  • In one aspect, the perfume delivery systems disclosed herein are suitable for use in consumer products, cleaning and treatment compositions and fabric and hard surface cleaning and/or treatment compositions, detergents, and highly compacted consumer products, including highly compacted fabric and hard surface cleaning and/or treatment compositions, for example highly compacted detergents that may be solids or fluids, at levels, based on total consumer product weight, from about 0.001% to about 20%, from about 0.01% to about 10%, from about 0.05% to about 5%, from about 0.1% to about 0.5%.
  • In one aspect, the amount of Table 1 PRMs, based on the total microcapsules and/or nanocapsules (Polymer Assisted Delivery (PAD) Reservoir System) weight, may be from about 0.1% to about 99%, from 25% to about 95%, from 30 to about 90%, from 45% to about 90%, from 65% to about 90%. In one aspect, microcapsules and/or nanocapsules that may comprise one or more PRMs selected from Table 1 PRMs 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161; stereoisomers of Table 1 PRMs 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161; and mixtures thereof. PRMs 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 21, 22, 23, 24, 25, 26, 27, 30, 31, 32, 33, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 64, 65, 66, 67, 68, 69, 70, 71, 72, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 92, 93, 94, 95, 96, 97, 98, 99, 100, 102, 103, 104, 105, 107, 108, 110, 111, 112, 113, 114, 115, 117, 120, 122, 123, 125, 126, 127, 128, 131, 133, 134, 137, 140, 142, 144, 145, 146, 147, 149, 150, 151, 153, 154, 155, 156, 159 and 160 are ketones. PRMs 15, 16, 17, 18, 19, 20, 116, 118, 119, 129, 135 and 141 are alcohols. PRMs 28, 29 and 52 are esters. PRMs 34, 73, 74, 75, 76, 77, 91, 101, 106, 109, 121, 124, 130, 132, 136, 138, 139, 143, 148, 152, 157, 158 and 161 are nitriles.
  • In one aspect, the amount of total perfume based on total weight of starch encapsulates and starch agglomerates (Starch Encapsulated Accord (SEA)) ranges from 0.1% to about 99%, from 25% to about 95%, from 30 to about 90%, from 45% to about 90%, from 65% to about 90%. In one aspect, the PRMs disclosed in Table 1 and stereoisomers thereof are suitable for use in such starch encapsulates and starch agglomerates. Such PRMs and stereoisomers thereof may be used in combination in such starch encapsulates and starch agglomerates.
  • In one aspect, the amount of total perfume based on total weight of [cyclodextrin-perfume] complexes (Cyclodextrin (CD)) ranges from 0.1% to about 99%, from 2.5% to about 75%, from 5% to about 60%, from 5% to about 50%, from 5% to about 25%. In one aspect, the PRMs disclosed in Table 1 and stereoisomers thereof are suitable for use in such [cyclodextrin-perfume] complexes. Such PRMs and stereoisomers thereof may be used in combination in such [cyclodextrin-perfume] complexes.
  • In one aspect, the amount of total perfume based on total weight of Polymer Assisted Delivery (PAD) Matrix Systems (including Silicones) ranges from 0.1% to about 99%, from 2.5% to about 75%, from 5% to about 60%, from 5% to about 50%, from 5% to about 25%. In one aspect, the amount of total perfume based on total weight of a hot melt perfume delivery system/perfume loaded plastic Matrix System and ranges from 1% to about 99%, from 2.5% to about 75%, from 5% to about 60%, from 5% to about 50%, from 10% to about 50%. In one aspect, the PRMs disclosed in Table 1 and stereoisomers thereof are suitable for use in such Polymer Assisted Delivery (PAD) Matrix Systems, including hot melt perfume delivery system/perfume loaded plastic Matrix Systems. Such PRMs and stereoisomers thereof may be used in combination in such Polymer Assisted Delivery (PAD) Matrix Systems (including hot melt perfume delivery system/perfume loaded plastic Matrix Systems).
  • In one aspect, the amount of total perfume based on total weight of Amine Assisted Delivery (AAD) (including Aminosilicones) ranges from 1% to about 99%, from 2.5% to about 75%, from 5% to about 60%, from 5% to about 50%, from 5% to about 25%. In one aspect, the PRMs disclosed in Table 1 and stereoisomers thereof are suitable for use in such Amine Assisted Delivery (AAD) systems. Such PRMs and stereoisomers thereof may be used in combination in such Amine Assisted Delivery (AAD) systems. In one aspect, an Amine Assisted Delivery (AAD) system that may comprise one or more PRMs selected from Table 1 PRMs 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160 and 161; stereoisomers of Table 1 PRMs 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160 and 161; and mixtures thereof is disclosed. PRMs 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 21, 22, 23, 24, 25, 26, 27, 30, 31, 32, 33, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 64, 65, 66, 67, 68, 69, 70, 71, 72, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 92, 93, 94, 95, 96, 97, 98, 99, 100, 102, 103, 104, 105, 107, 108, 110, 111, 112, 113, 114, 115, 117, 120, 122, 123, 125, 126, 127, 128, 131, 133, 134, 137, 140, 142, 144, 145, 146, 147, 149, 150, 151, 153, 154, 155, 156, 159 and 160 are ketones. PRMs 15, 16, 17, 18, 19, 20, 116, 118, 119, 129, 135 and 141 are alcohols. PRMs 34, 73, 74, 75, 76, 77, 91, 101, 106, 109, 121, 124, 130, 132, 136, 138, 139, 143, 148, 152, 157, 158 and 161 are nitriles.
  • In one aspect, a Pro-Perfume (PP) Amine Reaction Product (ARP) system that may comprise one or more PRMs selected from Table 1 PRMs 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 21, 22, 23, 24, 25, 26, 27, 30, 31, 32, 33, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 64, 65, 66, 67, 68, 69, 70, 71, 72, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 92, 93, 94, 95, 96, 97, 98, 99, 100, 102, 103, 104, 105, 107, 108, 110, 111, 112, 113, 114, 115, 117, 120, 122, 123, 125, 126, 127, 128, 131, 133, 134, 137, 140, 142, 144, 145, 146, 147, 149, 150, 151, 153, 154, 155, 156, 159 and 160 is disclosed. Such PRMs are ketones. In one aspect, the amount of total perfume based on total weight of Pro-Perfume (PP) Amine Reaction Product (ARP) system ranges from 0.1% to about 99%, from about 1% to about 99%, from 5% to about 90%, from 10% to about 75%, from 20% to about 75%, from 25% to about 60%.
  • The perfume delivery technologies also known as perfume delivery systems that are disclosed in the present specification may be used in any combination in any type of consumer product, cleaning and/or treatment composition, fabric and hard surface cleaning and/or treatment composition, detergent, and highly compact detergent.
    • Perfumes
  • The PRMs disclosed in Table 1 may be used to formulate perfumes. Such perfumes are combinations of PRMs that may comprise a combination of Table 1 PRMs, or one or Table 1 PRMs and one or more additional PRMs. When used in a perfume, the Table 1 PRMs may used, based on total perfume weight, at levels of from about 0.01% to about 50%, from about 0.1% to about 15%, from about 0.1% to about 10% or even from about 0.5% to about 10%. Such perfumes may be used in multiple applications including being applied neat to a situs or used in a consumer product, cleaning and/or treatment composition, fabric and hard surface cleaning and/or treatment composition, detergent, and/or a highly compact detergent.
    • Adjunct Materials
  • For the purposes of the present invention, the non-limiting list of adjuncts illustrated hereinafter are suitable for use in the instant compositions and may be desirably incorporated in certain embodiments of the invention, for example to assist or enhance performance, for treatment of the substrate to be cleaned, or to modify the aesthetics of the composition as is the case with perfumes, colorants, dyes or the like. It is understood that such adjuncts are in addition to the components that are supplied via Applicants' perfumes and/or perfume systems. The precise nature of these additional components, and levels of incorporation thereof, will depend on the physical form of the composition and the nature of the operation for which it is to be used. Suitable adjunct materials include, but are not limited to, surfactants, builders, chelating agents, dye transfer inhibiting agents, dispersants, enzymes, and enzyme stabilizers, catalytic materials, bleach activators, polymeric dispersing agents, clay soil removal/anti-redeposition agents, brighteners, suds suppressors, dyes, additional perfume and perfume delivery systems, structure elasticizing agents, fabric softeners, carriers, hydrotropes, processing aids and/or pigments. In addition to the disclosure below, suitable examples of such other adjuncts and levels of use are found in U.S. Pat. Nos. 5,576,282, 6,306,812 B1 and 6,326,348 B1 that are incorporated by reference.
  • Each adjunct ingredient is not essential to Applicants' compositions. Thus, certain embodiments of Applicants' compositions do not contain one or more of the following adjuncts materials: bleach activators, surfactants, builders, chelating agents, dye transfer inhibiting agents, dispersants, enzymes, and enzyme stabilizers, catalytic metal complexes, polymeric dispersing agents, clay and soil removal/anti-redeposition agents, brighteners, suds suppressors, dyes, additional perfumes and perfume delivery systems, structure elasticizing agents, fabric softeners, carriers, hydrotropes, processing aids and/or pigments. However, when one or more adjuncts are present, such one or more adjuncts may be present as detailed below:
  • Surfactants—The compositions according to the present invention can comprise a surfactant or surfactant system wherein the surfactant can be selected from nonionic and/or anionic and/or cationic surfactants and/or ampholytic and/or zwitterionic and/or semi-polar nonionic surfactants. The surfactant is typically present at a level of from about 0.1%, from about 1%, or even from about 5% by weight of the cleaning compositions to about 99.9%, to about 80%, to about 35%, or even to about 30% by weight of the cleaning compositions.
  • Builders—The compositions of the present invention can comprise one or more detergent builders or builder systems. When present, the compositions will typically comprise at least about 1% builder, or from about 5% or 10% to about 80%, 50%, or even 30% by weight, of said builder. Builders include, but are not limited to, the alkali metal, ammonium and alkanolammonium salts of polyphosphates, alkali metal silicates, alkaline earth and alkali metal carbonates, aluminosilicate builders polycarboxylate compounds. ether hydroxypolycarboxylates, copolymers of maleic anhydride with ethylene or vinyl methyl ether, 1,3,5-trihydroxybenzene-2,4,6-trisulphonic acid, and carboxymethyl-oxysuccinic acid, the various alkali metal, ammonium and substituted ammonium salts of polyacetic acids such as ethylenediamine tetraacetic acid and nitrilotriacetic acid, as well as polycarboxylates such as mellitic acid, succinic acid, oxydisuccinic acid, polymaleic acid, benzene 1,3,5-tricarboxylic acid, carboxymethyloxysuccinic acid, and soluble salts thereof.
  • Chelating Agents—The compositions herein may also optionally contain one or more copper, iron and/or manganese chelating agents. If utilized, chelating agents will generally comprise from about 0.1% by weight of the compositions herein to about 15%, or even from about 3.0% to about 15% by weight of the compositions herein.
  • Dye Transfer Inhibiting Agents—The compositions of the present invention may also include one or more dye transfer inhibiting agents. Suitable polymeric dye transfer inhibiting agents include, but are not limited to, polyvinylpyrrolidone polymers, polyamine N-oxide polymers, copolymers of N-vinylpyrrolidone and N-vinylimidazole, polyvinyloxazolidones and polyvinylimidazoles or mixtures thereof. When present in the compositions herein, the dye transfer inhibiting agents are present at levels from about 0.0001%, from about 0.01%, from about 0.05% by weight of the cleaning compositions to about 10%, about 2%, or even about 1% by weight of the cleaning compositions.
  • Dispersants—The compositions of the present invention can also contain dispersants. Suitable water-soluble organic materials are the homo- or co-polymeric acids or their salts, in which the polycarboxylic acid may comprise at least two carboxyl radicals separated from each other by not more than two carbon atoms.
  • Enzymes—The compositions can comprise one or more detergent enzymes which provide cleaning performance and/or fabric care benefits. Examples of suitable enzymes include, but are not limited to, hemicellulases, peroxidases, proteases, cellulases, xylanases, lipases, phospholipases, esterases, cutinases, pectinases, keratanases, reductases, oxidases, phenoloxidases, lipoxygenases, ligninases, pullulanases, tannases, pentosanases, malanases, β-glucanases, arabinosidases, hyaluronidase, chondroitinase, laccase, and amylases, or mixtures thereof. A typical combination is a cocktail of conventional applicable enzymes like protease, lipase, cutinase and/or cellulase in conjunction with amylase.
  • Enzyme Stabilizers—Enzymes for use in compositions, for example, detergents can be stabilized by various techniques. The enzymes employed herein can be stabilized by the presence of water-soluble sources of calcium and/or magnesium ions in the finished compositions that provide such ions to the enzymes.
  • Catalytic Metal Complexes—Applicants' compositions may include catalytic metal complexes. One type of metal-containing bleach catalyst is a catalyst system comprising a transition metal cation of defined bleach catalytic activity, such as copper, iron, titanium, ruthenium, tungsten, molybdenum, or manganese cations, an auxiliary metal cation having little or no bleach catalytic activity, such as zinc or aluminum cations, and a sequestrate having defined stability constants for the catalytic and auxiliary metal cations, particularly ethylenediaminetetraacetic acid, ethylenediaminetetra (methyl-enephosphonic acid) and water-soluble salts thereof. Such catalysts are disclosed in U.S. Pat. No. 4,430,243.
  • If desired, the compositions herein can be catalyzed by means of a manganese compound. Such compounds and levels of use are well known in the art and include, for example, the manganese-based catalysts disclosed in U.S. Pat. No. 5,576,282.
  • Cobalt bleach catalysts useful herein are known, and are described, for example, in U.S. Pat. Nos. 5,597,936 and 5,595,967. Such cobalt catalysts are readily prepared by known procedures, such as taught for example in U.S. Pat. Nos. 5,597,936, and 5,595,967.
  • Compositions herein may also suitably include a transition metal complex of a macropolycyclic rigid ligand—abbreviated as “MRL”. As a practical matter, and not by way of limitation, the compositions and cleaning processes herein can be adjusted to provide on the order of at least one part per hundred million of the benefit agent MRL species in the aqueous washing medium, and may provide from about 0.005 ppm to about 25 ppm, from about 0.05 ppm to about 10 ppm, or even from about 0.1 ppm to about 5 ppm, of the MRL in the wash liquor.
  • Suitable transition-metals in the instant transition-metal bleach catalyst include manganese, iron and chromium. Suitable MRL's herein are a special type of ultra-rigid ligand that is cross-bridged such as 5,12-diethyl-1,5,8,12-tetraazabicyclo[6.6.2]hexa-decane.
  • Suitable transition metal MRLs are readily prepared by known procedures, such as taught for example in WO 00/32601, and U.S. Pat. No. 6,225,464.
    • Method of Use
  • Certain of the consumer products disclosed herein can be used to clean or treat a situs inter alia a surface or fabric. Typically at least a portion of the situs is contacted with an embodiment of Applicants' composition, in neat form or diluted in a liquor, for example, a wash liquor and then the situs may be optionally washed and/or rinsed. In one aspect, a situs is optionally washed and/or rinsed, contacted with a particle according to the present invention or composition comprising said particle and then optionally washed and/or rinsed. For purposes of the present invention, washing includes but is not limited to, scrubbing, and mechanical agitation. The fabric may comprise most any fabric capable of being laundered or treated in normal consumer use conditions. Liquors that may comprise the disclosed compositions may have a pH of from about 3 to about 11.5. Such compositions are typically employed at concentrations of from about 500 ppm to about 15,000 ppm in solution. When the wash solvent is water, the water temperature typically ranges from about 5° C. to about 90° C. and, when the situs comprises a fabric, the water to fabric ratio is typically from about 1:1 to about 30:1.
    • EXAMPLES
  • While particular embodiments of the present invention have been illustrated and described, it would be obvious to those skilled in the art that various other changes and modifications can be made without departing from the spirit and scope of the invention. It is therefore intended to cover in the appended claims all such changes and modifications that are within the scope of this invention.
    • Example 1 Synthesis Examples For Table 1 PRMs 1-48
  • Procedure for the synthesis of Table 1 Molecule No. 31 (exemplified for a 7.5 mmolar scale:
  • Figure US20100137178A1-20100603-C00162
  • In an oven dried flask were mixed under dry conditions 7.5 mmol of but-3-en-2-ol (1 equiv), 7.5 mmol of sodium methoxide (1 equiv), 9.0 mmol of tributylamine (1.2 equiv), 7.5 mmol of 1-iodo-4-methylbenzene (1 equiv) with 0.75 mmol of PdCl2 (0.1 equiv) at room temperature in 10 mL of dry DMF. The reaction mixture was stirred while the temperature was first heated to 75° C. for 3 h and for 1 h to 20° C. This temperature cycle was repeated two more times. Then, the reaction mixture was filtered over a short silica path. The silica was washed with methyl tert-butyl ether (MTBE; 2*3 mL). The combined organic fractions were mixed with 25 mL of 0.5 M HCl and extracted with MTBE (2*5 mL) and washed with saturated aqueous NaHCO3 (5 mL) and brine (5 mL). The crude oil was obtained after drying over MgSO4, filtration and concentration. Additional flash chromatography was performed to obtain the compound in high purity, with a Biotage PS1: TLC-based method calculated from solvent conditions 80:20-mixture petroleum ether/Ethyl Acetate.
  • Procedure for the synthesis of compound Table 1 Molecule No. 48:
    Step 1, exemplified for a 30 mmolar scale:
  • Figure US20100137178A1-20100603-C00163
  • In an oven dried flask were mixed under dry conditions and under nitrogen atmosphere, 30 mmol of the aldehyde (3.6 g) with 1 mL of dry tetrahydrofuran (THF) at room temperature. The reaction mixture was stirred for 10 minutes in an ice bath, before 1.1 equivalents of iso-propylmagnesium chloride, dissolved in THF (2 M; 16.5 mL), were added drop wise upon this solution. The reaction was stirred for 16 h, while the temperature was allowed to come to room temperature. Then, the reaction was quenched by adding it to 17 mL of 2 M HCl, cooled with ice cubes. 30 mL of methyl tent-butyl ether (MTBE) were added to this mixture and was extracted with MTBE (2*10 mL). The combined organic fractions were washed with aqueous saturated NaHCO3 (5 mL) and brine (5 mL). The crude oil was obtained after drying over MgSO4, filtration and concentration. The pure compound was obtained after flash chromatography, performed with a Biotage PS1: TLC-based method calculated from solvent conditions 9:1-mixture petroleum ether/Ethyl Acetate.
  • Step 2, exemplified for a 24 mmolar scale:
  • Figure US20100137178A1-20100603-C00164
  • In an oven dried flask were mixed 24 mmol of the alcohol (5.3 g) with 30 mL of dichloromethane at room temperature. The reaction mixture was stirred for 10 minutes in an ice bath, before 1.1 equivalents of Dess-Martin periodinane (15 w % in CH2Cl2; 75 g), were added drop wise upon this solution. The reaction was stirred for 4 days, while the reaction temperature was allowed to come to room temperature. The reaction mixture was quenched by adding it to 100 mL of 1N NaOH solution, cooled with ice cubes. The organic layer was extracted with diethyl ether (Et2O; 2*15 mL) and washed with aq. NaHCO3 (10 mL) and brine (10 mL). The crude oil was obtained after drying over MgSO4, filtration and concentration. Then, the crude oil was dissolved again in Et2O and kept in the freezer for 16 hours. The white precipitate was filtered of and the filtrate was concentrated. The pure compound was obtained after flash chromatography, performed with a Biotage PS 1: TLC-based method calculated from solvent conditions 9:1-mixture petroleum ether/Ethyl Acetate.
  • Synthesis of compounds Table 1 Molecules Numbers 2, 3 and 4:
  • Figure US20100137178A1-20100603-C00165
  • A representative procedure is given for the synthesis of Table 1 Material No. 2 by alkylation of benzyl iso-propyl ketone with bromobutane at the benzylic position:
  • In a flask were mixed 1.6 mmol of 3-methyl-1-phenylbutan-2-one (1 equiv), 1.9 mmol of n-butylbromide (1.2 equiv), 0.022 mmol of N-benzyltriethylammonium bromide (2 mol %) with 0.5 mL of 50% NaOH at room temperature. The reaction mixture was vigorously stirred at room temperature for 1 h. The temperature of the reaction was increased to 60° C., whilst stifling was continued for 5 h. Then, the reaction mixture was quenched by adding it to a cooled 1 M HCl solution. 10 mL of methyl tent-butyl ether (MTBE) was added and the combined organic fractions were extracted with MTBE (2*5 mL) and washed with saturated aqueous NaHCO3 (5 mL) and brine (5 mL). The crude oil was obtained after drying over MgSO4, filtration and concentration. The pure compound was obtained after flash chromatography, performed with a Biotage PS1: TLC-based method calculated from solvent conditions 98:2-mixture petroleum ether/Ethyl Acetate.
  • Modification of the representative protocol for the analogues is given in the following Table:
  • Table 1 Reaction
    Molecules time at
    No. R1Br Scale 60° C.
    21 n-BuBr 1.6 mmol  5 h
    31 i-PrBr 1.5 mmol 24 h
    41 EtBr   3 mmol 16 h
    1Flash Chromatography was performed with a Biotage PS1: TLC-based method calculated from solvent conditions 98:2-mixture petroleum ether/Ethyl Acetate.
    • Synthesis of Table Molecules Numbers: 15, 16, 17, 18, 19 and 20:
  • Figure US20100137178A1-20100603-C00166
  • A representative procedure is given for the synthesis of Table 1 Molecule No. 16 by addition of ethylmagnesium bromide (R2=Et; X=Br) upon 3-(4-methylcyclohex-3-enyl)butanal (Limonenaldehyde; R1=H):
  • A 2-necked 4-L flask was dried for 24 h at 20 mbar and 80° C. in the oven. The glassware was allowed to cool to ambient temperature under nitrogen atmosphere, before 140 gram of 3-(4-methylcyclohex-3-enyl)butanal (Limonenaldehyde; 1 equiv; 0.85 mol) was dissolved in 2.8 L (5 w %) of dry 2-methyltetrahydrofuran (2-MeTHF) under dry conditions (canula). The solution was cooled to −50° C. for 1 hour. Then, 280 mL of ethyl-magnesium bromide, dissolved in 2-MeTHF (3.2 M; 1.06 equiv), were added via a dry dropping funnel under nitrogen atmosphere (over approximately 45 minutes; the temperature of the reaction mixture was probed and not allowed to heat over −40° C.). The reaction was prolonged for 1 hour at −50° C. Then, the reaction was allowed to stir overnight at 0° C. The reaction was quenched by adding it to 1 liter of 1 M HCl, cooled with ice cubes (approx. 600 gram of ice). Then, the aqueous phase was extracted with 2-MeTHF (2*200 mL). The combined organic phases were washed with aqueous sat. bicarbonate (2*100 mL) and with brine (2*100 mL). The combined fractions were dried over MgSO4, filtered and concentrated at the rotavap. The pure compound was obtained after distillation (111-127° C., 5-10 mbar).
  • Modification of the representative protocol for the analogues is given in following Table:
  • Table 1 Carbonyl Reaction
    Molecule compound Grignard temp (° C.) Purification
    No. (scale) R2, X time [h] protocol
    15 Limonenaldehyde R2 = Me 0° C., 1 h Biotage1
    (50 mmol) X = Br rt, 16 h
    17 4-(4-methylcyclo- R2 = Me 0° C., 1 h Biotage1
    hex-3-enyl)- X = Br rt, 16 h
    pentan-2-ol
     (2 mmol)
    16 Limonenaldehyde R2 = Et −50° C., 2 h Dist
    (0.85 mol)    X = Br 0° C., 16 h (111-127° C.,
    5-10 mbar)
    19 Limonenaldehyde R2 = i-Pr 0° C., 1 h Biotage1
    (20 mmol) X = Cl rt, 16 h
    18 Limonenaldehyde R2 = Allyl 0° C., 1 h Biotage1
    (10 mmol) X = Cl rt, 16 h
    20 Limonenaldehyde R2 = t-Bu 0° C., 1 h Biotage1
     (2 mmol) X = Cl rt, 16 h
    1Flash Chromatography was performed with a Biotage PS1: TLC-based method calculated from solvent conditions 85:15-mixture petroleum ether/Ethyl Acetate.
    • Synthesis of Table 1 Molecules Numbers 21, 22, 23, 24, 25, 26, and 27:
  • Figure US20100137178A1-20100603-C00167
  • A representative procedure is given for the synthesis of Table 1 Molecule 22 by addition of Des s-Martin periodinane upon 5-(4-methylcyclohex-3-enyl)hexan-3-ol (R1=Me):
  • In an oven dried flask were mixed 5.5 gram of 5-(4-methylcyclohex-3-enyl)hexan-3-ol (1 equiv; 30 mmol) with 30 mL of dichloromethane at room temperature. The reaction mixture was stirred for 10 minutes at 0° C., before 1.1 equivalents of Dess-Martin periodinane (15 w % in CH2Cl2; 94 g), were added drop wise to this solution. The reaction was stirred for 3 days, while the reaction temperature was allowed to come to room temperature. The reaction mixture was quenched by adding it to 100 mL of 1 N NaOH solution, cooled with ice cubes. The organic layer was extracted with diethyl ether (Et2O; 2*15 mL) and washed with aqueous saturated NaHCO3 (10 mL) and brine (10 mL). The crude oil was obtained after drying over MgSO4, filtration and concentration. Then, the crude oil was dissolved again in Et2O and kept in the freezer for 16 hours. The white precipitate was filtered of and the filtrate was concentrated at the rotavap. The pure compound was obtained after flash chromatography, performed with a Biotage PS 1: TLC-based method calculated from solvent conditions 85:15-mixture petroleum ether/Ethyl Acetate.
  • Modification of the representative protocol for the analogues is given in the following Table:
  • Table 1 Alcohol Reaction
    Molecule No. R1 = Scale time [h]
    22 Me 15 mmol 0° C.
    rt, 72 h
    23 Et 10 mmol 0° C.
    rt, 16 h
    24 i-Pr 10 mmol 0° C.
    rt, 72 h
    26 Allyl 20 mmol 0° C.
    rt, 16 h
    25 n-Pr  1 mmol 0° C.
    rt, 16 h
    21 n-Am  1 mmol 0° C.
    rt, 16 h
    27 t-Bu 20 mmol 0° C.
    rt, 48 h
    1Flash Chromatography was performed with a Biotage PS1: TLC-based method calculated from solvent conditions 85:15-mixture petroleum ether/Ethyl Acetate.
    • Synthesis of Table 1 Molecules Numbers 28 and 29:
  • Figure US20100137178A1-20100603-C00168
  • A representative procedure is given for the synthesis of Table 1 Molecule 29 by acetylation of 5-(4-methylcyclohex-3-enyl)hexan-3-ol:
  • In an oven dried flask were mixed at room temperature and under helium atmosphere 15 mL of 2-methyltetrahydrofuran (2-MeTHF), 0.15 gram of 4-(dimethylamino)pyridine (DMAP; 0.08 equiv), 8.2 gram of N-methylmorpholine (NMM; 5.3 equiv; 8.9 mL) and 3 gram of 5-(4-methylcyclohex-3-enyl)hexan-3-ol (15 mmol; 1 equiv) under dry conditions. The reaction mixture was stirred for 10 minutes in an ice bath, before 7.8 gram of acetic anhydride (5 equiv; 7.17 mL) was added via a dropping funnel over a 10 minutes period. The reaction was prolonged for 1 hour at 0° C. Then the ice bath was removed and the reaction was continued for 1 h at room temperature while the conversion of the reaction was followed by GC-FID, via analysis of aliquots of the reaction mixture, which were removed by syringe. Then 30 mL of water was added and the reaction mixture was heated to 50° C. for 15 min and extraction was performed at this temperature (2-MeTHF; 2*10 mL). The organic fractions were washed with sat. bi-carbonate and brine, dried over MgSO4, filtered and concentrated at the rotavap. Additional flash chromatography was performed to obtain the compound in high purity, with a Biotage PS1: TLC-based method calculated from solvent conditions 85:15-mixture petroleum ether/Ethyl Acetate.
    • Synthesis of Table 1 Molecules Numbers 1, 5, 6, 8, 9, 10, 11, 12, 13 and 14:
  • Figure US20100137178A1-20100603-C00169
  • A representative procedure is given for the synthesis of Table 1 Molecule 10 by addition of 2-cyclopentylacetyl chloride to benzene:
  • A 2-L flask, dropping funnel, stifling bar and septum were dried in the oven at 80° C. and 20 mbar for 24 h. The glassware was cooled to room temperature under nitrogen atmosphere, before 152 gram of aluminium trichloride (AlCl3; 1.2 equiv) was dissolved in 300 mL of anhydrous benzene. Then, 140 gram of cyclopentylacetyl chloride (1 equiv) were added drop wise and very slowly over a 2 h period to this reaction mixture while the temperature was controlled below 40° C. by the rate of addition of the acid chloride. The reaction start and progress were followed by the gas evolvement. Then, the reaction mixture was continued at 45° C. for 16 h. The reaction mixture was quenched by adding it to a large quantity of crushed ice (1.5 kg). 1 Liter of demineralised water was added, while controlling the temperature with ice. A white suspension was formed. The glassware was washed with 100 mL of methyl tent-butyl ether (MTBE) and the combined organic layers were filtered and extracted with MTBE (2*100 mL). Then the organic layers were washed with aqueous NaHCO3 solution and brine. The organic fractions were collected, dried over Na2SO4, filtered and dried in vacuo (70° C. at 15 mbar) to afford a red oil. This oil was mixed with 10 w % of active carbon and stirred at room temperature for 16 h. Then the mixture was filtered over a short Celite path and the glassware and filter were rinsed with 100 mL of ligroin. The organic fractions were combined and dried at the rotavap, affording a yellow oil.
  • Modification of the representative protocol for the analogues is given in the following Table:
  • Table 1 Reaction
    Molecule Acid Chloride temp (° C.) Purification
    No. (scale) Aryl ring time [h] protocol
    1 Cyclohexylacetyl benzene rt, 24 h —
    chloride
    (30 mmol)
    5 Cyclohexylacetyl toluene rt, 4 h —
    chloride
    (10 mmol)
    6 Cycloheptylacetyl benzene rt, 24 h —
    chloride
     (5 mol)
    10 Cyclopentylacetyl benzene rt —
    chloride 45° C., 16 h
    (500 mmol) 
    11 3-cyclohexyl- benzene rt Recryst
    propanoyl 45° C., 16 h (Et2O)
    chloride
    (50 mmol)
    12 3-cyclohexyl- ethylbenzene rt, 72 h Biotage1
    propanoyl
    chloride
    (50 mmol)
    13 3-cyclohexyl- toluene rt, 72 h Recryst
    propanoyl (Et2O)
    chloride
    (50 mmol)
    14 3-cyclohexyl- mesitylene rt, 72 h Biotage1
    propanoyl
    chloride
    (30 mmol)
    8 Cyclopentylacetyl ethylbenzene 0° C. Biotage1
    chloride rt, 16 h
    (15 mmol)
    9 Cyclopentylacetyl mesitylene 0° C. Biotage1
    chloride rt, 16 h
    (15 mmol)
    1Flash Chromatography was performed with a Biotage PS1: TLC-based method calculated from solvent conditions 95:5-mixture petroleum ether/Ethyl Acetate.
    • Synthesis of Table 1 Molecules Numbers 30, 33, 34, 37, 38, 39, 40 and 44:
  • Figure US20100137178A1-20100603-C00170
  • A representative procedure is given for the synthesis of Table 1 Molecule 33 with para-Tolualdehyde (R1, R2, R4=H; R3=Me) and methyl ethyl ketone (R5=Me):
  • In a reaction flask were mixed at room temperature 10.61 mol of ketone (1.7 equiv), 6.24 mol of aldehyde (1 equiv) and 0.5 mol % of RuCl3.nH2O (9.2 gram). Then, the reaction mixture was stirred whilst the temperature of the oil bath was increased to 115-130° C. Aliquots of the reaction mixture were removed by syringe and analyzed by GC-FID. Based on the GC-results, the reaction was allowed to progress (in this specific case) until 85% of the starting material was converted over a period of 7 days. Then, the reaction mixture was cooled to room temperature before 1.5 L of toluene was added. The organic phase was extracted with aqueous saturated bicarbonate (4*750 mL). Each time, the aqueous phase was washed with toluene (2*100 mL). After this washing, all the organic phases were combined and washed once more with aqueous saturated bicarbonate (750 mL) and with brine (3*250 mL).
  • Then, a series of bisulfite washings were performed on the crude oil obtained after concentration of the organic phase at the rotavap (70° C. at 100 mbar). The crude oil was dissolved in equal amounts of toluene and mixed at room temperature with a 40 w % of aqueous NaHSO3 (1.5 equiv of sodium bisulfite as calculated for the amount of aldehyde present in the crude oil). This mixture was vigorously stirred for 1 hour at room temperature before the organic fraction was decanted. The aqueous layer was extracted once with 50 mL of toluene.
  • The combined organic fractions were washed with aqueous saturated bicarbonate (2*25 mL) and brine (2*25 mL), dried over MgSO4, filtered and concentrated. The bisulfite washings were repeated until the total amount of aldehyde was below 4% (in this specific case, three washings were performed). The compound was purified via distillation (4-7 mbar; oil bath 115-160° C.) and recrystallisation from methyl tent-butyl ether (MTBE; 2*200 w %).
  • Modification of the representative protocol for the
    analogues is given in the following Table:
    Reaction
    Table 1 Ketone temp
    Molecule Aldehyde R5 (° C.) Purification
    No. R1, R2, R3, R4 (equiv) time [d] protocol
    30 R1, R2, R3, R5 = Me (120) [1] Biotage1
    R4 = H (0.5 equiv)
    33 R1, R2, R4 = H R5 = Me (120) [7] Distillation,
    R3 = Me (1.7 equiv) recrystallisation
    34 R1, R2, R4 = H R5 = Me (120) [7] Biotage1
    R3 = CN   (1 equiv)
    37 R2, R3, R4 = H R5 = Me (120) [14] Biotage1, Dist
    R1 = Me   (2 equiv)2 (102-121° C.;
    3-13 mbar)
    38 R1, R3, R4 = H R5 = Me (125) [1] Biotage1
    R2 = Me (0.5 equiv)
    39 R1, R2, R4 = H R5 = Me (125) [1] Biotage1
    R3 = OMe (0.5 equiv)
    40 R1, R2, R4 = H R5 = Et (130) [4] Biotage1, Dist
    R3 = Me (0.5 equiv) (110-135° C.;
    3-5 mbar)
    44 R1, R3, R4 = Me R5 = Me (125) [7] Dist
    R2 = H   (2 equiv)2 (91-93° C.;
    0.1-0.4 mbar)
    1Flash Chromatography was performed with a Biotage PS1: TLC-based method calculated from solvent conditions 9:1-mixture petroleum ether/Ethyl Acetate.
    2more RuCl3 catalyst was added.
    • Synthesis of Table 1 Molecules Numbers 32, 35, 36, 41, 42, 43, 45, 46 and 47:
  • Figure US20100137178A1-20100603-C00171
  • A representative procedure is given for the synthesis of Table 1 Molecule 35 by condensation of benzaldehyde (R1, R2, R3, R4=H) with 2-pentanone (R5=Et; R6, R7=H):1 1In analogy to: Cao, Y.-Q.; Dai, Z.; Zhang, R. and Chen, B.-H. Synth. Commun., 2005, 35, 1045-1049.
  • In a 2-L flask, 330 gram of benzaldehyde (1 equiv) was mixed with 1 Liter of 2-pentanone (3 equiv). The reaction mixture was cooled to 5-10° C. and thoroughly stirred, before 40 mL of NaOH, 50 w % solution in water (0.5 equiv, 61 g), was slowly added in one portion. After 30 minutes, the temperature of the reaction mixture was allowed to rise to 20° C. The reaction was continued for 5 hours at ambient temperature. Then, the reaction was quenched by adding the reaction mixture to a 2 M HCl solution which was cooled with equal amounts of ice. After extraction with 2-pentanone (2*100 mL), the combined organic fractions were washed with saturated, aqueous bicarbonate solution (50 mL) and brine (50 mL). The organic fractions were combined and concentrated at the rotavap, resulting in a yellow oil. This crude oil was poured in an Erlenmeyer, containing 400 mL of diethyl ether (Et2O). The flask was rinsed with 100 mL of Et2O, which was added to the organic phase. Then, 500 mL of aqueous saturated NaHSO3 solution was added to the combined organic fractions at room temperature. This mixture was vigorously stirred for 1 hour before the organic phase was decanted and washed with saturated, aqueous bicarbonate solution (25 mL) and brine (25 mL). The yellow oil obtained was concentrated at the rotavap and dried at the membrane pump (70° C. at 4 mbar). The compound was first purified via distillation (115-125° C., 1-3 mbar). Afterwards, two additional bisulfite washings were performed.
  • Modification of the representative protocol for the analogues is given in the following Table:
  • Compound Aldehyde Ketone
    Number R1, R2, R3, R4 R5 equiv ketone Purification protocol
    32 R1, R3, R4 = H R5 = Me 2.8 equiv   Biotage1
    R2 = Me R6, R7 = H
    36 R2, R3, R4 = H R5 = Me 2.8 equiv   Biotage1
    R1 = Me R6, R7 = H
    35 R1, R2, R3, R4 = H R5 = Et 3 equiv Dist (115-125° C.; 1-3 mbar)
    R6, R7 = H
    47 R1, R3, R4 = H R5 = Et 3.5 equiv   Biotage1
    R2 = Me R6, R7 = H
    43 R1, R3, R4 = Me R5 = Et 3 equiv Dist (105-125° C.;
    R2 = H R6, R7 = H 0.1-0.4 mbar)
    recryst (MTBE)
    41 R2, R3, R4 = H R5 = Et 3.5 equiv   Dist(90-95° C.;
    R1 = Me R6, R7 = H 0.01-0.04 mbar)
    42 R1, R3, R4 = Me R5 = Et 3 equiv Dist (91-93° C.; 0.1-0.4 mbar)
    R2 = H R6, R7 = H
    45 R2, R3 = H R5 = Et 3 equiv Dist (105-125° C.;
    R1, R4 = Me R6, R7 = H 0.05-0.2 mbar)
    46 R2, R3 = H R5 = Me 6 equiv Dist (80-90° C.;
    R1, R4 = Me R6, R7 = H 0.02-0.1 mbar)
    1Flash Chromatography was performed with a Biotage PS1: TLC-based method calculated from solvent conditions 7:3-mixture petroleum ether/Ethyl Acetate.
    • Synthesis of Table 1 Molecule Number 7:
  • Figure US20100137178A1-20100603-C00172
  • Reaction Components
    1 Cyclopentylacetyl Chloride C7H11OCl 1 equiv. - 10 g
    146.61 g/mol
    2 Toluene C7H9 30 mL
     92.11 g/mol
    3 Aluminium Chloride AlCl3 1.2 equiv. - 10.9 g
    133.34 g/mol
  • Glassware for parallel synthesis (flask, condenser and dropping funnel), stifling bar, septum and syringe were dried in the oven at 80° C. and 20 mbar for 24 h. All the glassware was mounted as foreseen and was cooled down to room temperature under Argon atmosphere, before A1Cl3 was dissolved in the toluene. The reaction vessel was placed in an ice bath and the acid chloride was added drop wise after some time. Even though the acid chloride was added very slow via the dropping funnel a slightly exothermic reaction started and a lot of gas evolved. Every 2 minutes the pressure was released. The reaction mixture was stirred at room temperature overnight, before the reaction was checked via GC MS. Then the reaction mixture was quenched in demineralised water with 5 ice cubes in it. A white suspension was formed (exothermic; additional ice cubes were added). The glassware was washed with 25 mL of Et2O and the combined organic layers were filtered and extracted with ether (2*20 mL). Then the organic layers were treated with 2*25 mL of aqueous NaHCO3 solution and this aqueous layer was extracted again with diethyl ether (2*10 mL). Then, the organic fractions were collected, dried over Na2SO4, filtered and dried in vacuum (low pressure; high temperature resulting in a dark oil formed. The compound was placed in the fridge and solidified after some time. It was tried to purify the ketone via re-crystallisation. First it was dissolved in the minimal amount of Et2O. Upon cooling it solidified after a few hours. This procedure was repeated two times resulting in colourless crystals.
    • Synthesis of Table 1 Molecule Number 49, 50 & 61:
  • Figure US20100137178A1-20100603-C00173
  • Compound applied scale
    Number R (mmol substrate)
    49 t-Bu 10
    50 i-Pr 11
    61 Me 10
  • A representative procedure is given for the synthesis of Table 1 Molecule 50.
    • Step 1.
  • A solution of n-butyllithium (2.2M in cyclohexane—1 eq.) was added drop wise to an ice cold solution of diisopropylamine (1 eq.) in dry THF. After stirring for 10 minutes at this temperature, propionitrile (5 eq.) was added to the mixture. Prenyl bromide (1 eq.) was added after another mixing of 10 minutes at 0° C. Reaction conversion was followed by GC-MS and seen as complete after 15 minutes stirring at 0° C.
  • The reaction was quenched by addition of saturated NH4Cl aqueous solution and extracted with Et2O. The combined organic layers were dried over MgSO4 and concentrated under reduced pressure. The resulting oil was purified using a quick filtration over silica by elution with a petroleum ether-Et2O mixture (9-1). Concentration of the eluent under reduced pressure resulted in the compound as a colorless oil.
    • Step 2.
  • A methyllithium solution (1.2 equiv.) was added drop wise to a solution of the nitrile (1 eq.) in dry THF (0.5M) at −20° C. After stirring for 15 minutes at −10/-20° C., full conversion was observed by GC-MS. The reaction was quenched with a H2SO4 solution (2M—2 eq.) and stirred at ambient temperature till full hydrolysis of the in situ formed imine was observed. The mixture was then extracted with Et2O and washed with a saturated NaHCO3 aqueous solution. The combined organic phases were dried over MgSO4 and concentrated under reduced pressure. The resulting oil was purified with column chromatography by eluting with a petroleum ether—MTBE mixture (95-5). Concentration of the desired fractions under reduced pressure resulted in the compound as a colorless oil.
    • Synthesis of Table 1 Molecule Number 52:
  • Figure US20100137178A1-20100603-C00174
  • Compound 52 was synthesized starting from 20 mmol 4,4-dimethyl-3-oxopentanoate.
    • Step 1.
  • To a solution of 4,4-dimethyl-3-oxopentanoate (1 eq.) and K2CO3 (2.2 eq.) in dry acetone (0.9 M) was added iodomethane (3.3 eq.) at 60° C. The mixture was stirred for 16 hours at the same temperature and dried over MgSO4 after cooling to ambient temperature. The organic mixture was concentrated under reduced pressure to yield the product without further purification.
    • Step 2.
  • The β-keto-ester (1 eq.) formed in step 1 was solved in MTBE (0.6 M) and sodium t-butoxide (1.1 eq.) and prenyl bromide (1.5 eq.) were added at room temperature. The resulting mixture was stirred for 16 hours at the same temperature and quenched with an aqueous H2SO4 solution (0.5 M). After extracting the mixture with MTBE, the collected organic layers were dried over MgSO4 and concentrated under reduced pressure. The resulting oil was purified by column chromatography using a petroleum ether-MTBE mixture (95-5) as eluens. Concentration of the eluent under reduced pressure resulted in the compound as a colorless oil.
    • Synthesis of Table 1 Molecule Number 53:
  • Figure US20100137178A1-20100603-C00175
  • Compound 53 was synthesized starting from 45 mmol 3,3-dimethyl-2-butanone.
  • A solution of n-butyllithium (2.2M in cyclohexane—2 eq.) was added drop wise to an ice cold solution of diisopropylamine (2 eq.) in dry THF (0.5 M). After stirring for 10 minutes at this temperature, 3,3-dimethyl-2-butanone (1 eq.) was added to the mixture. Prenyl bromide (2 eq.) was added after another mixing of 10 minutes at 0° C. Reaction conversion was followed by GC-MS and seen as complete after 12 h at ambient temperature.
  • The reaction was quenched by addition of saturated NH4Cl aqueous solution and extracted with Et2O. The combined organic layers were dried over MgSO4 and concentrated under reduced pressure. The resulting oil was purified by column chromatography using a petroleum ether-MTBE mixture (95-5) as eluens. Concentration of the eluent under reduced pressure resulted in the compound as a colorless oil.
    • Synthesis of Table 1 Molecule Number 63:
  • Figure US20100137178A1-20100603-C00176
  • Compound 63 was synthesized starting from 15 mmol lavandulol.
  • To a stirred solution of lavandulol (1 eq.) in dry CH2Cl2 (0.2 M) at ambient temperature was added NaHCO3 (4 eq.) and Dess-Martin periodane (1.5 eq.). Complete reaction conversion was observed via GC-MS after 1 hour stirring at the same temperature. The reaction was quenched by the addition of petroleum ether and filtered over a silica gel plug and rinsed with a petroleum ether—Et2O mixture (9-1). The crude aldehyde is obtained by concentration under reduced pressure.
  • This aldehyde was resolved in t-BuOH (0.2 M) and 2-methyl-2-butene (0.6 M). The resulting solution was cooled to 0° C. and a solution of NaClO2 (10 eq.) and NaH2PO4 (8 eq.) in water (0.3 M) was added. The reaction mixture was allowed to warm to ambient temperature and stirred for 2 hours. The resulting mixture was quenched by the addition of a phosphate buffer (pH 7). The two layers were separated and the aqueous layer was extracted with CH2Cl2. The combined organic phases were dried over MgSO4 and concentrated under reduced pressure. Column chromatography using the eluent petroleum ether—Et2O (1-1) resulted in the compound as a colorless oil.
    • Synthesis of Table 1 Molecule Number 73, 74, 75, 76, 77, 91, 106, 109, 121, 124, 130, 132, 136, 138, 139, 143, 148, 152, 157, 158 & 161:
  • Figure US20100137178A1-20100603-C00177
  • Compound applied scale
    Number R1 R2 (mmol substrate)
     73 R1 = Me, H
    Figure US20100137178A1-20100603-C00178
         		28
    Figure US20100137178A1-20100603-C00179
     74 2R1 = cyclopentyl
    Figure US20100137178A1-20100603-C00180
         		54
     75 2R1 = cyclohexyl
    Figure US20100137178A1-20100603-C00181
         		64
     76 2R1 = cyclopropyl
    Figure US20100137178A1-20100603-C00182
         		63
     77 2R1 = cyclobutyl
    Figure US20100137178A1-20100603-C00183
         		600 
     91 Me
    Figure US20100137178A1-20100603-C00184
         		165 
    106 Me
    Figure US20100137178A1-20100603-C00185
         		137
    109 2R1 = cyclopropyl
    Figure US20100137178A1-20100603-C00186
         		68
    121 Me
    Figure US20100137178A1-20100603-C00187
         		72
    124 Me
    Figure US20100137178A1-20100603-C00188
         		55
    130 Me
    Figure US20100137178A1-20100603-C00189
         		28
    132 2R1 = cyclobutyl
    Figure US20100137178A1-20100603-C00190
         		49
    136 2R1 = cyclopropyl
    Figure US20100137178A1-20100603-C00191
         		54
    138 Me
    Figure US20100137178A1-20100603-C00192
         		55
    139 Me
    Figure US20100137178A1-20100603-C00193
         		55
    143 Me
    Figure US20100137178A1-20100603-C00194
         		55
    148 Me
    Figure US20100137178A1-20100603-C00195
         		25
    152 Me
    Figure US20100137178A1-20100603-C00196
         		55
    157 Me
    Figure US20100137178A1-20100603-C00197
         		55
    158 Me
    Figure US20100137178A1-20100603-C00198
         		55
    161 Me
    Figure US20100137178A1-20100603-C00199
         		26
    (used for synthesis compounds 98 + 99) Me
    Figure US20100137178A1-20100603-C00200
         		19
    (used for synthesis compounds 115) Me
    Figure US20100137178A1-20100603-C00201
         		55
  • A representative procedure is given for the synthesis of Table 1 Molecule 152.
  • A solution of n-butyllithium (2.2M in cyclohexane—1 eq.) was added drop wise to an ice cold solution of diisopropylamine (1 eq.) in dry THF (0.5 M). After stirring for 10 minutes at this temperature, i-butyronitrile (1 eq.) was added to the mixture. 3-Bromocyclohex-1-ene (1 eq.) was added after another mixing of 10 minutes at 0° C. Reaction conversion was followed by GC-MS and seen as complete after 15 minutes stirring at 0° C.
  • The reaction was quenched by addition of a saturated NH4Cl aqueous solution and extracted with Et2O. The combined organic layers were dried over MgSO4 and concentrated under reduced pressure. The resulting oil was purified using a quick filtration over silica by elution with a petroleum ether-Et2O mixture (9-1). Concentration of the eluent under reduced pressure resulted in the compound as a colorless oil.
  • Synthesis of Table 1 Molecule Number 51, 54, 55, 56, 57, 58, 59, 60, 62, 64, 65, 66, 67, 68, 69, 70, 71, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 92, 93, 94, 95, 96, 97, 98, 99, 100, 102, 103, 104, 107, 108, 110, 111, 112, 113, 114, 115, 117, 122, 126, 127, 128, 131, 133, 134, 137, 142, 149, 150, 151, 153, 154, 155, 156, 159 & 160:
  • Figure US20100137178A1-20100603-C00202
  • Compound
    Number Nitrile R3 applied scale (mmol substrate)
    51  91 t-Bu 6
    54  75 Me 5
    55  75 Et 6
    56  75 i-Pr 14
    Compound 62 was isolated as
    side product in the imine
    hydrolysis to compound 56.
    57  91 Et 16
    58  74 Me 12
    59  74 Et 12
    60  73 Me 8
    64  74 i-Pr 15
    65  73 Et 10
    66  73 i-Pr 10
    67  91 s-Bu 15
    68  76 Me 7
    69  76 s-Bu 15
    70  76 i-Pr 15
    71  76 n-Bu 15
    78  77 s-Bu 11
    79  77 Me 13
    80 [935-44-4] s-Bu 10
    81  77 n-Bu 11
    82  77 i-Pr 13
    83 [935-44-4] Et 14
    84 [935-44-4] i-Pr 13
    85  76 Et 14
    86  76 i-Bu 13
    87 [71172-78-6] Et 11
    88 [71172-78-6] s-Bu 10
    89 [15760-35-7] Me 10
    90 [14377-68-5] n-Bu 10
    92  91 n-Bu 11
    93  91 i-Bu 11
    94  74 n-Bu 10
    95  74 i-Bu 10
    96  76 t-Bu 12
    97 [71172-78-6] i-Pr 11
    98 described in Me 9
    nitrile synthesis
    99 protocol s-Bu 8
    100 101 i-Pr 11
    102 101 Me 12
    103 101 Et 13
    104 [68983-70-0] Me 11
    107 106 Me 12
    108 106 Et 12
    110 106 s-Bu 129
    111 109 Et 11
    112 109 Me 11
    113 109 s-Bu 10
    114 109 i-Pr 11
    115 [35863-45-7] i-Bu 10
    117  77 Et 167
    122 121 Et 10
    126 124 s-Bu 9
    127 121 Me 10
    128 124 Et 10
    131 130 i-Pr 10
    133 132 Me 11
    134 132 i-Pr 19
    137 136 Me 12
    142 139 Me 9
    149 148 Et 9
    150 148 n-Bu 9
    151 143 Me 12
    153 152 i-Bu 11
    154 143 n-Bu 9
    155 152 Et 12
    156 143 Et 10
    159 158 n-Bu 11
    160 157 Me 11
  • A representative procedure is given for the synthesis of Table 1 Molecule 151.
  • A methyllithium solution (1.2 equiv.) was added drop wise to a solution of the nitrile (1 eq.) in dry THF (0.5M) at −20° C. After stifling for 15 minutes at −10/−20° C., full conversion was observed by GC-MS.
  • The reaction was quenched with a H2SO4 solution (2M—2 eq.) and stirred at ambient temperature till full hydrolysis of the in situ formed imine was observed. The mixture was then extracted with Et2O and washed with a saturated NaHCO3 aqueous solution. The combined organic phases were dried over MgSO4 and concentrated under reduced pressure. The resulting oil was purified using a quick filtration over silica gel by eluting with a petroleum ether—Et2O mixture (9-1). Concentration of the eluent under reduced pressure resulted in the compound as a colorless oil.
    • Synthesis of Table 1 Molecule Number 72, 105, 120, 123, 144, 145, 146 & 147:
  • Figure US20100137178A1-20100603-C00203
  • Compound applied scale
    Number RM (mmol substrate)
    72 EtMgBr 146
    105 PhLi 7
    120 VinylMgBr 100
    123 cyclopentylMgCl 5
    144 n-BuLi 6
    145 i-PrMgCl 6
    146 i-BuLi 6
    147 t-BuLi 5
  • A representative procedure is given for the synthesis of Table 1 Molecule 72.
    • Step 1.
  • To a solution of the phosphonium bromide [50889-29-7] (1.2 eq.) in dry THF (0.3 M) was added KHMDS (Potassiumhexamethyldisilazane—2.4 eq.) at ambient temperature. After stirring for 30 minutes at the same temperature, a solution of acetone (1 eq.) in dry THF (0.3 M) was added drop wise. The mixture was stirred for 3 hours, quenched with water (0.3 M) and extracted with Et2O. The resulting water layer was acidified with a HCl aqueous solution (10%) till pH 2 was obtained. This mixture was extracted with Et2O and the extracts were dried over MgSO4 and concentrated under reduced pressure. The resulting oil was purified using a quick filtration over silica gel by eluting with a petroleum ether—Et2O mixture (1-1). Concentration under reduced pressure resulted in the compound as a slightly yellow oil.
    • Step 2.
  • To a solution of the acid formed in step 1 (1 eq.) in dry CH2Cl2 (0.5 M) was added 1,1′-carbonyldiimidazole (1 eq.) at ambient temperature. The mixture was stirred for 15 minutes and N,O-Dimethylhydroxylamine hydrochloride (1 eq.) was added. Stirring was continued at the same temperature for 1 hour and the mixture was quenched with an aqueous HCl solution (1 M—1.1 eq.). The aqueous layer was extracted with Et2O, washed with NaHCO3 and dried over MgSO4. Concentration under reduced pressure resulted in the compound as a colorless oil.
    • Step 3.
  • The Weinreb amide formed in step 2 was solved in dry THF (0.5 M) and cooled to −15° C. A solution of EtMgBr (1 M—1.5 eq.) was added drop wise to the mixture. Complete reaction conversion was observed with GC-MS after 10 minutes stirring at −10/−15° C. This reaction mixture was quenched with a saturated aqueous NH4Cl solution, extracted with Et2O; dried over MgSO4 and concentrated under reduced pressure. The resulting oil was purified using a quick filtration over silica gel by eluting with a petroleum ether—Et2O mixture (9-1). Concentration under reduced pressure resulted in the compound as a colorless oil.
    • Synthesis of Table 1 Molecule Number 101:
  • Figure US20100137178A1-20100603-C00204
  • Compound 101 was synthesized starting from 100 mmol nitrile [2947-60-6].
  • To a solution of diisopropylamine (2.2 eq.—28.1 mL) in dry THF (0.5 M) was added drop wise a solution of n-butyllithium (2.2 eq.—100 mL 2.2 M) at 0° C. 2-m-Tolylacetonitrile (1 eq.—13 mL) was added to the solution after 10 minutes of stirring at the same temperature. A supplementary stirring for 10 minutes was followed by the drop wise addition of iodomethane (2.5 eq.—15.6 mL). Reaction completion was observed after 10 minutes stirring at 0° C. The mixture was quenched with an aqueous solution of NH4Cl, extracted with Et2O, dried over MgSO4 and concentrated under reduced pressure. The resulting oil was purified using a quick filtration over silica gel by eluting with a petroleum ether—Et2O mixture (9-1). Concentration under reduced pressure resulted in the compound as a colorless oil.
    • Synthesis of Table 1 Molecule Number 116, 118 & 129:
  • Figure US20100137178A1-20100603-C00205
  • applied scale
    Compound (mmol
    Number R1 R2 R3 R4 substrate)
    116 2R1 = cyclopropyl prenyl Me Me 13
    118 2R1 = cyclobutyl prenyl Et Me 8
    129 2R1 = cyclobutyl prenyl Et n-Bu 10
  • A representative procedure is given for the synthesis of Table 1 Molecule 116.
  • To a solution of compound 68 (1 eq.) in dry THF (0.5 M) was added a solution of methylmagnesium bromide (1.5 eq.—3M) at −20° C. The reaction mixture was allowed to warm to ambient temperature and stirring was continued for 2 hours. The reaction was quenched with the addition of a saturated aqueous NH4Cl solution and extracted with Et2O. The combined organic layers were dried over MgSO4 and concentrated under reduced pressure. The resulting oil was purified by column chromatography using the eluens petroleum ether—MTBE (95-5). Concentration of the required fractions resulted in the compound as a colorless oil.
    • Synthesis of Table 1 Molecule Number 119, 135 & 141:
  • Figure US20100137178A1-20100603-C00206
  • Compound applied scale
    Number Ketone R1 R2 R3 (mmol substrate)
    119 117 2R1 = cyclobutyl prenyl Et 8
    135 134 2R1 = cyclobutyl
    Figure US20100137178A1-20100603-C00207
         		i-Pr 7
    141 140 2R1 = cyclopropyl
    Figure US20100137178A1-20100603-C00208
         		allyl 11 
  • A representative procedure is given for the synthesis of Table 1 Molecule 119.
  • To a solution of compound 117 (1 eq.) in dry Et2O (0.5 M) was added portion wise lithium-aluminiumhydride (1 eq.) at 0° C. Reaction completion was observed by GC-MS after 15 minutes of stirring at ambient temperature. The mixture was cooled to 0° C. and consequently was added: water (same amount of mL as mg hydride used), 15% NaOH solution (same amount of mL as mg hydride used) & water (2 times amount of mL as mg hydride used). This quenching was followed by stirring for 1 hour at ambient temperature. The resulting mixture was filtered over celite and the filter was washed with Et2O. Concentration of the filtrate under reduced pressure resulted in the compound as a colorless oil.
    • Synthesis of Table 1 Molecule Number 125:
  • Figure US20100137178A1-20100603-C00209
  • Compound 125 was synthesized starting from 11 mmol iso-butyronitrile.
    • Step 1.
  • 4-Fluoro-2-methylanisole (1 eq.) was solved in dry THF (0.7 M) and KHMDS (Potassiumhexa-methyldisilazane—1.5 eq.) was added at room temperature. The mixture was heated to 60° C. after the addition of iso-butyronitrile (4 eq.). Refluxing was continued for 12 hours. The reaction was quenched with an aqueous HCl solution (1M) and extracted with Et2O. The organic layers were dried over MgSO4 and concentrated under reduced pressure (1 mbar at 55° C.). The resulting oil was purified using a quick filtration over silica gel by eluting with a petroleum ether-Et2O mixture (9-1). Concentration under reduced pressure resulted in the compound as a colorless oil.
    • Step 2.
  • The nitrile formed in step 1 was solved in dry THF (0.5 M) and cooled to −20° C. A solution of methyllithium (1.3 eq.—1.6 M) was added drop wise. Reaction completion was observed after 10 minutes stifling at −20° C. The reaction was quenched with a H2SO4 solution (2M—2 eq.) and stirred at ambient temperature till full hydrolysis of the in situ formed imine was observed (over night ambient temperature). The mixture was then extracted with Et2O and washed with a saturated NaHCO3 aqueous solution. The combined organic phases were dried over MgSO4 and concentrated under reduced pressure. The resulting oil was purified using a quick filtration over silica gel by eluting with a petroleum ether-Et2O mixture (9-1). Concentration of the eluent under reduced pressure resulted in the compound as a colorless oil.
    • Synthesis of Table 1 Molecule Number 140:
  • Figure US20100137178A1-20100603-C00210
  • Compound 140 was synthesized starting from 24 mmol acid [6120-95-2].
    • Step 1.
  • To a solution of 1-Phenyl-1-cyclopropanecarboxylic acid (1 eq.) in dry CH2Cl2 (0.5 M) was added 1,1′-carbonyldiimidazole (1 eq.) at ambient temperature. The mixture was stirred for 15 minutes and N,O-dimethylhydroxylamine hydrochloride (1 eq.) was added. Stirring was continued at the same temperature for 1 hour and the mixture was quenched with an aqueous HCl solution (1 M—1.1 eq.). The aqueous layer was extracted with Et2O, washed with NaHCO3 and dried over MgSO4. Concentration under reduced pressure resulted in the compound as a colorless oil.
    • Step 2.
  • The Weinreb amide formed in step 2 was solved in dry THF (0.5 M) and cooled to −15° C. A solution of EtMgBr (1 M—1.5 eq.) was added drop wise to the mixture. Complete reaction conversion was observed with GC-MS after 10 minutes stirring at −10/−15° C. This reaction mixture was quenched with a saturated aqueous NH4Cl solution, extracted with Et2O; dried over MgSO4 and concentrated under reduced pressure. The resulting oil was purified using a quick filtration over silica gel by eluting with a petroleum ether-Et2O mixture (9-1). Concentration under reduced pressure resulted in the compound as a colorless oil.
    • Example 2 Preformed Amine Reaction Product
  • The following ingredients are weighted off in a glass vial:
  • 50% of the perfume material comprising one or more Table 1 PRMs
  • 50% of Lupasol WF (CAS# 09002-98-6) from BASF, is put at 60° C. in warm water bath for 1 hour before use. Mixing of the two ingredients was done by using the Ultra-Turrax T25 Basic equipment (from IKA) during 5 minutes. When the mixing is finished the sample is put in a warm water bath at 60° C. for ±12 hours. A homogenous, viscous material is obtained. In the same way as described above different ratios between the components can be used:
  • Weight %
    Perfume Material 40 50 60 70 80
    Lupasol WF 60 50 40 30 20
    • Example 3 84 wt % Core/16 wt % Wall Melamine Formaldehyde (MF) Capsule (PAD Reservoir System
  • 25 grams of butyl acrylate-acrylic acid copolymer emulsifier (Colloid C351, 25% solids, pka 4.5-4.7, (Kemira Chemicals, Inc. Kennesaw, Georgia U.S.A.) is dissolved and mixed in 200 grams deionized water. The pH of the solution is adjusted to pH of 4.0 with sodium hydroxide solution. 8 grams of partially methylated methylol melamine resin (Cymel 385, 80% solids, (Cytec Industries West Paterson, N.J., U.S.A.)) is added to the emulsifier solution. 200 grams of perfume oil comprising one or more Table 1 PRMs is added to the previous mixture under mechanical agitation and the temperature is raised to 50° C. After mixing at higher speed until a stable emulsion is obtained, the second solution and 4 grams of sodium sulfate salt are added to the emulsion. This second solution contains 10 grams of butyl acrylate-acrylic acid copolymer emulsifier (Colloid C351, 25% solids, pka 4.5-4.7, Kemira), 120 grams of distilled water, sodium hydroxide solution to adjust pH to 4.8, 25 grams of partially methylated methylol melamine resin (Cymel 385, 80% solids, Cytec). This mixture is heated to 70° C. and maintained overnight with continuous stirring to complete the encapsulation process. 23 grams of acetoacetamide (Sigma-Aldrich, Saint Louis, Mo., U.S.A.) is added to the suspension. An average capsule size of 30 um is obtained as analyzed by a Model 780 Accusizer.
    • Example 4 Process of Making a Polymer Assisted Delivery (PAD) Matrix System
  • A mixture comprising 50% of a perfume composition comprising one or more Table 1 PRMs, 40% of carboxyl-terminated Hycar®1300×18 (CAS#0068891-50-9) from Noveon, (put at 60° C. in warm water bath for 1 hour before mixing) and 10% of Lupasol® WF(CAS# 09002-98-6) from BASF (put at 60° C. in warm water bath for 1 hour before mixing). Mixing is achieved by mixing for five minutes using a Ultra-Turrax T25 Basic equipment (from IKA). After mixing, the mixture is put in a warm water bath at 60° C. for ±12 hours. A homogenous, viscous and sticky material is obtained.
  • In the same way as described above different ratios between the components can be used:
  • Weight %
    Perfume composition 40 50 60 70 80
    Lupasol ® WF 12 10 8 6 4
    Hycar ® 48 40 32 24 16
    CTBN1300X18
    Perfume composition 50 50 50 50 50 50 50 50
    Lupasol ® WF 2.5 5 7.5 10 12.5 15 17.5 20
    Hycar ® CTBN 47.5 45 42.5 40 37.5 35 32.5 30
    1300X18
    • Example 5 Product Formulation
  • Non-limiting examples of product formulations containing PRMs disclosed in the present specification perfume and amines summarized in the following table.
  • EXAMPLES
    (% wt) XI XII XIII XIV XV XVI XVII XVIII XIX XX
    FSAa 14 16.47 14 12 12 16.47 — — 5 5
    FSAb — 3.00 — — —
    FSAc — — 6.5   — —
    Ethanol 2.18 2.57 2.18 1.95 1.95 2.57 — — 0.81 0.81
    Isopropyl — — — — — — 0.33 1.22 — —
    Alcohol
    Starchd 1.25 1.47 2.00 1.25 — 2.30 0.5 0.70 0.71 0.42
    Amine* 0.6 0.75 0.6 0.75 0.37 0.60 0.37 0.6  0.37 0.37
    Perfume Xe 0.40 0.13 0.065 0.25 0.03 0.030 0.030  0.065 0.03 0.03
    Phase 0.21 0.25 0.21 0.21 0.14 — — 0.14 — —
    Stabilizing
    Polymerf
    Suds — — — — — — — 0.1  — —
    Suppressorg
    Calcium 0.15 0.176 0.15 0.15 0.30 0.176 — 0.1-0.15 — —
    Chloride
    DTPAh 0.017 0.017 0.017 0.017 0.007 0.007 0.20 — 0.002 0.002
    Preservative 5 5 5 5 5 5 — 250j      5 5
    (ppm)i,j
    Antifoamk 0.015 0.018 0.015 0.015 0.015 0.015 — — 0.015 0.015
    Dye 40 40 40 40 40 40 11 30-300 30 30
    (ppm)
    Ammonium 0.100 0.118 0.100 0.100 0.115 0.115 — — — —
    Chloride
    HCl 0.012 0.014 0.012 0.012 0.028 0.028 0.016  0.025 0.011 0.011
    Structurantl 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
    Additional 0.8 0.7 0.9 0.5 1.2 0.5 1.1 0.6  1.0 0.9
    Neat
    Perfume
    Deionized † † † † † † † † † †
    Water
    aN,N-di(tallowoyloxyethyl)-N,N-dimethylammonium chloride.
    bMethyl bis(tallow amidoethyl)2-hydroxyethyl ammonium methyl sulfate.
    cReaction product of Fatty acid with Methyldiethanolamine in a molar ratio 1.5:1, quaternized with Methylchloride, resulting in a 1:1 molar mixture of N,N-bis(stearoyl-oxy-ethyl) N,N-dimethyl ammonium chloride and N-(stearoyl-oxy-ethyl) N,-hydroxyethyl N,N dimethyl ammonium chloride.
    dCationic high amylose maize starch available from National Starch under the trade name CATO ®.
    ePerfume comprising one or more Table 1 PRMs.
    fCopolymer of ethylene oxide and terephthalate having the formula described in U.S. Pat. No. 5,574,179 at col.15, lines 1-5, wherein each X is methyl, each n is 40, u is 4, each R1 is essentially 1,4-phenylene moieties, each R2 is essentially ethylene, 1,2-propylene moieties, or mixtures thereof.
    gSE39 from Wacker
    hDiethylenetriaminepentaacetic acid.
    iKATHON ® CG available from Rohm and Haas Co. “PPM” is “parts per million.”
    jGluteraldehyde
    kSilicone antifoam agent available from Dow Corning Corp. under the trade name DC2310.
    lHydrophobically-modified ethoxylated urethane available from Rohm and Haas under the tradename Aculan 44.
    *One or more materials comprising an amine moiety as disclosed in the present specification.
    † balance
    • Example 6 Dry Laundry Formulations
  • % w/w granular laundry detergent composition
    Component A B C D E F G
    Brightener 0.1 0.1 0.1 0.2 0.1 0.2 0.1
    Soap 0.6 0.6 0.6 0.6 0.6 0.6 0.6
    Ethylenediamine disuccinic acid 0.1 0.1 0.1 0.1 0.1 0.1 0.1
    Acrylate/maleate copolymer 1.5 1.5 1.5 1.5 1.5 1.5 1.5
    Hydroxyethane di(methylene 0.4 0.4 0.4 0.4 0.4 0.4 0.4
    phosphonic acid)
    Mono-C12-14 alkyl, di-methyl, 0.5 0.5 0.5 0.5 0.5 0.5 0.5
    mono-hydroyethyl quaternary
    ammonium chloride
    Linear alkyl benzene 0.1 0.1 0.2 0.1 0.1 0.2 0.1
    Linear alkyl benzene sulphonate 10.3 10.1 19.9 14.7 10.3 17 10.5
    Magnesium sulphate 0.4 0.4 0.4 0.4 0.4 0.4 0.4
    Sodium carbonate 19.5 19.2 10.1 18.5 29.9 10.1 16.8
    Sodium sulphate 29.6 29.8 38.8 15.1 24.4 19.7 19.1
    Sodium Chloride 0.1 0.1 0.1 0.1 0.1 0.1 0.1
    Zeolite 9.6 9.4 8.1 18 10 13.2 17.3
    Photobleach particle 0.1 0.1 0.2 0.1 0.2 0.1 0.2
    Blue and red carbonate speckles 1.8 1.8 1.8 1.8 1.8 1.8 1.8
    Ethoxylated Alcohol AE7 1 1 1 1 1 1 1
    Tetraacetyl ethylene diamine 0.9 0.9 0.9 0.9 0.9 0.9 0.9
    agglomerate (92 wt % active)
    Citric acid 1.4 1.4 1.4 1.4 1.4 1.4 1.4
    PDMS/clay agglomerates (9.5% 10.5 10.3 5 15 5.1 7.3 10.2
    wt % active PDMS)
    Polyethylene oxide 0.2 0.2 0.2 0.2 0.2 0.2 0.2
    Enzymes e.g. Protease (84 mg/g 0.2 0.3 0.2 0.1 0.2 0.1 0.2
    active), Amylase (22 mg/g active)
    Suds suppressor agglomerate 0.2 0.2 0.2 0.2 0.2 0.2 0.2
    (12.4 wt % active)
    Sodium percarbonate (having 7.2 7.1 4.9 5.4 6.9 19.3 13.1
    from 12% to 15% active AvOx)
    Additional Neat Perfume** 0.5 0.5 0.5 0.5 0.5 0.5 0.5
    Amine* 0.1 0.5 0.0 0.01 0.02 0.00 0.07
    Perfume Delivery System As 0.05 0.0 0.1 0.0 0.2 0.4 0.0
    Disclosed In The Present
    Specification Including
    Examples 2-4
    Perfume comprising one or more 0.3 0.4 0.01 0.02 0.04 0.1 0.1
    PRMs from Table 1
    Water 1.4 1.4 1.4 1.4 1.4 1.4 1.4
    Misc 0.1 0.1 0.1 0.1 0.1 0.1 0.1
    Total Parts 100 100 100 100 100 100 100
    *One or more materials comprising an amine moiety as disclosed in the present specification.
    **Optional
    • Example 7 Liquid Laundry Formulations (HDLs)
  • Ingredient HDL 1 HDL 2 HDL3 HDL4 HDL 5 HDL 6
    Alkyl Ether Sulphate 0.00 0.50 12.0 12.0 6.0 7.0
    Dodecyl Benzene 8.0 8.0 1.0 1.0 2.0 3.0
    Sulphonic Acid
    Ethoxylated Alcohol 8.0 6.0 5.0 7.0 5.0 3.0
    Citric Acid 5.0 3.0 3.0 5.0 2.0 3.0
    Fatty Acid 3.0 5.0 5.0 3.0 6.0 5.0
    Ethoxysulfated 1.9 1.2 1.5 2.0 1.0 1.0
    hexamethylene diamine
    quaternized
    Diethylene triamine penta 0.3 0.2 0.2 0.3 0.1 0.2
    methylene phosphonic acid
    Enzymes 1.20 0.80 0 1.2 0 0.8
    Brightener (disulphonated 0.14 0.09 0 0.14 0.01 0.09
    diamino stilbene based FWA)
    Cationic hydroxyethyl 0 0 0.10 0 0.200 0.30
    cellulose
    Poly(acrylamide-co- 0 0 0 0.50 0.10 0
    diallyldimethylammonium
    chloride)
    Hydrogenated Castor Oil 0.50 0.44 0.2 0.2 0.3 0.3
    Structurant
    Boric acid 2.4 1.5 1.0 2.4 1.0 1.5
    Ethanol 0.50 1.0 2.0 2.0 1.0 1.0
    1,2 propanediol 2.0 3.0 1.0 1.0 0.01 0.01
    Glutaraldehyde 0 0 19 ppm 0 13 ppm 0
    Diethyleneglycol (DEG) 1.6 0 0 0 0 0
    2,3-Methyl-1,3- 1.0 1.0 0 0 0 0
    propanediol (M pdiol)
    Mono Ethanol Amine 1.0 0.5 0 0 0 0
    NaOH Sufficient To pH 8 pH 8 pH 8 pH 8 pH 8 pH 8
    Provide Formulation pH of:
    Sodium Cumene 2.00 0 0 0 0 0
    Sulphonate (NaCS)
    Silicone (PDMS) emulsion 0.003 0.003 0.003 0.003 0.003 0.003
    Additional Neat Perfume** 0.7 0.5 0.8 0.8 0.6 0.6
    Amine* 0.01 0.10 0.0 0.10 0.20 0.05
    Perfume comprising one or 0.02 0.15 0.0 0.2 0.3 0.1
    more PRMs from Table 1
    Perfume Delivery System 0.2 0.02 0.4 0.0 0.0 0.0
    As Disclosed In The
    Present Specification
    Including Examples 2-4
    Water Balance Balance Balance Balance Balance Balance
    *One or more materials comprising an amine moiety as disclosed in the present specification.
    **Optional.
    • Example 8 Shampoo Formulation
  • Ingredient
    Ammonium Laureth Sulfate (AE3S) 6.00
    Ammonium Lauryl Sulfate (ALS) 10.00
    Laureth-4 Alcohol 0.90
    Trihydroxystearin(7) 0.10
    Perfume comprising one or more 0.60
    PRMs from Table 1
    Sodium Chloride 0.40
    Citric Acid 0.04
    Sodium Citrate 0.40
    Sodium Benzoate 0.25
    Ethylene Diamine Tetra Acetic Acid 0.10
    Dimethicone(9, 10, 11) 1.00(9)
    Water and Minors (QS to 100%) Balance
    • Example 9 Fine Fragrance Formulation
  • Ingredient 1 2 3
    Cyclic oligosaccharide 0 5 10
    Ethanol 90 75 80
    Perfume comprising one or more 10 20 10
    PRMs from Table 1
  • The dimensions and values disclosed herein are not to be understood as being strictly limited to the exact numerical values recited. Instead, unless otherwise specified, each such dimension is intended to mean both the recited value and a functionally equivalent range surrounding that value. For example, a dimension disclosed as “40 mm” is intended to mean “about 40 mm”.
  • All documents cited in the Detailed Description of the Invention are, in relevant part, incorporated herein by reference; the citation of any document is not to be construed as an admission that it is prior art with respect to the present invention. To the extent that any meaning or definition of a term in this document conflicts with any meaning or definition of the same term in a document incorporated by reference, the meaning or definition assigned to that term in this document shall govern.
  • While particular embodiments of the present invention have been illustrated and described, it would be obvious to those skilled in the art that various other changes and modifications can be made without departing from the spirit and scope of the invention. It is therefore intended to cover in the appended claims all such changes and modifications that are within the scope of this invention.

Claims (19)

1. A perfume raw material selected from 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-cyclopentyl-7-methyloct-6-en-1-one; and 1-(1-phenylcyclopropyl)but-3-en-1-one.
2. A perfume comprising, based on total perfume weight, from about 0.01% to about 50%, of one or more PRMs selected from 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 4-(4-methylcyclohex-3-enyl)pentan-2-ol; 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 3-methyl-4-phenylbut-3-en-2-one; 4-(4-methylphenyl)butan-2-one, 4-p-tolylbutan-2-one; 1-(3-methylphenyl)pent-1-en-3-one 1-m-tolylpent-1-en-3-one; 3-methyl-4-(4-methylphenyl)but-3-en-2-one 3-methyl-4-p-tolylbut-3-en-2-one; 4-(2-methyl-3-oxobut-1-enyl)benzonitrile; 1-phenylhex-1-en-3-one; 1-(2-methylphenyl)pent-1-en-3-one 1-o-tolylpent-1-en-3-one; 3-methyl-4-(2-methylphenyl)but-3-en-2-one 3-methyl-4-o-tolylbut-3-en-2-one; 3-methyl-4-(3-methylphenyl)but-3-en-2-one 3-methyl-4-m-tolylbut-3-en-2-one; 4-(4-methoxyphenyl)-3-methylbut-3-en-2-one; 3-(4-methylbenzylidene)pentan-2-one; 1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one; 1-(2,4,6-trimethylphenyl)hex-1-en-3-one; 1-(2,4,6-trimethylphenyl)pent-1-en-3-one; 3-methyl-4-(2,4,6-trimethylphenyl)but-3-en-2-one; 1-(2,6-dimethylphenyl)hex-1-en-3-one; 1-(2,6-dimethylphenyl)pent-1-en-3-one; 1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one; 1-cyclohexyl-2-phenylpropan-1-one; 2,2,4,7-tetramethyloct-6-en-3-one; 2,4(R,S),7-trimethyloct-6-en-3-one; 2,2,4,4,7-pentamethyloct-6-en-3-one; Ethyl 2(R,S),5-dimethyl-2-(pivaloyl)hex-4-enoate; 2,2,7-Trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclohexyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 4,4,7-trimethyloct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 3,6-dimethyl-3-(3-methylbut-2-enyl)hept-5-en-2-one; 3 (R,S),6-dimethylhept-5-en-2-one; 1-(1-(3-hydroxy-3-methylbutyl)cyclohexyl)-2-methylpropan-1-one; 5-methyl-2(R,S)-(prop-1-en-2-yl)-hex-4-enoic acid; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 4,7-dimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 2,4,7-trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 3 (R,S),5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)ethanone; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)pentan-1-one; 9-methyldec-8-en-3 one; 2,5-dimethyl-2-(3-methylbut-2-enyl)hex-4-enenitrile; 1-(3-methylbut-2-enyl)cyclopentanecarbonitrile; 1-(3-methylbut-2-enyl)cyclohexanecarbonitrile; 1-(3-methylbut-2-enyl)cyclopropanecarbonitrile; 1-(3-methylbut-2-enyl)cyclobutanecarbonitrile; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclobutyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)ethanone; 2-(R,S)-methyl-1-(1-phenylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)pentan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-one; 1-(1-phenylcyclopropyl)propan-1-one; 2-methyl-1-(1-phenylcyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)butan-1-one; 1-(1-p-tolylcyclopropyl)propan-1-one; 2-(R,S)-methyl-1-(1-p-tolylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)-3-methylenecyclobutyl)ethanone; 1-(1-phenylcyclobutyl)pentan-1-one; 2,2,5-trimethylhex-4-enenitrile; 6,6,9-trimethyldec-8-en-5-one; 2,5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)pentan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)butan-1-one; 2,2-dimethyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 2-methyl-1-(1-p-tolylcyclopropyl)propan-1-one; 1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)ethanone; 2-methyl-1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)butan-1-one; 2,4-dimethyl-2-m-tolylpentan-3-one; 2-methyl-2-m-tolylpropanenitrile; 3-methyl-3-m-tolylbutan-2-one; 2-methyl-2-m-tolylpentan-3-one; 1-(1-p-tolylcyclopentyl)ethanone; 7-methyl-1-phenyloct-6-en-1-one; 2,2-dimethyl-3-o-tolylpropanenitrile; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; o-methyl-benzylcyclopropanecarbonitrile; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(2-methylbenzyl)-cyclopropyl)propanone; 1-(1-(2-methylbenzyl)cyclopropyl)ethanone; 2-(R,S)-methyl-1-(1-(2-methylbenzyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(2-methylbenzyl)cyclopropyl)propan-1-one; 2,2,5-trimethyl-1-phenylhexan-3-one; 2-(1-(3-methylbut-2-enyl)cyclopropyl)propan-2-ol; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-ol; 9-methyldec-1,8-dien-3-one; 2,2-dimethyl-3-(R,S)-phenylbutanenitrile; 4,4-dimethyl-5-(R,S)-phenylhexan-3-one; 1-cyclopentyl-7-methyloct-6-en-1-one; 2,2-dimethyl-3-p-tolylpropanenitrile; 3-(4-methoxy-3-methylphenyl)-3-methylbutan-2-one; 2,2,4-(R,S)-trimethyl-1-p-tolylhexan-3-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 2,2-dimethyl-1-p-tolylpentan-3-one; 3-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)heptan-3-ol; 3-cyclohexyl-2,2-dimethylpropanenitrile; 1-cyclohexyl-2,2,4-trimethylpentan-3-one; 1-(R,S)-(1-phenylethyl)-cyclobutanecarbonitrile; 1-(1-(R,S)-(1-phenylethyl)-cyclobutyl)ethanone; 2-methyl-1-(1-(R,S)— (1-phenylethyl)cyclobutyl)propan-1-one; 2-methyl-1-(R,S)-(1-(1-(R,s)-phenylethyl)cyclobutyl)propan-1-ol; 1-(1-(R,S)-phenylethyl)cyclopropanecarbonitrile; 1-(1-(1-(R,S)-phenylethyl)cyclopropyl)ethanone; 2,2-dimethyl-3-m-tolylpropanenitrile; 3-(4-tert-butylphenyl)-2,2-dimethylpropanenitrile; 1-(1-phenylcyclopropyl)but-3-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-(R,S)-ol; 4-(4-tert-butylphenyl)-3,3-dimethylbutan-2-one; 2,2-dimethyl-4-phenylbutanenitrile; 11-methyldodec-10-en-5-one; 2,9-dimethyldec-8-en-3-one; 2,10-dimethylundec-9-en-4-one; 2,2,9-trimethyldec-8-en-3-one; 2,2,3-(R,S),7-tetramethyloct-6-enenitrile; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 3,3-dimethyl-5-phenylpentan-s-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpropanenitrile; 2-((R,S)-cyclohex-2-enyl)-2,5-dimethylhexan-3-one; 3,3-dimethyl-1-phenyloctan-4-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpentan-3-one; 4,4-dimethyl-6-phenylhexan-3-one; 2,2-dimethyl-5-phenylpentanenitrile; 2,2-dimethylhept-6-enenitrile; 6,6-dimethylundec-10-en-5-one; 3,3-dimethyl-6-phenylhexan-2-one; 2,2-dimethyl-4-((1R,5S)-6,6-dimethylbicyclo [3.1.1]hept-2-en-2-yl)butanenitrile; stereoisomers of 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 4-(4-methylcyclohex-3-enyl)pentan-2-ol; 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 3-methyl-4-phenylbut-3-en-2-one; 4-(4-methylphenyl)butan-2-one, 4-p-tolylbutan-2-one; 1-(3-methylphenyl)pent-1-en-3-one 1-m-tolylpent-1-en-3-one; 3-methyl-4-(4-methylphenyl)but-3-en-2-one 3-methyl-4-p-tolylbut-3-en-2-one; 4-(2-methyl-3-oxobut-1-enyl)benzonitrile; 1-phenylhex-1-en-3-one; 1-(2-methylphenyl)pent-1-en-3-one 1-o-tolylpent-1-en-3-one; 3-methyl-4-(2-methylphenyl)but-3-en-2-one 3-methyl-4-o-tolylbut-3-en-2-one; 3-methyl-4-(3-methylphenyl)but-3-en-2-one 3-methyl-4-m-tolylbut-3-en-2-one; 4-(4-methoxyphenyl)-3-methylbut-3-en-2-one; 3-(4-methylbenzylidene)pentan-2-one; 1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one; 1-(2,4,6-trimethylphenyl)hex-1-en-3-one; 1-(2,4,6-trimethylphenyl)pent-1-en-3-one; 3-methyl-4-(2,4,6-trimethylphenyl)but-3-en-2-one; 1-(2,6-dimethylphenyl)hex-1-en-3-one; 1-(2,6-dimethylphenyl)pent-1-en-3-one; 1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one; 1-cyclohexyl-2-phenylpropan-1-one; 2,2,4,7-tetramethyloct-6-en-3-one; 2,4(R,S),7-trimethyloct-6-en-3-one; 2,2,4,4,7-pentamethyloct-6-en-3-one; Ethyl 2(R,S),5-dimethyl-2-(pivaloyl)hex-4-enoate; 2,2,7-Trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclohexyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 4,4,7-trimethyloct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 3,6-dimethyl-3-(3-methylbut-2-enyl)hept-5-en-2-one; 3(R,S),6-dimethylhept-5-en-2-one; 1-(1-(3-hydroxy-3-methylbutyl)cyclohexyl)-2-methylpropan-1-one; 5-methyl-2(R,S)-(prop-1-en-2-yl)-hex-4-enoic acid; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 4,7-dimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 2,4,7-trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 3(R,S),5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)ethanone; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)pentan-1-one; 9-methyldec-8-en-3 one; 2,5-dimethyl-2-(3-methylbut-2-enyl)hex-4-enenitrile; 1-(3-methylbut-2-enyl)cyclopentanecarbonitrile; 1-(3-methylbut-2-enyl)cyclohexanecarbonitrile; 1-(3-methylbut-2-enyl)cyclopropanecarbonitrile; 1-(3-methylbut-2-enyl)cyclobutanecarbonitrile; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclobutyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)ethanone; 2-(R,S)-methyl-1-(1-phenylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)pentan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-one; 1-(1-phenylcyclopropyl)propan-1-one; 2-methyl-1-(1-phenylcyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)butan-1-one; 1-(1-p-tolylcyclopropyl)propan-1-one; 2-(R,S)-methyl-1-(1-p-tolylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)-3-methylenecyclobutyl)ethanone; 1-(1-phenylcyclobutyl)pentan-1-one; 2,2,5-trimethylhex-4-enenitrile; 6,6,9-trimethyldec-8-en-5-one; 2,5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)pentan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)butan-1-one; 2,2-dimethyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 2-methyl-1-(1-p-tolylcyclopropyl)propan-1-one; 1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)ethanone; 2-methyl-1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)butan-1-one; 2,4-dimethyl-2-m-tolylpentan-3-one; 2-methyl-2-m-tolylpropanenitrile; 3-methyl-3-m-tolylbutan-2-one; 2-methyl-2-m-tolylpentan-3-one; 1-(1-p-tolylcyclopentyl)ethanone; 7-methyl-1-phenyloct-6-en-1-one; 2,2-dimethyl-3-o-tolylpropanenitrile; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; o-methyl-benzylcyclopropanecarbonitrile; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(2-methylbenzyl)-cyclopropyl)propanone; 1-(1-(2-methylbenzyl)cyclopropyl)ethanone; 2-(R,S)-methyl-1-(1-(2-methylbenzyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(2-methylbenzyl)cyclopropyl)propan-1-one; 2,2,5-trimethyl-1-phenylhexan-3-one; 2-(1-(3-methylbut-2-enyl)cyclopropyl)propan-2-ol; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-ol; 9-methyldec-1,8-dien-3-one; 2,2-dimethyl-3-(R,S)-phenylbutanenitrile; 4,4-dimethyl-5-(R,S)-phenylhexan-3-one; 1-cyclopentyl-7-methyloct-6-en-1-one; 2,2-dimethyl-3-p-tolylpropanenitrile; 3-(4-methoxy-3-methylphenyl)-3-methylbutan-2-one; 2,2,4-(R,S)-trimethyl-1-p-tolylhexan-3-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 2,2-dimethyl-1-p-tolylpentan-3-one; 3-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)heptan-3-ol; 3-cyclohexyl-2,2-dimethylpropanenitrile; 1-cyclohexyl-2,2,4-trimethylpentan-3-one; 1-(R,S)-(1-phenylethyl)-cyclobutanecarbonitrile; 1-(1-(R,S)-(1-phenylethyl)-cyclobutyl)ethanone; 2-methyl-1-(1-(R,S)-(1-phenylethyl)cyclobutyl)propan-1-one; 2-methyl-1-(R,S)-(1-(1-(R,s)-phenylethyl)cyclobutyl)propan-1-ol; 1-(1-(R,S)-phenylethyl)cyclopropanecarbonitrile; 1-(1-(1-(R,S)-phenylethyl)cyclopropyl)ethanone; 2,2-dimethyl-3-m-tolylpropanenitrile; 3-(4-tert-butylphenyl)-2,2-dimethylpropanenitrile; 1-(1-phenylcyclopropyl)but-3-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-(R,s)-ol; 4-(4-tert-butylphenyl)-3,3-dimethylbutan-2-one; 2,2-dimethyl-4-phenylbutanenitrile; 11-methyldodec-10-en-5-one; 2,9-dimethyldec-8-en-3-one; 2,10-dimethylundec-9-en-4-one; 2,2,9-trimethyldec-8-en-3-one; 2,2,3-(R,S),7-tetramethyloct-6-enenitrile; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 3,3-dimethyl-5-phenylpentan-s-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpropanenitrile; 2-((R,S)-cyclohex-2-enyl)-2,5-dimethylhexan-3-one; 3,3-dimethyl-1-phenyloctan-4-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpentan-3-one; 4,4-dimethyl-6-phenylhexan-3-one; 2,2-dimethyl-5-phenylpentanenitrile; 2,2-dimethylhept-6-enenitrile; 6,6-dimethylundec-10-en-5-one; 3,3-dimethyl-6-phenylhexan-2-one; 2,2-dimethyl-4-((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)butanenitrile; and mixtures thereof.
3. A consumer product comprising, based on total consumer product weight, from about 0.0001% to about 25% of a PRM selected from 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 4-(4-methylcyclohex-3-enyl)pentan-2-ol; 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 3-methyl-4-phenylbut-3-en-2-one; 4-(4-methylphenyl)butan-2-one, 4-p-tolylbutan-2-one; 1-(3-methylphenyl)pent-1-en-3-one 1-m-tolylpent-1-en-3-one; 3-methyl-4-(4-methylphenyl)but-3-en-2-one 3-methyl-4-p-tolylbut-3-en-2-one; 4-(2-methyl-3-oxobut-1-enyl)benzonitrile; 1-phenylhex-1-en-3-one; 1-(2-methylphenyl)pent-1-en-3-one 1-o-tolylpent-1-en-3-one; 3-methyl-4-(2-methylphenyl)but-3-en-2-one 3-methyl-4-o-tolylbut-3-en-2-one; 3-methyl-4-(3-methylphenyl)but-3-en-2-one 3-methyl-4-m-tolylbut-3-en-2-one; 4-(4-methoxyphenyl)-3-methylbut-3-en-2-one; 3-(4-methylbenzylidene)pentan-2-one; 1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one; 1-(2,4,6-trimethylphenyl)hex-1-en-3-one; 1-(2,4,6-trimethylphenyl)pent-1-en-3-one; 3-methyl-4-(2,4,6-trimethylphenyl)but-3-en-2-one; 1-(2,6-dimethylphenyl)hex-1-en-3-one; 1-(2,6-dimethylphenyl)pent-1-en-3-one; 1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one; 1-cyclohexyl-2-phenylpropan-1-one; 2,2,4,7-tetramethyloct-6-en-3-one; 2,4(R,S),7-trimethyloct-6-en-3-one; 2,2,4,4,7-pentamethyloct-6-en-3-one; Ethyl 2(R,S),5-dimethyl-2-(pivaloyl)hex-4-enoate; 2,2,7-Trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclohexyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 4,4,7-trimethyloct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 3,6-dimethyl-3-(3-methylbut-2-enyl)hept-5-en-2-one; 3 (R,S),6-dimethylhept-5-en-2-one; 1-(1-(3-hydroxy-3-methylbutyl)cyclohexyl)-2-methylpropan-1-one; 5-methyl-2(R,S)-(prop-1-en-2-yl)-hex-4-enoic acid; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 4,7-dimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 2,4,7-trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 3 (R,S),5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)ethanone; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)pentan-1-one; 9-methyldec-8-en-3 one; 2,5-dimethyl-2-(3-methylbut-2-enyl)hex-4-enenitrile; 1-(3-methylbut-2-enyl)cyclopentanecarbonitrile; 1-(3-methylbut-2-enyl)cyclohexanecarbonitrile; 1-(3-methylbut-2-enyl)cyclopropanecarbonitrile; 1-(3-methylbut-2-enyl)cyclobutanecarbonitrile; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclobutyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)ethanone; 2-(R,S)-methyl-1-(1-phenylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)pentan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-one; 1-(1-phenylcyclopropyl)propan-1-one; 2-methyl-1-(1-phenylcyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)butan-1-one; 1-(1-p-tolylcyclopropyl)propan-1-one; 2-(R,S)-methyl-1-(1-p-tolylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)-3-methylenecyclobutyl)ethanone; 1-(1-phenylcyclobutyl)pentan-1-one; 2,2,5-trimethylhex-4-enenitrile; 6,6,9-trimethyldec-8-en-5-one; 2,5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)pentan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)butan-1-one; 2,2-dimethyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 2-methyl-1-(1-p-tolylcyclopropyl)propan-1-one; 1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)ethanone; 2-methyl-1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)butan-1-one; 2,4-dimethyl-2-m-tolylpentan-3-one; 2-methyl-2-m-tolylpropanenitrile; 3-methyl-3-m-tolylbutan-2-one; 2-methyl-2-m-tolylpentan-3-one; 1-(1-p-tolylcyclopentyl)ethanone; 7-methyl-1-phenyloct-6-en-1-one; 2,2-dimethyl-3-o-tolylpropanenitrile; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; o-methyl-benzylcyclopropanecarbonitrile; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(2-methylbenzyl)-cyclopropyl)propanone; 1-(1-(2-methylbenzyl)cyclopropyl)ethanone; 2-(R,S)-methyl-1-(1-(2-methylbenzyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(2-methylbenzyl)cyclopropyl)propan-1-one; 2,2,5-trimethyl-1-phenylhexan-3-one; 2-(1-(3-methylbut-2-enyl)cyclopropyl)propan-2-ol; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-ol; 9-methyldec-1,8-dien-3-one; 2,2-dimethyl-3-(R,S)-phenylbutanenitrile; 4,4-dimethyl-5-(R,S)-phenylhexan-3-one; 1-cyclopentyl-7-methyloct-6-en-1-one; 2,2-dimethyl-3-p-tolylpropanenitrile; 3-(4-methoxy-3-methylphenyl)-3-methylbutan-2-one; 2,2,4-(R,S)-trimethyl-1-p-tolylhexan-3-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 2,2-dimethyl-1-p-tolylpentan-3-one; 3-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)heptan-3-ol; 3-cyclohexyl-2,2-dimethylpropanenitrile; 1-cyclohexyl-2,2,4-trimethylpentan-3-one; 1-(R,S)-(1-phenylethyl)-cyclobutanecarbonitrile; 1-(1-(R,S)-(1-phenylethyl)-cyclobutyl)ethanone; 2-methyl-1-(1-(R,S)-(1-phenylethyl)cyclobutyl)propan-1-one; 2-methyl-1-(R,S)-(1-(1-(R,s)-phenylethyl)cyclobutyl)propan-1-ol; 1-(1-(R,S)-phenylethyl)cyclopropanecarbonitrile; 1-(1-(1-(R,S)-phenylethyl)cyclopropyl)ethanone; 2,2-dimethyl-3-m-tolylpropanenitrile; 3-(4-tert-butylphenyl)-2,2-dimethylpropanenitrile; 1-(1-phenylcyclopropyl)but-3-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-(R,s)-ol; 4-(4-tert-butylphenyl)-3,3-dimethylbutan-2-one; 2,2-dimethyl-4-phenylbutanenitrile; 11-methyldodec-10-en-5-one; 2,9-dimethyldec-8-en-3-one; 2,10-dimethylundec-9-en-4-one; 2,2,9-trimethyldec-8-en-3-one; 2,2,3-(R,S),7-tetramethyloct-6-enenitrile; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 3,3-dimethyl-5-phenylpentan-s-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpropanenitrile; 2-((R,S)-cyclohex-2-enyl)-2,5-dimethylhexan-3-one; 3,3-dimethyl-1-phenyloctan-4-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpentan-3-one; 4,4-dimethyl-6-phenylhexan-3-one; 2,2-dimethyl-5-phenylpentanenitrile; 2,2-dimethylhept-6-enenitrile; 6,6-dimethylundec-10-en-5-one; 3,3-dimethyl-6-phenylhexan-2-one; 2,2-dimethyl-4-((1R,5S)-6,6-dimethylbicyclo [3.1.1]hept-2-en-2-yl)butanenitrile; stereoisomers of 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 4-(4-methylcyclohex-3-enyl)pentan-2-ol; 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 3-methyl-4-phenylbut-3-en-2-one; 4-(4-methylphenyl)butan-2-one, 4-p-tolylbutan-2-one; 1-(3-methylphenyl)pent-1-en-3-one 1-m-tolylpent-1-en-3-one; 3-methyl-4-(4-methylphenyl)but-3-en-2-one 3-methyl-4-p-tolylbut-3-en-2-one; 4-(2-methyl-3-oxobut-1-enyl)benzonitrile; 1-phenylhex-1-en-3-one; 1-(2-methylphenyl)pent-1-en-3-one 1-o-tolylpent-1-en-3-one; 3-methyl-4-(2-methylphenyl)but-3-en-2-one 3-methyl-4-o-tolylbut-3-en-2-one; 3-methyl-4-(3-methylphenyl)but-3-en-2-one 3-methyl-4-m-tolylbut-3-en-2-one; 4-(4-methoxyphenyl)-3-methylbut-3-en-2-one; 3-(4-methylbenzylidene)pentan-2-one; 1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one; 1-(2,4,6-trimethylphenyl)hex-1-en-3-one; 1-(2,4,6-trimethylphenyl)pent-1-en-3-one; 3-methyl-4-(2,4,6-trimethylphenyl)but-3-en-2-one; 1-(2,6-dimethylphenyl)hex-1-en-3-one; 1-(2,6-dimethylphenyl)pent-1-en-3-one; 1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one; 1-cyclohexyl-2-phenylpropan-1-one; 2,2,4,7-tetramethyloct-6-en-3-one; 2,4(R,S),7-trimethyloct-6-en-3-one; 2,2,4,4,7-pentamethyloct-6-en-3-one; Ethyl 2(R,S),5-dimethyl-2-(pivaloyl)hex-4-enoate; 2,2,7-Trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclohexyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 4,4,7-trimethyloct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 3,6-dimethyl-3-(3-methylbut-2-enyl)hept-5-en-2-one; 3(R,S),6-dimethylhept-5-en-2-one; 1-(1-(3-hydroxy-3-methylbutyl)cyclohexyl)-2-methylpropan-1-one; 5-methyl-2(R,S)-(prop-1-en-2-yl)-hex-4-enoic acid; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 4,7-dimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 2,4,7-trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 3(R,S),5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)ethanone; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)pentan-1-one; 9-methyldec-8-en-3 one; 2,5-dimethyl-2-(3-methylbut-2-enyl)hex-4-enenitrile; 1-(3-methylbut-2-enyl)cyclopentanecarbonitrile; 1-(3-methylbut-2-enyl)cyclohexanecarbonitrile; 1-(3-methylbut-2-enyl)cyclopropanecarbonitrile; 1-(3-methylbut-2-enyl)cyclobutanecarbonitrile; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclobutyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)ethanone; 2-(R,S)-methyl-1-(1-phenylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)pentan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-one; 1-(1-phenylcyclopropyl)propan-1-one; 2-methyl-1-(1-phenylcyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)butan-1-one; 1-(1-p-tolylcyclopropyl)propan-1-one; 2-(R,S)-methyl-1-(1-p-tolylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)-3-methylenecyclobutyl)ethanone; 1-(1-phenylcyclobutyl)pentan-1-one; 2,2,5-trimethylhex-4-enenitrile; 6,6,9-trimethyldec-8-en-5-one; 2,5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)pentan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)butan-1-one; 2,2-dimethyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 2-methyl-1-(1-p-tolylcyclopropyl)propan-1-one; 1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)ethanone; 2-methyl-1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)butan-1-one; 2,4-dimethyl-2-m-tolylpentan-3-one; 2-methyl-2-m-tolylpropanenitrile; 3-methyl-3-m-tolylbutan-2-one; 2-methyl-2-m-tolylpentan-3-one; 1-(1-p-tolylcyclopentyl)ethanone; 7-methyl-1-phenyloct-6-en-1-one; 2,2-dimethyl-3-o-tolylpropanenitrile; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; o-methyl-benzylcyclopropanecarbonitrile; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(2-methylbenzyl)-cyclopropyl)propanone; 1-(1-(2-methylbenzyl)cyclopropyl)ethanone; 2-(R,S)-methyl-1-(1-(2-methylbenzyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(2-methylbenzyl)cyclopropyl)propan-1-one; 2,2,5-trimethyl-1-phenylhexan-3-one; 2-(1-(3-methylbut-2-enyl)cyclopropyl)propan-2-ol; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-ol; 9-methyldec-1,8-dien-3-one; 2,2-dimethyl-3-(R,S)-phenylbutanenitrile; 4,4-dimethyl-5-(R,S)-phenylhexan-3-one; 1-cyclopentyl-7-methyloct-6-en-1-one; 2,2-dimethyl-3-p-tolylpropanenitrile; 3-(4-methoxy-3-methylphenyl)-3-methylbutan-2-one; 2,2,4-(R,S)-trimethyl-1-p-tolylhexan-3-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 2,2-dimethyl-1-p-tolylpentan-3-one; 3-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)heptan-3-ol; 3-cyclohexyl-2,2-dimethylpropanenitrile; 1-cyclohexyl-2,2,4-trimethylpentan-3-one; 1-(R,S)-(1-phenylethyl)-cyclobutanecarbonitrile; 1-(1-(R,S)-(1-phenylethyl)-cyclobutyl)ethanone; 2-methyl-1-(1-(R,S)-(1-phenylethyl)cyclobutyl)propan-1-one; 2-methyl-1-(R,S)-(1-(1-(R,s)-phenylethyl)cyclobutyl)propan-1-ol; 1-(1-(R,S)-phenylethyl)cyclopropanecarbonitrile; 1-(1-(1-(R,S)-phenylethyl)cyclopropyl)ethanone; 2,2-dimethyl-3-m-tolylpropanenitrile; 3-(4-tert-butylphenyl)-2,2-dimethylpropanenitrile; 1-(1-phenylcyclopropyl)but-3-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-(R,s)-ol; 4-(4-tert-butylphenyl)-3,3-dimethylbutan-2-one; 2,2-dimethyl-4-phenylbutanenitrile; 11-methyldodec-10-en-5-one; 2,9-dimethyldec-8-en-3-one; 2,10-dimethylundec-9-en-4-one; 2,2,9-trimethyldec-8-en-3-one; 2,2,3-(R,S),7-tetramethyloct-6-enenitrile; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 3,3-dimethyl-5-phenylpentan-s-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpropanenitrile; 2-((R,S)-cyclohex-2-enyl)-2,5-dimethylhexan-3-one; 3,3-dimethyl-1-phenyloctan-4-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpentan-3-one; 4,4-dimethyl-6-phenylhexan-3-one; 2,2-dimethyl-5-phenylpentanenitrile; 2,2-dimethylhept-6-enenitrile; 6,6-dimethylundec-10-en-5-one; 3,3-dimethyl-6-phenylhexan-2-one; 2,2-dimethyl-4-((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)butanenitrile; and mixtures thereof; and an adjunct ingredient.
4. A consumer product according to claim 3 comprising one or more PRMs selected from 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-cyclopentyl-7-methyloct-6-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-one; stereoisomers of 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-cyclopentyl-7-methyloct-6-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-one; and mixtures thereof.
5. A consumer product according to claim 3, said consumer product being a cleaning and/or treatment composition, said composition comprising, based on total composition weight, from about 0.0001% to about 25% of a Table 1 PRM selected from 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-cyclopentyl-7-methyloct-6-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-one; 1-(3-methylbut-2-enyl)cyclobutanecarbonitrile; 2,4-dimethyl-2-m-tolylpentan-3-one; 2-methyl-2-m-tolylpropanenitrile; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-cyclopentyl-7-methyloct-6-en-1-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 1-(1-phenylcyclopropyl)but-3-en-1-one; stereoisomers of 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-cyclopentyl-7-methyloct-6-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-one; 1-(3-methylbut-2-enyl)cyclobutanecarbonitrile; 2,4-dimethyl-2-m-tolylpentan-3-one; 2-methyl-2-m-tolylpropanenitrile; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-cyclopentyl-7-methyloct-6-en-1-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 1-(1-phenylcyclopropyl)but-3-en-1-one; and mixtures thereof.
6. A consumer product according to claim 3, said consumer product being a fabric and/or hard surface cleaning and/or treatment composition, said composition comprising, based on total composition weight, from about 0.00001% to about 25% of one or more PRMs selected from 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 3-methyl-4-(4-methylphenyl)but-3-en-2-one 3-methyl-4-p-tolylbut-3-en-2-one; 4-(2-methyl-3-oxobut-1-enyl)benzonitrile; 1-phenylhex-1-en-3-one; 3-methyl-4-(2-methylphenyl)but-3-en-2-one 3-methyl-4-o-tolylbut-3-en-2-one; 3-methyl-4-(3-ethylphenyl)but-3-en-2-one 3-methyl-4-m-tolylbut-3-en-2-one; 4-(4-methoxyphenyl)-3-methylbut-3-en-2-one; 3-(4-methylbenzylidene)pentan-2-one; 1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one; 1-(2,4,6-trimethylphenyl)hex-1-en-3-one; 1-(2,4,6-trimethylphenyl)pent-1-en-3-one; 3-methyl-4-(2,4,6-trimethylphenyl)but-3-en-2-one; 1-(2,6-dimethylphenyl)hex-1-en-3-one; 1-(2,6-dimethylphenyl)pent-1-en-3-one; 1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one; 1-cyclohexyl-2-phenylpropan-1-one; 2,4(R,S),7-trimethyloct-6-en-3-one; 2,2,4,4,7-pentamethyloct-6-en-3-one; Ethyl 2(R,S),5-dimethyl-2-(pivaloyl)hex-4-enoate; 2,2,7-Trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclohexyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 4,4,7-trimethyloct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 3,6-dimethyl-3-(3-methylbut-2-enyl)hept-5-en-2-one; 3(R,S),6-dimethylhept-5-en-2-one; 1-(1-(3-hydroxy-3-methylbutyl)cyclohexyl)-2-methylpropan-1-one; 5-methyl-2(R,S)-(prop-1-en-2-yl)-hex-4-enoic acid; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 4,7-dimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 2,4,7-trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 3(R,S),5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)ethanone; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)pentan-1-one; 1-(3-methylbut-2-enyl)cyclopentanecarbonitrile; 1-(3-methylbut-2-enyl)cyclohexanecarbonitrile; 1-(3-methylbut-2-enyl)cyclobutanecarbonitrile; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclobutyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)ethanone; 2-(R,S)-methyl-1-(1-phenylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)pentan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-one; 1-(1-phenylcyclopropyl)propan-1-one; 2-methyl-1-(1-phenylcyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)butan-1-one; 1-(1-p-tolylcyclopropyl)propan-1-one; 2-(R,S)-methyl-1-(1-p-tolylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)-3-methylenecyclobutyl)ethanone; 1-(1-phenylcyclobutyl)pentan-1-one; 2,5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)pentan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)butan-1-one; 2,2-dimethyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 2-methyl-1-(1-p-tolylcyclopropyl)propan-1-one; 1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)ethanone; 2-methyl-1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)butan-1-one; 2,4-dimethyl-2-m-tolylpentan-3-one; 2-methyl-2-m-tolylpropanenitrile; 3-methyl-3-m-tolylbutan-2-one; 2-methyl-2-m-tolylpentan-3-one; 1-(1-p-tolylcyclopentyl)ethanone; 7-methyl-1-phenyloct-6-en-1-one; 2,2-dimethyl-3-o-tolylpropanenitrile; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; o-methyl-benzylcyclopropanecarbonitrile; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(2-methylbenzyl)-cyclopropyl)propanone; 1-(1-(2-methylbenzyl)cyclopropyl)ethanone; 2-(R,S)-methyl-1-(1-(2-methylbenzyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(2-methylbenzyl)cyclopropyl)propan-1-one; 2,2,5-trimethyl-1-phenylhexan-3-one; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-ol; 2,2-dimethyl-3-(R,S)-phenylbutanenitrile; 4,4-dimethyl-5-(R,S)-phenylhexan-3-one; 1-cyclopentyl-7-methyloct-6-en-1-one; 2,2-dimethyl-3-p-tolylpropanenitrile; 3-(4-methoxy-3-methylphenyl)-3-methylbutan-2-one; 2,2,4-(R,S)-trimethyl-1-p-tolylhexan-3-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 2,2-dimethyl-1-p-tolylpentan-3-one; 3-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)heptan-3-ol; 3-cyclohexyl-2,2-dimethylpropanenitrile; 1-cyclohexyl-2,2,4-trimethylpentan-3-one; 1-(R,S)-(1-phenylethyl)-cyclobutanecarbonitrile; 1-(1-(R,S)-(1-phenylethyl)-cyclobutyl)ethanone; 2-methyl-1-(1-(R,S)-(1-phenylethyl)cyclobutyl)propan-1-one; 2-methyl-1-(R,S)-(1-(1-(R,s)-phenylethyl)cyclobutyl)propan-1-ol; 1-(1-(R,S)-phenylethyl)cyclopropanecarbonitrile; 1-(1-(1-(R,S)-phenylethyl)cyclopropyl)ethanone; 2,2-dimethyl-3-m-tolylpropanenitrile; 3-(4-tert-butylphenyl)-2,2-dimethylpropanenitrile; 1-(1-phenylcyclopropyl)but-3-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-(R,s)-ol; 4-(4-tert-butylphenyl)-3,3-dimethylbutan-2-one; 2,2-dimethyl-4-phenylbutanenitrile; 11-methyldodec-10-en-5-one; 2,9-dimethyldec-8-en-3-one; 2,10-dimethylundec-9-en-4-one; 2,2,9-trimethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 3,3-dimethyl-5-phenylpentan-s-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpropanenitrile; 2-((R,S)-cyclohex-2-enyl)-2,5-dimethylhexan-3-one; 3,3-dimethyl-1-phenyloctan-4-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpentan-3-one; 4,4-dimethyl-6-phenylhexan-3-one; 2,2-dimethyl-5-phenylpentanenitrile; 2,2-dimethylhept-6-enenitrile; 6,6-dimethylundec-10-en-5-one; 3,3-dimethyl-6-phenylhexan-2-one; 2,2-dimethyl-4-((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)butanenitrile; stereoisomers of 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 3-methyl-4-(4-methylphenyl)but-3-en-2-one 3-methyl-4-p-tolylbut-3-en-2-one; 4-(2-methyl-3-oxobut-1-enyl)benzonitrile; 1-phenylhex-1-en-3-one; 3-methyl-4-(2-methylphenyl)but-3-en-2-one 3-methyl-4-o-tolylbut-3-en-2-one; 3-methyl-4-(3-ethylphenyl)but-3-en-2-one 3-methyl-4-m-tolylbut-3-en-2-one; 4-(4-methoxyphenyl)-3-methylbut-3-en-2-one; 3-(4-methylbenzylidene)pentan-2-one; 1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one; 1-(2,4,6-trimethylphenyl)hex-1-en-3-one; 1-(2,4,6-trimethylphenyl)pent-1-en-3-one; 3-methyl-4-(2,4,6-trimethylphenyl)but-3-en-2-one; 1-(2,6-dimethylphenyl)hex-1-en-3-one; 1-(2,6-dimethylphenyl)pent-1-en-3-one; 1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one; 1-cyclohexyl-2-phenylpropan-1-one; 2,4(R,S),7-trimethyloct-6-en-3-one; 2,2,4,4,7-pentamethyloct-6-en-3-one; Ethyl 2(R,S),5-dimethyl-2-(pivaloyl)hex-4-enoate; 2,2,7-Trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclohexyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 4,4,7-trimethyloct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 3,6-dimethyl-3-(3-methylbut-2-enyl)hept-5-en-2-one; 3(R,S),6-dimethylhept-5-en-2-one; 1-(1-(3-hydroxy-3-methylbutyl)cyclohexyl)-2-methylpropan-1-one; 5-methyl-2(R,S)-(prop-1-en-2-yl)-hex-4-enoic acid; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 4,7-dimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 2,4,7-trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 3(R,S),5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)ethanone; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)pentan-1-one; 1-(3-methylbut-2-enyl)cyclopentanecarbonitrile; 1-(3-methylbut-2-enyl)cyclohexanecarbonitrile; 1-(3-methylbut-2-enyl)cyclobutanecarbonitrile; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclobutyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)ethanone; 2-(R,S)-methyl-1-(1-phenylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)pentan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-one; 1-(1-phenylcyclopropyl)propan-1-one; 2-methyl-1-(1-phenylcyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)butan-1-one; 1-(1-p-tolylcyclopropyl)propan-1-one; 2-(R,S)-methyl-1-(1-p-tolylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)-3-methylenecyclobutyl)ethanone; 1-(1-phenylcyclobutyl)pentan-1-one; 2,5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)pentan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)butan-1-one; 2,2-dimethyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 2-methyl-1-(1-p-tolylcyclopropyl)propan-1-one; 1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)ethanone; 2-methyl-1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)butan-1-one; 2,4-dimethyl-2-m-tolylpentan-3-one; 2-methyl-2-m-tolylpropanenitrile; 3-methyl-3-m-tolylbutan-2-one; 2-methyl-2-m-tolylpentan-3-one; 1-(1-p-tolylcyclopentyl)ethanone; 7-methyl-1-phenyloct-6-en-1-one; 2,2-dimethyl-3-o-tolylpropanenitrile; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; o-methyl-benzylcyclopropanecarbonitrile; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(2-methylbenzyl)-cyclopropyl)propanone; 1-(1-(2-methylbenzyl)cyclopropyl)ethanone; 2-(R,S)-methyl-1-(1-(2-methylbenzyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(2-methylbenzyl)cyclopropyl)propan-1-one; 2,2,5-trimethyl-1-phenylhexan-3-one; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-ol; 2,2-dimethyl-3-(R,S)-phenylbutanenitrile; 4,4-dimethyl-5-(R,S)-phenylhexan-3-one; 1-cyclopentyl-7-methyloct-6-en-1-one; 2,2-dimethyl-3-p-tolylpropanenitrile; 3-(4-methoxy-3-methylphenyl)-3-methylbutan-2-one; 2,2,4-(R,S)-trimethyl-1-p-tolylhexan-3-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 2,2-dimethyl-1-p-tolylpentan-3-one; 3-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)heptan-3-ol; 3-cyclohexyl-2,2-dimethylpropanenitrile; 1-cyclohexyl-2,2,4-trimethylpentan-3-one; 1-(R,S)-(1-phenylethyl)-cyclobutanecarbonitrile; 1-(1-(R,S)-(1-phenylethyl)-cyclobutyl)ethanone; 2-methyl-1-(1-(R,S)-(1-phenylethyl)cyclobutyl)propan-1-one; 2-methyl-1-(R,S)-(1-(1-(R,s)-phenylethyl)cyclobutyl)propan-1-ol; 1-(1-(R,S)-phenylethyl)cyclopropanecarbonitrile; 1-(1-(1-(R,S)-phenylethyl)cyclopropyl)ethanone; 2,2-dimethyl-3-m-tolylpropanenitrile; 3-(4-tert-butylphenyl)-2,2-dimethylpropanenitrile; 1-(1-phenylcyclopropyl)but-3-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-(R,s)-ol; 4-(4-tert-butylphenyl)-3,3-dimethylbutan-2-one; 2,2-dimethyl-4-phenylbutanenitrile; 11-methyldodec-10-en-5-one; 2,9-dimethyldec-8-en-3-one; 2,10-dimethylundec-9-en-4-one; 2,2,9-trimethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 3,3-dimethyl-5-phenylpentan-s-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpropanenitrile; 2-((R,S)-cyclohex-2-enyl)-2,5-dimethylhexan-3-one; 3,3-dimethyl-1-phenyloctan-4-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpentan-3-one; 4,4-dimethyl-6-phenylhexan-3-one; 2,2-dimethyl-5-phenylpentanenitrile; 2,2-dimethylhept-6-enenitrile; 6,6-dimethylundec-10-en-5-one; 3,3-dimethyl-6-phenylhexan-2-one; 2,2-dimethyl-4-((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)butanenitrile; and mixtures thereof.
7. A consumer product according to claim 3, said consumer product being a detergent, said detergent comprising, based on total detergent weight, from about 0.00001% to about 25% of one or more PRMs selected from 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 3-methyl-4-(4-methylphenyl)but-3-en-2-one 3-methyl-4-p-tolylbut-3-en-2-one; 4-(2-methyl-3-oxobut-1-enyl)benzonitrile; 1-phenylhex-1-en-3-one; 3-methyl-4-(2-methylphenyl)but-3-en-2-one 3-methyl-4-o-tolylbut-3-en-2-one; 3-methyl-4-(3-ethylphenyl)but-3-en-2-one 3-methyl-4-m-tolylbut-3-en-2-one; 4-(4-methoxyphenyl)-3-methylbut-3-en-2-one; 3-(4-methylbenzylidene)pentan-2-one; 1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one; 1-(2,4,6-trimethylphenyl)hex-1-en-3-one; 1-(2,4,6-trimethylphenyl)pent-1-en-3-one; 3-methyl-4-(2,4,6-trimethylphenyl)but-3-en-2-one; 1-(2,6-dimethylphenyl)hex-1-en-3-one; 1-(2,6-dimethylphenyl)pent-1-en-3-one; 1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one; 1-cyclohexyl-2-phenylpropan-1-one; 2,4(R,S),7-trimethyloct-6-en-3-one; 2,2,4,4,7-pentamethyloct-6-en-3-one; Ethyl 2(R,S),5-dimethyl-2-(pivaloyl)hex-4-enoate; 2,2,7-Trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclohexyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 4,4,7-trimethyloct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 3,6-dimethyl-3-(3-methylbut-2-enyl)hept-5-en-2-one; 3(R,S),6-dimethylhept-5-en-2-one; 1-(1-(3-hydroxy-3-methylbutyl)cyclohexyl)-2-methylpropan-1-one; 5-methyl-2(R,S)-(prop-1-en-2-yl)-hex-4-enoic acid; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 4,7-dimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 2,4,7-trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 3(R,S),5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)ethanone; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)pentan-1-one; 1-(3-methylbut-2-enyl)cyclopentanecarbonitrile; 1-(3-methylbut-2-enyl)cyclohexanecarbonitrile; 1-(3-methylbut-2-enyl)cyclobutanecarbonitrile; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclobutyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)ethanone; 2-(R,S)-methyl-1-(1-phenylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)pentan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-one; 1-(1-phenylcyclopropyl)propan-1-one; 2-methyl-1-(1-phenylcyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)butan-1-one; 1-(1-p-tolylcyclopropyl)propan-1-one; 2-(R,S)-methyl-1-(1-p-tolylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)-3-methylenecyclobutyl)ethanone; 1-(1-phenylcyclobutyl)pentan-1-one; 2,5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)pentan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)butan-1-one; 2,2-dimethyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 2-methyl-1-(1-p-tolylcyclopropyl)propan-1-one; 1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)ethanone; 2-methyl-1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)butan-1-one; 2,4-dimethyl-2-m-tolylpentan-3-one; 2-methyl-2-m-tolylpropanenitrile; 3-methyl-3-m-tolylbutan-2-one; 2-methyl-2-m-tolylpentan-3-one; 1-(1-p-tolylcyclopentyl)ethanone; 7-methyl-1-phenyloct-6-en-1-one; 2,2-dimethyl-3-o-tolylpropanenitrile; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; o-methyl-benzylcyclopropanecarbonitrile; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(2-methylbenzyl)-cyclopropyl)propanone; 1-(1-(2-methylbenzyl)cyclopropyl)ethanone; 2-(R,S)-methyl-1-(1-(2-methylbenzyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(2-methylbenzyl)cyclopropyl)propan-1-one; 2,2,5-trimethyl-1-phenylhexan-3-one; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-ol; 2,2-dimethyl-3-(R,S)-phenylbutanenitrile; 4,4-dimethyl-5-(R,S)-phenylhexan-3-one; 1-cyclopentyl-7-methyloct-6-en-1-one; 2,2-dimethyl-3-p-tolylpropanenitrile; 3-(4-methoxy-3-methylphenyl)-3-methylbutan-2-one; 2,2,4-(R,S)-trimethyl-1-p-tolylhexan-3-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 2,2-dimethyl-1-p-tolylpentan-3-one; 3-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)heptan-3-ol; 3-cyclohexyl-2,2-dimethylpropanenitrile; 1-cyclohexyl-2,2,4-trimethylpentan-3-one; 1-(R,S)-(1-phenylethyl)-cyclobutanecarbonitrile; 1-(1-(R,S)-(1-phenylethyl)-cyclobutyl)ethanone; 2-methyl-1-(1-(R,S)-(1-phenylethyl)cyclobutyl)propan-1-one; 2-methyl-1-(R,S)-(1-(1-(R,s)-phenylethyl)cyclobutyl)propan-1-ol; 1-(1-(R,S)-phenylethyl)cyclopropanecarbonitrile; 1-(1-(1-(R,S)-phenylethyl)cyclopropyl)ethanone; 2,2-dimethyl-3-m-tolylpropanenitrile; 3-(4-tert-butylphenyl)-2,2-dimethylpropanenitrile; 1-(1-phenylcyclopropyl)but-3-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-(R,s)-ol; 4-(4-tert-butylphenyl)-3,3-dimethylbutan-2-one; 2,2-dimethyl-4-phenylbutanenitrile; 11-methyldodec-10-en-5-one; 2,9-dimethyldec-8-en-3-one; 2,10-dimethylundec-9-en-4-one; 2,2,9-trimethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 3,3-dimethyl-5-phenylpentan-s-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpropanenitrile; 2-((R,S)-cyclohex-2-enyl)-2,5-dimethylhexan-3-one; 3,3-dimethyl-1-phenyloctan-4-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpentan-3-one; 4,4-dimethyl-6-phenylhexan-3-one; 2,2-dimethyl-5-phenylpentanenitrile; 2,2-dimethylhept-6-enenitrile; 6,6-dimethylundec-10-en-5-one; 3,3-dimethyl-6-phenylhexan-2-one; 2,2-dimethyl-4-((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)butanenitrile; stereoisomers of 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 3-methyl-4-(4-methylphenyl)but-3-en-2-one 3-methyl-4-p-tolylbut-3-en-2-one; 4-(2-methyl-3-oxobut-1-enyl)benzonitrile; 1-phenylhex-1-en-3-one; 3-methyl-4-(2-methylphenyl)but-3-en-2-one 3-methyl-4-o-tolylbut-3-en-2-one; 3-methyl-4-(3-ethylphenyl)but-3-en-2-one 3-methyl-4-m-tolylbut-3-en-2-one; 4-(4-methoxyphenyl)-3-methylbut-3-en-2-one; 3-(4-methylbenzylidene)pentan-2-one; 1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one; 1-(2,4,6-trimethylphenyl)hex-1-en-3-one; 1-(2,4,6-trimethylphenyl)pent-1-en-3-one; 3-methyl-4-(2,4,6-trimethylphenyl)but-3-en-2-one; 1-(2,6-dimethylphenyl)hex-1-en-3-one; 1-(2,6-dimethylphenyl)pent-1-en-3-one; 1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one; 1-cyclohexyl-2-phenylpropan-1-one; 2,4(R,S),7-trimethyloct-6-en-3-one; 2,2,4,4,7-pentamethyloct-6-en-3-one; Ethyl 2(R,S),5-dimethyl-2-(pivaloyl)hex-4-enoate; 2,2,7-Trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclohexyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 4,4,7-trimethyloct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 3,6-dimethyl-3-(3-methylbut-2-enyl)hept-5-en-2-one; 3(R,S),6-dimethylhept-5-en-2-one; 1-(1-(3-hydroxy-3-methylbutyl)cyclohexyl)-2-methylpropan-1-one; 5-methyl-2(R,S)-(prop-1-en-2-yl)-hex-4-enoic acid; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 4,7-dimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 2,4,7-trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 3(R,S),5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)ethanone; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)pentan-1-one; 1-(3-methylbut-2-enyl)cyclopentanecarbonitrile; 1-(3-methylbut-2-enyl)cyclohexanecarbonitrile; 1-(3-methylbut-2-enyl)cyclobutanecarbonitrile; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclobutyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)ethanone; 2-(R,S)-methyl-1-(1-phenylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)pentan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-one; 1-(1-phenylcyclopropyl)propan-1-one; 2-methyl-1-(1-phenylcyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)butan-1-one; 1-(1-p-tolylcyclopropyl)propan-1-one; 2-(R,S)-methyl-1-(1-p-tolylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)-3-methylenecyclobutyl)ethanone; 1-(1-phenylcyclobutyl)pentan-1-one; 2,5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)pentan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)butan-1-one; 2,2-dimethyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 2-methyl-1-(1-p-tolylcyclopropyl)propan-1-one; 1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)ethanone; 2-methyl-1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)butan-1-one; 2,4-dimethyl-2-m-tolylpentan-3-one; 2-methyl-2-m-tolylpropanenitrile; 3-methyl-3-m-tolylbutan-2-one; 2-methyl-2-m-tolylpentan-3-one; 1-(1-p-tolylcyclopentyl)ethanone; 7-methyl-1-phenyloct-6-en-1-one; 2,2-dimethyl-3-o-tolylpropanenitrile; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; o-methyl-benzylcyclopropanecarbonitrile; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(2-methylbenzyl)-cyclopropyl)propanone; 1-(1-(2-methylbenzyl)cyclopropyl)ethanone; 2-(R,S)-methyl-1-(1-(2-methylbenzyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(2-methylbenzyl)cyclopropyl)propan-1-one; 2,2,5-trimethyl-1-phenylhexan-3-one; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-ol; 2,2-dimethyl-3-(R,S)-phenylbutanenitrile; 4,4-dimethyl-5-(R,S)-phenylhexan-3-one; 1-cyclopentyl-7-methyloct-6-en-1-one; 2,2-dimethyl-3-p-tolylpropanenitrile; 3-(4-methoxy-3-methylphenyl)-3-methylbutan-2-one; 2,2,4-(R,S)-trimethyl-1-p-tolylhexan-3-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 2,2-dimethyl-1-p-tolylpentan-3-one; 3-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)heptan-3-ol; 3-cyclohexyl-2,2-dimethylpropanenitrile; 1-cyclohexyl-2,2,4-trimethylpentan-3-one; 1-(R,S)-(1-phenylethyl)-cyclobutanecarbonitrile; 1-(1-(R,S)-(1-phenylethyl)-cyclobutyl)ethanone; 2-methyl-1-(1-(R,S)-(1-phenylethyl)cyclobutyl)propan-1-one; 2-methyl-1-(R,S)-(1-(1-(R,s)-phenylethyl)cyclobutyl)propan-1-ol; 1-(1-(R,S)-phenylethyl)cyclopropanecarbonitrile; 1-(1-(1-(R,S)-phenylethyl)cyclopropyl)ethanone; 2,2-dimethyl-3-m-tolylpropanenitrile; 3-(4-tert-butylphenyl)-2,2-dimethylpropanenitrile; 1-(1-phenylcyclopropyl)but-3-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-(R,s)-ol; 4-(4-tert-butylphenyl)-3,3-dimethylbutan-2-one; 2,2-dimethyl-4-phenylbutanenitrile; 11-methyldodec-10-en-5-one; 2,9-dimethyldec-8-en-3-one; 2,10-dimethylundec-9-en-4-one; 2,2,9-trimethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 3,3-dimethyl-5-phenylpentan-s-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpropanenitrile; 2-((R,S)-cyclohex-2-enyl)-2,5-dimethylhexan-3-one; 3,3-dimethyl-1-phenyloctan-4-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpentan-3-one; 4,4-dimethyl-6-phenylhexan-3-one; 2,2-dimethyl-5-phenylpentanenitrile; 2,2-dimethylhept-6-enenitrile; 6,6-dimethylundec-10-en-5-one; 3,3-dimethyl-6-phenylhexan-2-one; 2,2-dimethyl-4-((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)butanenitrile; and mixtures thereof.
8. A consumer product according to claim 3, said consumer product being a highly compacted consumer product, said highly compacted consumer product comprising based on total highly compacted consumer product weight, from about 0.00001% to about 25% of one or more PRMs selected from 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 4-(4-methylcyclohex-3-enyl)pentan-2-ol; 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 3-methyl-4-phenylbut-3-en-2-one; 4-(4-methylphenyl)butan-2-one, 4-p-tolylbutan-2-one; 1-(3-methylphenyl)pent-1-en-3-one 1-m-tolylpent-1-en-3-one; 3-methyl-4-(4-methylphenyl)but-3-en-2-one 3-methyl-4-p-tolylbut-3-en-2-one; 4-(2-methyl-3-oxobut-1-enyl)benzonitrile; 1-phenylhex-1-en-3-one; 1-(2-methylphenyl)pent-1-en-3-one 1-o-tolylpent-1-en-3-one; 3-methyl-4-(2-methylphenyl)but-3-en-2-one 3-methyl-4-o-tolylbut-3-en-2-one; 3-methyl-4-(3-methylphenyl)but-3-en-2-one 3-methyl-4-m-tolylbut-3-en-2-one; 4-(4-methoxyphenyl)-3-methylbut-3-en-2-one; 3-(4-methylbenzylidene)pentan-2-one; 1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one; 1-(2,4,6-trimethylphenyl)hex-1-en-3-one; 1-(2,4,6-trimethylphenyl)pent-1-en-3-one; 3-methyl-4-(2,4,6-trimethylphenyl)but-3-en-2-one; 1-(2,6-dimethylphenyl)hex-1-en-3-one; 1-(2,6-dimethylphenyl)pent-1-en-3-one; 1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one; 1-cyclohexyl-2-phenylpropan-1-one; 2,2,4,7-tetramethyloct-6-en-3-one; 2,4(R,S),7-trimethyloct-6-en-3-one; 2,2,4,4,7-pentamethyloct-6-en-3-one; Ethyl 2(R,S),5-dimethyl-2-(pivaloyl)hex-4-enoate; 2,2,7-Trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclohexyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 4,4,7-trimethyloct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 3,6-dimethyl-3-(3-methylbut-2-enyl)hept-5-en-2-one; 3 (R,S),6-dimethylhept-5-en-2-one; 1-(1-(3-hydroxy-3-methylbutyl)cyclohexyl)-2-methylpropan-1-one; 5-methyl-2(R,S)-(prop-1-en-2-yl)-hex-4-enoic acid; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 4,7-dimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 2,4,7-trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 3 (R,S),5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)ethanone; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)pentan-1-one; 9-methyldec-8-en-3 one; 2,5-dimethyl-2-(3-methylbut-2-enyl)hex-4-enenitrile; 1-(3-methylbut-2-enyl)cyclopentanecarbonitrile; 1-(3-methylbut-2-enyl)cyclohexanecarbonitrile; 1-(3-methylbut-2-enyl)cyclopropanecarbonitrile; 1-(3-methylbut-2-enyl)cyclobutanecarbonitrile; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclobutyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)ethanone; 2-(R,S)-methyl-1-(1-phenylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)pentan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-one; 1-(1-phenylcyclopropyl)propan-1-one; 2-methyl-1-(1-phenylcyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)butan-1-one; 1-(1-p-tolylcyclopropyl)propan-1-one; 2-(R,S)-methyl-1-(1-p-tolylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)-3-methylenecyclobutyl)ethanone; 1-(1-phenylcyclobutyl)pentan-1-one; 2,2,5-trimethylhex-4-enenitrile; 6,6,9-trimethyldec-8-en-5-one; 2,5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)pentan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)butan-1-one; 2,2-dimethyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 2-methyl-1-(1-p-tolylcyclopropyl)propan-1-one; 1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)ethanone; 2-methyl-1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)butan-1-one; 2,4-dimethyl-2-m-tolylpentan-3-one; 2-methyl-2-m-tolylpropanenitrile; 3-methyl-3-m-tolylbutan-2-one; 2-methyl-2-m-tolylpentan-3-one; 1-(1-p-tolylcyclopentyl)ethanone; 7-methyl-1-phenyloct-6-en-1-one; 2,2-dimethyl-3-o-tolylpropanenitrile; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; o-methyl-benzylcyclopropanecarbonitrile; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(2-methylbenzyl)-cyclopropyl)propanone; 1-(1-(2-methylbenzyl)cyclopropyl)ethanone; 2-(R,S)-methyl-1-(1-(2-methylbenzyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(2-methylbenzyl)cyclopropyl)propan-1-one; 2,2,5-trimethyl-1-phenylhexan-3-one; 2-(1-(3-methylbut-2-enyl)cyclopropyl)propan-2-ol; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-ol; 9-methyldec-1,8-dien-3-one; 2,2-dimethyl-3-(R,S)-phenylbutanenitrile; 4,4-dimethyl-5-(R,S)-phenylhexan-3-one; 1-cyclopentyl-7-methyloct-6-en-1-one; 2,2-dimethyl-3-p-tolylpropanenitrile; 3-(4-methoxy-3-methylphenyl)-3-methylbutan-2-one; 2,2,4-(R,S)-trimethyl-1-p-tolylhexan-3-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 2,2-dimethyl-1-p-tolylpentan-3-one; 3-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)heptan-3-ol; 3-cyclohexyl-2,2-dimethylpropanenitrile; 1-cyclohexyl-2,2,4-trimethylpentan-3-one; 1-(R,S)-(1-phenylethyl)-cyclobutanecarbonitrile; 1-(1-(R,S)-(1-phenylethyl)-cyclobutyl)ethanone; 2-methyl-1-(1-(R,S)-(1-phenylethyl)cyclobutyl)propan-1-one; 2-methyl-1-(R,S)-(1-(1-(R,s)-phenylethyl)cyclobutyl)propan-1-ol; 1-(1-(R,S)-phenylethyl)cyclopropanecarbonitrile; 1-(1-(1-(R,S)-phenylethyl)cyclopropyl)ethanone; 2,2-dimethyl-3-m-tolylpropanenitrile; 3-(4-tert-butylphenyl)-2,2-dimethylpropanenitrile; 1-(1-phenylcyclopropyl)but-3-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-(R,s)-ol; 4-(4-tert-butylphenyl)-3,3-dimethylbutan-2-one; 2,2-dimethyl-4-phenylbutanenitrile; 11-methyldodec-10-en-5-one; 2,9-dimethyldec-8-en-3-one; 2,10-dimethylundec-9-en-4-one; 2,2,9-trimethyldec-8-en-3-one; 2,2,3-(R,S),7-tetramethyloct-6-enenitrile; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 3,3-dimethyl-5-phenylpentan-s-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpropanenitrile; 2-((R,S)-cyclohex-2-enyl)-2,5-dimethylhexan-3-one; 3,3-dimethyl-1-phenyloctan-4-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpentan-3-one; 4,4-dimethyl-6-phenylhexan-3-one; 2,2-dimethyl-5-phenylpentanenitrile; 2,2-dimethylhept-6-enenitrile; 6,6-dimethylundec-10-en-5-one; 3,3-dimethyl-6-phenylhexan-2-one; 2,2-dimethyl-4-((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)butanenitrile.
9. A consumer product according to claim 8, said consumer product being a highly compacted detergent, said highly compacted detergent comprising one or more PRMs selected from 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 4-(4-methylcyclohex-3-enyl)pentan-2-ol; 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 3-methyl-4-phenylbut-3-en-2-one; 4-(4-methylphenyl)butan-2-one, 4-p-tolylbutan-2-one; 1-(3-methylphenyl)pent-1-en-3-one 1-m-tolylpent-1-en-3-one; 3-methyl-4-(4-methylphenyl)but-3-en-2-one 3-methyl-4-p-tolylbut-3-en-2-one; 4-(2-methyl-3-oxobut-1-enyl)benzonitrile; 1-phenylhex-1-en-3-one; 1-(2-methylphenyl)pent-1-en-3-one 1-o-tolylpent-1-en-3-one; 3-methyl-4-(2-methylphenyl)but-3-en-2-one 3-methyl-4-o-tolylbut-3-en-2-one; 3-methyl-4-(3-methylphenyl)but-3-en-2-one 3-methyl-4-m-tolylbut-3-en-2-one; 4-(4-methoxyphenyl)-3-methylbut-3-en-2-one; 3-(4-methylbenzylidene)pentan-2-one; 1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one; 1-(2,4,6-trimethylphenyl)hex-1-en-3-one; 1-(2,4,6-trimethylphenyl)pent-1-en-3-one; 3-methyl-4-(2,4,6-trimethylphenyl)but-3-en-2-one; 1-(2,6-dimethylphenyl)hex-1-en-3-one; 1-(2,6-dimethylphenyl)pent-1-en-3-one; 1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one; 1-cyclohexyl-2-phenylpropan-1-one; 2,2,4,7-tetramethyloct-6-en-3-one; 2,4(R,S),7-trimethyloct-6-en-3-one; 2,2,4,4,7-pentamethyloct-6-en-3-one; Ethyl 2(R,S),5-dimethyl-2-(pivaloyl)hex-4-enoate; 2,2,7-Trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclohexyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 4,4,7-trimethyloct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 3,6-dimethyl-3-(3-methylbut-2-enyl)hept-5-en-2-one; 3(R,S),6-dimethylhept-5-en-2-one; 1-(1-(3-hydroxy-3-methylbutyl)cyclohexyl)-2-methylpropan-1-one; 5-methyl-2(R,S)-(prop-1-en-2-yl)-hex-4-enoic acid; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 4,7-dimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 2,4,7-trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 3(R,S),5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)ethanone; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)pentan-1-one; 9-methyldec-8-en-3 one; 2,5-dimethyl-2-(3-methylbut-2-enyl)hex-4-enenitrile; 1-(3-methylbut-2-enyl)cyclopentanecarbonitrile; 1-(3-methylbut-2-enyl)cyclohexanecarbonitrile; 1-(3-methylbut-2-enyl)cyclopropanecarbonitrile; 1-(3-methylbut-2-enyl)cyclobutanecarbonitrile; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclobutyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)ethanone; 2-(R,S)-methyl-1-(1-phenylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)pentan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-one; 1-(1-phenylcyclopropyl)propan-1-one; 2-methyl-1-(1-phenylcyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)butan-1-one; 1-(1-p-tolylcyclopropyl)propan-1-one; 2-(R,S)-methyl-1-(1-p-tolylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)-3-methylenecyclobutyl)ethanone; 1-(1-phenylcyclobutyl)pentan-1-one; 2,2,5-trimethylhex-4-enenitrile; 6,6,9-trimethyldec-8-en-5-one; 2,5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)pentan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)butan-1-one; 2,2-dimethyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 2-methyl-1-(1-p-tolylcyclopropyl)propan-1-one; 1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)ethanone; 2-methyl-1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)butan-1-one; 2,4-dimethyl-2-m-tolylpentan-3-one; 2-methyl-2-m-tolylpropanenitrile; 3-methyl-3-m-tolylbutan-2-one; 2-methyl-2-m-tolylpentan-3-one; 1-(1-p-tolylcyclopentyl)ethanone; 7-methyl-1-phenyloct-6-en-1-one; 2,2-dimethyl-3-o-tolylpropanenitrile; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; o-methyl-benzylcyclopropanecarbonitrile; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(2-methylbenzyl)-cyclopropyl)propanone; 1-(1-(2-methylbenzyl)cyclopropyl)ethanone; 2-(R,S)-methyl-1-(1-(2-methylbenzyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(2-methylbenzyl)cyclopropyl)propan-1-one; 2,2,5-trimethyl-1-phenylhexan-3-one; 2-(1-(3-methylbut-2-enyl)cyclopropyl)propan-2-ol; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-ol; 9-methyldec-1,8-dien-3-one; 2,2-dimethyl-3-(R,S)-phenylbutanenitrile; 4,4-dimethyl-5-(R,S)-phenylhexan-3-one; 1-cyclopentyl-7-methyloct-6-en-1-one; 2,2-dimethyl-3-p-tolylpropanenitrile; 3-(4-methoxy-3-methylphenyl)-3-methylbutan-2-one; 2,2,4-(R,S)-trimethyl-1-p-tolylhexan-3-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 2,2-dimethyl-1-p-tolylpentan-3-one; 3-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)heptan-3-ol; 3-cyclohexyl-2,2-dimethylpropanenitrile; 1-cyclohexyl-2,2,4-trimethylpentan-3-one; 1-(R,S)-(1-phenylethyl)-cyclobutanecarbonitrile; 1-(1-(R,S)-(1-phenylethyl)-cyclobutyl)ethanone; 2-methyl-1-(1-(R,S)-(1-phenylethyl)cyclobutyl)propan-1-one; 2-methyl-1-(R,S)-(1-(1-(R,s)-phenylethyl)cyclobutyl)propan-1-ol; 1-(1-(R,S)-phenylethyl)cyclopropanecarbonitrile; 1-(1-(1-(R,S)-phenylethyl)cyclopropyl)ethanone; 2,2-dimethyl-3-m-tolylpropanenitrile; 3-(4-tert-butylphenyl)-2,2-dimethylpropanenitrile; 1-(1-phenylcyclopropyl)but-3-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-(R,s)-ol; 4-(4-tert-butylphenyl)-3,3-dimethylbutan-2-one; 2,2-dimethyl-4-phenylbutanenitrile; 11-methyldodec-10-en-5-one; 2,9-dimethyldec-8-en-3-one; 2,10-dimethylundec-9-en-4-one; 2,2,9-trimethyldec-8-en-3-one; 2,2,3-(R,S),7-tetramethyloct-6-enenitrile; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 3,3-dimethyl-5-phenylpentan-s-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpropanenitrile; 2-((R,S)-cyclohex-2-enyl)-2,5-dimethylhexan-3-one; 3,3-dimethyl-1-phenyloctan-4-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpentan-3-one; 4,4-dimethyl-6-phenylhexan-3-one; 2,2-dimethyl-5-phenylpentanenitrile; 2,2-dimethylhept-6-enenitrile; 6,6-dimethylundec-10-en-5-one; 3,3-dimethyl-6-phenylhexan-2-one; 2,2-dimethyl-4-((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)butanenitrile; stereoisomers of 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 4-(4-methylcyclohex-3-enyl)pentan-2-ol; 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 3-methyl-4-phenylbut-3-en-2-one; 4-(4-methylphenyl)butan-2-one, 4-p-tolylbutan-2-one; 1-(3-methylphenyl)pent-1-en-3-one 1-m-tolylpent-1-en-3-one; 3-methyl-4-(4-methylphenyl)but-3-en-2-one 3-methyl-4-p-tolylbut-3-en-2-one; 4-(2-methyl-3-oxobut-1-enyl)benzonitrile; 1-phenylhex-1-en-3-one; 1-(2-methylphenyl)pent-1-en-3-one 1-o-tolylpent-1-en-3-one; 3-methyl-4-(2-methylphenyl)but-3-en-2-one 3-methyl-4-o-tolylbut-3-en-2-one; 3-methyl-4-(3-methylphenyl)but-3-en-2-one 3-methyl-4-m-tolylbut-3-en-2-one; 4-(4-methoxyphenyl)-3-methylbut-3-en-2-one; 3-(4-methylbenzylidene)pentan-2-one; 1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one; 1-(2,4,6-trimethylphenyl)hex-1-en-3-one; 1-(2,4,6-trimethylphenyl)pent-1-en-3-one; 3-methyl-4-(2,4,6-trimethylphenyl)but-3-en-2-one; 1-(2,6-dimethylphenyl)hex-1-en-3-one; 1-(2,6-dimethylphenyl)pent-1-en-3-one; 1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one; 1-cyclohexyl-2-phenylpropan-1-one; 2,2,4,7-tetramethyloct-6-en-3-one; 2,4(R,S),7-trimethyloct-6-en-3-one; 2,2,4,4,7-pentamethyloct-6-en-3-one; Ethyl 2(R,S),5-dimethyl-2-(pivaloyl)hex-4-enoate; 2,2,7-Trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclohexyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 4,4,7-trimethyloct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 3,6-dimethyl-3-(3-methylbut-2-enyl)hept-5-en-2-one; 3(R,S),6-dimethylhept-5-en-2-one; 1-(1-(3-hydroxy-3-methylbutyl)cyclohexyl)-2-methylpropan-1-one; 5-methyl-2(R,S)-(prop-1-en-2-yl)-hex-4-enoic acid; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 4,7-dimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 2,4,7-trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 3(R,S),5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)ethanone; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)pentan-1-one; 9-methyldec-8-en-3 one; 2,5-dimethyl-2-(3-methylbut-2-enyl)hex-4-enenitrile; 1-(3-methylbut-2-enyl)cyclopentanecarbonitrile; 1-(3-methylbut-2-enyl)cyclohexanecarbonitrile; 1-(3-methylbut-2-enyl)cyclopropanecarbonitrile; 1-(3-methylbut-2-enyl)cyclobutanecarbonitrile; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclobutyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)ethanone; 2-(R,S)-methyl-1-(1-phenylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)pentan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-one; 1-(1-phenylcyclopropyl)propan-1-one; 2-methyl-1-(1-phenylcyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)butan-1-one; 1-(1-p-tolylcyclopropyl)propan-1-one; 2-(R,S)-methyl-1-(1-p-tolylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)-3-methylenecyclobutyl)ethanone; 1-(1-phenylcyclobutyl)pentan-1-one; 2,2,5-trimethylhex-4-enenitrile; 6,6,9-trimethyldec-8-en-5-one; 2,5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)pentan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)butan-1-one; 2,2-dimethyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 2-methyl-1-(1-p-tolylcyclopropyl)propan-1-one; 1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)ethanone; 2-methyl-1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)butan-1-one; 2,4-dimethyl-2-m-tolylpentan-3-one; 2-methyl-2-m-tolylpropanenitrile; 3-methyl-3-m-tolylbutan-2-one; 2-methyl-2-m-tolylpentan-3-one; 1-(1-p-tolylcyclopentyl)ethanone; 7-methyl-1-phenyloct-6-en-1-one; 2,2-dimethyl-3-o-tolylpropanenitrile; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; o-methyl-benzylcyclopropanecarbonitrile; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(2-methylbenzyl)-cyclopropyl)propanone; 1-(1-(2-methylbenzyl)cyclopropyl)ethanone; 2-(R,S)-methyl-1-(1-(2-methylbenzyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(2-methylbenzyl)cyclopropyl)propan-1-one; 2,2,5-trimethyl-1-phenylhexan-3-one; 2-(1-(3-methylbut-2-enyl)cyclopropyl)propan-2-ol; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-ol; 9-methyldec-1,8-dien-3-one; 2,2-dimethyl-3-(R,S)-phenylbutanenitrile; 4,4-dimethyl-5-(R,S)-phenylhexan-3-one; 1-cyclopentyl-7-methyloct-6-en-1-one; 2,2-dimethyl-3-p-tolylpropanenitrile; 3-(4-methoxy-3-methylphenyl)-3-methylbutan-2-one; 2,2,4-(R,S)-trimethyl-1-p-tolylhexan-3-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 2,2-dimethyl-1-p-tolylpentan-3-one; 3-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)heptan-3-ol; 3-cyclohexyl-2,2-dimethylpropanenitrile; 1-cyclohexyl-2,2,4-trimethylpentan-3-one; 1-(R,S)-(1-phenylethyl)-cyclobutanecarbonitrile; 1-(1-(R,S)-(1-phenylethyl)-cyclobutyl)ethanone; 2-methyl-1-(1-(R,S)-(1-phenylethyl)cyclobutyl)propan-1-one; 2-methyl-1-(R,S)-(1-(1-(R,s)-phenylethyl)cyclobutyl)propan-1-ol; 1-(1-(R,S)-phenylethyl)cyclopropanecarbonitrile; 1-(1-(1-(R,S)-phenylethyl)cyclopropyl)ethanone; 2,2-dimethyl-3-m-tolylpropanenitrile; 3-(4-tert-butylphenyl)-2,2-dimethylpropanenitrile; 1-(1-phenylcyclopropyl)but-3-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-(R,s)-ol; 4-(4-tert-butylphenyl)-3,3-dimethylbutan-2-one; 2,2-dimethyl-4-phenylbutanenitrile; 11-methyldodec-10-en-5-one; 2,9-dimethyldec-8-en-3-one; 2,10-dimethylundec-9-en-4-one; 2,2,9-trimethyldec-8-en-3-one; 2,2,3-(R,S),7-tetramethyloct-6-enenitrile; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 3,3-dimethyl-5-phenylpentan-s-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpropanenitrile; 2-((R,S)-cyclohex-2-enyl)-2,5-dimethylhexan-3-one; 3,3-dimethyl-1-phenyloctan-4-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpentan-3-one; 4,4-dimethyl-6-phenylhexan-3-one; 2,2-dimethyl-5-phenylpentanenitrile; 2,2-dimethylhept-6-enenitrile; 6,6-dimethylundec-10-en-5-one; 3,3-dimethyl-6-phenylhexan-2-one; 2,2-dimethyl-4-((1R,5S)-6,6-dimethylbicyclo [3.1.1]hept-2-en-2-yl)butanenitrile; and mixtures thereof.
10. A perfume delivery system comprising from 0.001% to about 50% of one or more PRMs selected from 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 4-(4-methylcyclohex-3-enyl)pentan-2-ol; 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 3-methyl-4-phenylbut-3-en-2-one; 4-(4-methylphenyl)butan-2-one, 4-p-tolylbutan-2-one; 1-(3-methylphenyl)pent-1-en-3-one 1-m-tolylpent-1-en-3-one; 3-methyl-4-(4-methylphenyl)but-3-en-2-one 3-methyl-4-p-tolylbut-3-en-2-one; 4-(2-methyl-3-oxobut-1-enyl)benzonitrile; 1-phenylhex-1-en-3-one; 1-(2-methylphenyl)pent-1-en-3-one 1-o-tolylpent-1-en-3-one; 3-methyl-4-(2-methylphenyl)but-3-en-2-one 3-methyl-4-o-tolylbut-3-en-2-one; 3-methyl-4-(3-methylphenyl)but-3-en-2-one 3-methyl-4-m-tolylbut-3-en-2-one; 4-(4-methoxyphenyl)-3-methylbut-3-en-2-one; 3-(4-methylbenzylidene)pentan-2-one; 1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one; 1-(2,4,6-trimethylphenyl)hex-1-en-3-one; 1-(2,4,6-trimethylphenyl)pent-1-en-3-one; 3-methyl-4-(2,4,6-trimethylphenyl)but-3-en-2-one; 1-(2,6-dimethylphenyl)hex-1-en-3-one; 1-(2,6-dimethylphenyl)pent-1-en-3-one; 1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one; 1-cyclohexyl-2-phenylpropan-1-one; 2,2,4,7-tetramethyloct-6-en-3-one; 2,4(R,S),7-trimethyloct-6-en-3-one; 2,2,4,4,7-pentamethyloct-6-en-3-one; Ethyl 2(R,S),5-dimethyl-2-(pivaloyl)hex-4-enoate; 2,2,7-Trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclohexyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 4,4,7-trimethyloct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 3,6-dimethyl-3-(3-methylbut-2-enyl)hept-5-en-2-one; 3(R,S),6-dimethylhept-5-en-2-one; 1-(1-(3-hydroxy-3-methylbutyl)cyclohexyl)-2-methylpropan-1-one; 5-methyl-2(R,S)-(prop-1-en-2-yl)-hex-4-enoic acid; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 4,7-dimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 2,4,7-trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 3(R,S),5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)ethanone; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)pentan-1-one; 9-methyldec-8-en-3 one; 2,5-dimethyl-2-(3-methylbut-2-enyl)hex-4-enenitrile; 1-(3-methylbut-2-enyl)cyclopentanecarbonitrile; 1-(3-methylbut-2-enyl)cyclohexanecarbonitrile; 1-(3-methylbut-2-enyl)cyclopropanecarbonitrile; 1-(3-methylbut-2-enyl)cyclobutanecarbonitrile; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclobutyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)ethanone; 2-(R,S)-methyl-1-(1-phenylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)pentan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-one; 1-(1-phenylcyclopropyl)propan-1-one; 2-methyl-1-(1-phenylcyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)butan-1-one; 1-(1-p-tolylcyclopropyl)propan-1-one; 2-(R,S)-methyl-1-(1-p-tolylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)-3-methylenecyclobutyl)ethanone; 1-(1-phenylcyclobutyl)pentan-1-one; 2,2,5-trimethylhex-4-enenitrile; 6,6,9-trimethyldec-8-en-5-one; 2,5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)pentan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)butan-1-one; 2,2-dimethyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 2-methyl-1-(1-p-tolylcyclopropyl)propan-1-one; 1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)ethanone; 2-methyl-1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)butan-1-one; 2,4-dimethyl-2-m-tolylpentan-3-one; 2-methyl-2-m-tolylpropanenitrile; 3-methyl-3-m-tolylbutan-2-one; 2-methyl-2-m-tolylpentan-3-one; 1-(1-p-tolylcyclopentyl)ethanone; 7-methyl-1-phenyloct-6-en-1-one; 2,2-dimethyl-3-o-tolylpropanenitrile; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; o-methyl-benzylcyclopropanecarbonitrile; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(2-methylbenzyl)-cyclopropyl)propanone; 1-(1-(2-methylbenzyl)cyclopropyl)ethanone; 2-(R,S)-methyl-1-(1-(2-methylbenzyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(2-methylbenzyl)cyclopropyl)propan-1-one; 2,2,5-trimethyl-1-phenylhexan-3-one; 2-(1-(3-methylbut-2-enyl)cyclopropyl)propan-2-ol; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-ol; 9-methyldec-1,8-dien-3-one; 2,2-dimethyl-3-(R,S)-phenylbutanenitrile; 4,4-dimethyl-5-(R,S)-phenylhexan-3-one; 1-cyclopentyl-7-methyloct-6-en-1-one; 2,2-dimethyl-3-p-tolylpropanenitrile; 3-(4-methoxy-3-methylphenyl)-3-methylbutan-2-one; 2,2,4-(R,S)-trimethyl-1-p-tolylhexan-3-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 2,2-dimethyl-1-p-tolylpentan-3-one; 3-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)heptan-3-ol; 3-cyclohexyl-2,2-dimethylpropanenitrile; 1-cyclohexyl-2,2,4-trimethylpentan-3-one; 1-(R,S)-(1-phenylethyl)-cyclobutanecarbonitrile; 1-(1-(R,S)-(1-phenylethyl)-cyclobutyl)ethanone; 2-methyl-1-(1-(R,S)-(1-phenylethyl)cyclobutyl)propan-1-one; 2-methyl-1-(R,S)-(1-(1-(R,s)-phenylethyl)cyclobutyl)propan-1-ol; 1-(1-(R,S)-phenylethyl)cyclopropanecarbonitrile; 1-(1-(1-(R,S)-phenylethyl)cyclopropyl)ethanone; 2,2-dimethyl-3-m-tolylpropanenitrile; 3-(4-tert-butylphenyl)-2,2-dimethylpropanenitrile; 1-(1-phenylcyclopropyl)but-3-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-(R,s)-ol; 4-(4-tert-butylphenyl)-3,3-dimethylbutan-2-one; 2,2-dimethyl-4-phenylbutanenitrile; 11-methyldodec-10-en-5-one; 2,9-dimethyldec-8-en-3-one; 2,10-dimethylundec-9-en-4-one; 2,2,9-trimethyldec-8-en-3-one; 2,2,3-(R,S),7-tetramethyloct-6-enenitrile; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 3,3-dimethyl-5-phenylpentan-s-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpropanenitrile; 2-((R,S)-cyclohex-2-enyl)-2,5-dimethylhexan-3-one; 3,3-dimethyl-1-phenyloctan-4-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpentan-3-one; 4,4-dimethyl-6-phenylhexan-3-one; 2,2-dimethyl-5-phenylpentanenitrile; 2,2-dimethylhept-6-enenitrile; 6,6-dimethylundec-10-en-5-one; 3,3-dimethyl-6-phenylhexan-2-one; 2,2-dimethyl-4-((1R,5S)-6,6-dimethylbicyclo [3.1.1]hept-2-en-2-yl)butanenitrile and/or stereoisomers of 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 4-(4-methylcyclohex-3-enyl)pentan-2-ol; 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 3-methyl-4-phenylbut-3-en-2-one; 4-(4-methylphenyl)butan-2-one, 4-p-tolylbutan-2-one; 1-(3-methylphenyl)pent-1-en-3-one 1-m-tolylpent-1-en-3-one; 3-methyl-4-(4-methylphenyl)but-3-en-2-one 3-methyl-4-p-tolylbut-3-en-2-one; 4-(2-methyl-3-oxobut-1-enyl)benzonitrile; 1-phenylhex-1-en-3-one; 1-(2-methylphenyl)pent-1-en-3-one 1-o-tolylpent-1-en-3-one; 3-methyl-4-(2-methylphenyl)but-3-en-2-one 3-methyl-4-o-tolylbut-3-en-2-one; 3-methyl-4-(3-methylphenyl)but-3-en-2-one 3-methyl-4-m-tolylbut-3-en-2-one; 4-(4-methoxyphenyl)-3-methylbut-3-en-2-one; 3-(4-methylbenzylidene)pentan-2-one; 1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one; 1-(2,4,6-trimethylphenyl)hex-1-en-3-one; 1-(2,4,6-trimethylphenyl)pent-1-en-3-one; 3-methyl-4-(2,4,6-trimethylphenyl)but-3-en-2-one; 1-(2,6-dimethylphenyl)hex-1-en-3-one; 1-(2,6-dimethylphenyl)pent-1-en-3-one; 1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one; 1-cyclohexyl-2-phenylpropan-1-one; 2,2,4,7-tetramethyloct-6-en-3-one; 2,4(R,S),7-trimethyloct-6-en-3-one; 2,2,4,4,7-pentamethyloct-6-en-3-one; Ethyl 2(R,S),5-dimethyl-2-(pivaloyl)hex-4-enoate; 2,2,7-Trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclohexyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 4,4,7-trimethyloct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 3,6-dimethyl-3-(3-methylbut-2-enyl)hept-5-en-2-one; 3(R,S),6-dimethylhept-5-en-2-one; 1-(1-(3-hydroxy-3-methylbutyl)cyclohexyl)-2-methylpropan-1-one; 5-methyl-2(R,S)-(prop-1-en-2-yl)-hex-4-enoic acid; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 4,7-dimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 2,4,7-trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 3(R,S),5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)ethanone; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)pentan-1-one; 9-methyldec-8-en-3 one; 2,5-dimethyl-2-(3-methylbut-2-enyl)hex-4-enenitrile; 1-(3-methylbut-2-enyl)cyclopentanecarbonitrile; 1-(3-methylbut-2-enyl)cyclohexanecarbonitrile; 1-(3-methylbut-2-enyl)cyclopropanecarbonitrile; 1-(3-methylbut-2-enyl)cyclobutanecarbonitrile; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclobutyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)ethanone; 2-(R,S)-methyl-1-(1-phenylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)pentan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-one; 1-(1-phenylcyclopropyl)propan-1-one; 2-methyl-1-(1-phenylcyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)butan-1-one; 1-(1-p-tolylcyclopropyl)propan-1-one; 2-(R,S)-methyl-1-(1-p-tolylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)-3-methylenecyclobutyl)ethanone; 1-(1-phenylcyclobutyl)pentan-1-one; 2,2,5-trimethylhex-4-enenitrile; 6,6,9-trimethyldec-8-en-5-one; 2,5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)pentan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)butan-1-one; 2,2-dimethyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 2-methyl-1-(1-p-tolylcyclopropyl)propan-1-one; 1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)ethanone; 2-methyl-1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)butan-1-one; 2,4-dimethyl-2-m-tolylpentan-3-one; 2-methyl-2-m-tolylpropanenitrile; 3-methyl-3-m-tolylbutan-2-one; 2-methyl-2-m-tolylpentan-3-one; 1-(1-p-tolylcyclopentyl)ethanone; 7-methyl-1-phenyloct-6-en-1-one; 2,2-dimethyl-3-o-tolylpropanenitrile; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; o-methyl-benzylcyclopropanecarbonitrile; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(2-methylbenzyl)-cyclopropyl)propanone; 1-(1-(2-methylbenzyl)cyclopropyl)ethanone; 2-(R,S)-methyl-1-(1-(2-methylbenzyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(2-methylbenzyl)cyclopropyl)propan-1-one; 2,2,5-trimethyl-1-phenylhexan-3-one; 2-(1-(3-methylbut-2-enyl)cyclopropyl)propan-2-ol; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-ol; 9-methyldec-1,8-dien-3-one; 2,2-dimethyl-3-(R,S)-phenylbutanenitrile; 4,4-dimethyl-5-(R,S)-phenylhexan-3-one; 1-cyclopentyl-7-methyloct-6-en-1-one; 2,2-dimethyl-3-p-tolylpropanenitrile; 3-(4-methoxy-3-methylphenyl)-3-methylbutan-2-one; 2,2,4-(R,S)-trimethyl-1-p-tolylhexan-3-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 2,2-dimethyl-1-p-tolylpentan-3-one; 3-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)heptan-3-ol; 3-cyclohexyl-2,2-dimethylpropanenitrile; 1-cyclohexyl-2,2,4-trimethylpentan-3-one; 1-(R,S)-(1-phenylethyl)-cyclobutanecarbonitrile; 1-(1-(R,S)-(1-phenylethyl)-cyclobutyl)ethanone; 2-methyl-1-(1-(R,S)-(1-phenylethyl)cyclobutyl)propan-1-one; 2-methyl-1-(R,S)-(1-(1-(R,s)-phenylethyl)cyclobutyl)propan-1-ol; 1-(1-(R,S)-phenylethyl)cyclopropanecarbonitrile; 1-(1-(1-(R,S)-phenylethyl)cyclopropyl)ethanone; 2,2-dimethyl-3-m-tolylpropanenitrile; 3-(4-tert-butylphenyl)-2,2-dimethylpropanenitrile; 1-(1-phenylcyclopropyl)but-3-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-(R,s)-ol; 4-(4-tert-butylphenyl)-3,3-dimethylbutan-2-one; 2,2-dimethyl-4-phenylbutanenitrile; 11-methyldodec-10-en-5-one; 2,9-dimethyldec-8-en-3-one; 2,10-dimethylundec-9-en-4-one; 2,2,9-trimethyldec-8-en-3-one; 2,2,3-(R,S),7-tetramethyloct-6-enenitrile; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 3,3-dimethyl-5-phenylpentan-s-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpropanenitrile; 2-((R,S)-cyclohex-2-enyl)-2,5-dimethylhexan-3-one; 3,3-dimethyl-1-phenyloctan-4-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpentan-3-one; 4,4-dimethyl-6-phenylhexan-3-one; 2,2-dimethyl-5-phenylpentanenitrile; 2,2-dimethylhept-6-enenitrile; 6,6-dimethylundec-10-en-5-one; 3,3-dimethyl-6-phenylhexan-2-one; 2,2-dimethyl-4-((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)butanenitrile, said perfume delivery system being a polymer assisted delivery system; molecule-assisted delivery system; fiber-assisted delivery system; amine assisted delivery system; cyclodextrin delivery system; starch encapsulated accord; inorganic carrier delivery system; or pro-perfume.
11. A perfume delivery system according to claim 10, said perfume delivery system being nanocapsule or microcapsule comprising, based on total nanocapsule or microcapsule weight, from about 0.1% to about 99% of one or more PRMs selected from 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 4-(4-methylcyclohex-3-enyl)pentan-2-ol; 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 3-methyl-4-phenylbut-3-en-2-one; 4-(4-methylphenyl)butan-2-one, 4-p-tolylbutan-2-one; 1-(3-methylphenyl)pent-1-en-3-one 1-m-tolylpent-1-en-3-one; 3-methyl-4-(4-methylphenyl)but-3-en-2-one 3-methyl-4-p-tolylbut-3-en-2-one; 4-(2-methyl-3-oxobut-1-enyl)benzonitrile; 1-phenylhex-1-en-3-one; 1-(2-methylphenyl)pent-1-en-3-one 1-o-tolylpent-1-en-3-one; 3-methyl-4-(2-methylphenyl)but-3-en-2-one 3-methyl-4-o-tolylbut-3-en-2-one; 3-methyl-4-(3-methylphenyl)but-3-en-2-one 3-methyl-4-m-tolylbut-3-en-2-one; 4-(4-methoxyphenyl)-3-methylbut-3-en-2-one; 3-(4-methylbenzylidene)pentan-2-one; 1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one; 1-(2,4,6-trimethylphenyl)hex-1-en-3-one; 1-(2,4,6-trimethylphenyl)pent-1-en-3-one; 3-methyl-4-(2,4,6-trimethylphenyl)but-3-en-2-one; 1-(2,6-dimethylphenyl)hex-1-en-3-one; 1-(2,6-dimethylphenyl)pent-1-en-3-one; 1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one; 1-cyclohexyl-2-phenylpropan-1-one; 2,2,4,7-tetramethyloct-6-en-3-one; 2,4(R,S),7-trimethyloct-6-en-3-one; 2,2,4,4,7-pentamethyloct-6-en-3-one; Ethyl 2(R,S),5-dimethyl-2-(pivaloyl)hex-4-enoate; 2,2,7-Trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclohexyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 4,4,7-trimethyloct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 3,6-dimethyl-3-(3-methylbut-2-enyl)hept-5-en-2-one; 3 (R,S),6-dimethylhept-5-en-2-one; 1-(1-(3-hydroxy-3-methylbutyl)cyclohexyl)-2-methylpropan-1-one; 5-methyl-2(R,S)-(prop-1-en-2-yl)-hex-4-enoic acid; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 4,7-dimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 2,4,7-trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 3 (R,S),5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)ethanone; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)pentan-1-one; 9-methyldec-8-en-3 one; 2,5-dimethyl-2-(3-methylbut-2-enyl)hex-4-enenitrile; 1-(3-methylbut-2-enyl)cyclopentanecarbonitrile; 1-(3-methylbut-2-enyl)cyclohexanecarbonitrile; 1-(3-methylbut-2-enyl)cyclopropanecarbonitrile; 1-(3-methylbut-2-enyl)cyclobutanecarbonitrile; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclobutyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)ethanone; 2-(R,S)-methyl-1-(1-phenylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)pentan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-one; 1-(1-phenylcyclopropyl)propan-1-one; 2-methyl-1-(1-phenylcyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)butan-1-one; 1-(1-p-tolylcyclopropyl)propan-1-one; 2-(R,S)-methyl-1-(1-p-tolylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)-3-methylenecyclobutyl)ethanone; 1-(1-phenylcyclobutyl)pentan-1-one; 2,2,5-trimethylhex-4-enenitrile; 6,6,9-trimethyldec-8-en-5-one; 2,5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)pentan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)butan-1-one; 2,2-dimethyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 2-methyl-1-(1-p-tolylcyclopropyl)propan-1-one; 1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)ethanone; 2-methyl-1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)butan-1-one; 2,4-dimethyl-2-m-tolylpentan-3-one; 2-methyl-2-m-tolylpropanenitrile; 3-methyl-3-m-tolylbutan-2-one; 2-methyl-2-m-tolylpentan-3-one; 1-(1-p-tolylcyclopentyl)ethanone; 7-methyl-1-phenyloct-6-en-1-one; 2,2-dimethyl-3-o-tolylpropanenitrile; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; o-methyl-benzylcyclopropanecarbonitrile; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(2-methylbenzyl)-cyclopropyl)propanone; 1-(1-(2-methylbenzyl)cyclopropyl)ethanone; 2-(R,S)-methyl-1-(1-(2-methylbenzyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(2-methylbenzyl)cyclopropyl)propan-1-one; 2,2,5-trimethyl-1-phenylhexan-3-one; 2-(1-(3-methylbut-2-enyl)cyclopropyl)propan-2-ol; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-ol; 9-methyldec-1,8-dien-3-one; 2,2-dimethyl-3-(R,S)-phenylbutanenitrile; 4,4-dimethyl-5-(R,S)-phenylhexan-3-one; 1-cyclopentyl-7-methyloct-6-en-1-one; 2,2-dimethyl-3-p-tolylpropanenitrile; 3-(4-methoxy-3-methylphenyl)-3-methylbutan-2-one; 2,2,4-(R,S)-trimethyl-1-p-tolylhexan-3-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 2,2-dimethyl-1-p-tolylpentan-3-one; 3-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)heptan-3-ol; 3-cyclohexyl-2,2-dimethylpropanenitrile; 1-cyclohexyl-2,2,4-trimethylpentan-3-one; 1-(R,S)-(1-phenylethyl)-cyclobutanecarbonitrile; 1-(1-(R,S)-(1-phenylethyl)-cyclobutyl)ethanone; 2-methyl-1-(1-(R,S)-(1-phenylethyl)cyclobutyl)propan-1-one; 2-methyl-1-(R,S)-(1-(1-(R,s)-phenylethyl)cyclobutyl)propan-1-ol; 1-(1-(R,S)-phenylethyl)cyclopropanecarbonitrile; 1-(1-(1-(R,S)-phenylethyl)cyclopropyl)ethanone; 2,2-dimethyl-3-m-tolylpropanenitrile; 3-(4-tert-butylphenyl)-2,2-dimethylpropanenitrile; 1-(1-phenylcyclopropyl)but-3-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-(R,s)-ol; 4-(4-tert-butylphenyl)-3,3-dimethylbutan-2-one; 2,2-dimethyl-4-phenylbutanenitrile; 11-methyldodec-10-en-5-one; 2,9-dimethyldec-8-en-3-one; 2,10-dimethylundec-9-en-4-one; 2,2,9-trimethyldec-8-en-3-one; 2,2,3-(R,S),7-tetramethyloct-6-enenitrile; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 3,3-dimethyl-5-phenylpentan-s-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpropanenitrile; 2-((R,S)-cyclohex-2-enyl)-2,5-dimethylhexan-3-one; 3,3-dimethyl-1-phenyloctan-4-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpentan-3-one; 4,4-dimethyl-6-phenylhexan-3-one; 2,2-dimethyl-5-phenylpentanenitrile; 2,2-dimethylhept-6-enenitrile; 6,6-dimethylundec-10-en-5-one; 3,3-dimethyl-6-phenylhexan-2-one; 2,2-dimethyl-4-((1R,5S)-6,6-dimethylbicyclo [3.1.1]hept-2-en-2-yl)butanenitrile and/or stereoisomers of 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 4-(4-methylcyclohex-3-enyl)pentan-2-ol; 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 3-methyl-4-phenylbut-3-en-2-one; 4-(4-methylphenyl)butan-2-one, 4-p-tolylbutan-2-one; 1-(3-methylphenyl)pent-1-en-3-one 1-m-tolylpent-1-en-3-one; 3-methyl-4-(4-methylphenyl)but-3-en-2-one 3-methyl-4-p-tolylbut-3-en-2-one; 4-(2-methyl-3-oxobut-1-enyl)benzonitrile; 1-phenylhex-1-en-3-one; 1-(2-methylphenyl)pent-1-en-3-one 1-o-tolylpent-1-en-3-one; 3-methyl-4-(2-methylphenyl)but-3-en-2-one 3-methyl-4-o-tolylbut-3-en-2-one; 3-methyl-4-(3-methylphenyl)but-3-en-2-one 3-methyl-4-m-tolylbut-3-en-2-one; 4-(4-methoxyphenyl)-3-methylbut-3-en-2-one; 3-(4-methylbenzylidene)pentan-2-one; 1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one; 1-(2,4,6-trimethylphenyl)hex-1-en-3-one; 1-(2,4,6-trimethylphenyl)pent-1-en-3-one; 3-methyl-4-(2,4,6-trimethylphenyl)but-3-en-2-one; 1-(2,6-dimethylphenyl)hex-1-en-3-one; 1-(2,6-dimethylphenyl)pent-1-en-3-one; 1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one; 1-cyclohexyl-2-phenylpropan-1-one; 2,2,4,7-tetramethyloct-6-en-3-one; 2,4(R,S),7-trimethyloct-6-en-3-one; 2,2,4,4,7-pentamethyloct-6-en-3-one; Ethyl 2(R,S),5-dimethyl-2-(pivaloyl)hex-4-enoate; 2,2,7-Trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclohexyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 4,4,7-trimethyloct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 3,6-dimethyl-3-(3-methylbut-2-enyl)hept-5-en-2-one; 3(R,S),6-dimethylhept-5-en-2-one; 1-(1-(3-hydroxy-3-methylbutyl)cyclohexyl)-2-methylpropan-1-one; 5-methyl-2(R,S)-(prop-1-en-2-yl)-hex-4-enoic acid; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 4,7-dimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 2,4,7-trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 3(R,S),5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)ethanone; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)pentan-1-one; 9-methyldec-8-en-3 one; 2,5-dimethyl-2-(3-methylbut-2-enyl)hex-4-enenitrile; 1-(3-methylbut-2-enyl)cyclopentanecarbonitrile; 1-(3-methylbut-2-enyl)cyclohexanecarbonitrile; 1-(3-methylbut-2-enyl)cyclopropanecarbonitrile; 1-(3-methylbut-2-enyl)cyclobutanecarbonitrile; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclobutyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)ethanone; 2-(R,S)-methyl-1-(1-phenylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)pentan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-one; 1-(1-phenylcyclopropyl)propan-1-one; 2-methyl-1-(1-phenylcyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)butan-1-one; 1-(1-p-tolylcyclopropyl)propan-1-one; 2-(R,S)-methyl-1-(1-p-tolylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)-3-methylenecyclobutyl)ethanone; 1-(1-phenylcyclobutyl)pentan-1-one; 2,2,5-trimethylhex-4-enenitrile; 6,6,9-trimethyldec-8-en-5-one; 2,5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)pentan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)butan-1-one; 2,2-dimethyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 2-methyl-1-(1-p-tolylcyclopropyl)propan-1-one; 1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)ethanone; 2-methyl-1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)butan-1-one; 2,4-dimethyl-2-m-tolylpentan-3-one; 2-methyl-2-m-tolylpropanenitrile; 3-methyl-3-m-tolylbutan-2-one; 2-methyl-2-m-tolylpentan-3-one; 1-(1-p-tolylcyclopentyl)ethanone; 7-methyl-1-phenyloct-6-en-1-one; 2,2-dimethyl-3-o-tolylpropanenitrile; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; o-methyl-benzylcyclopropanecarbonitrile; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(2-methylbenzyl)-cyclopropyl)propanone; 1-(1-(2-methylbenzyl)cyclopropyl)ethanone; 2-(R,S)-methyl-1-(1-(2-methylbenzyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(2-methylbenzyl)cyclopropyl)propan-1-one; 2,2,5-trimethyl-1-phenylhexan-3-one; 2-(1-(3-methylbut-2-enyl)cyclopropyl)propan-2-ol; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-ol; 9-methyldec-1,8-dien-3-one; 2,2-dimethyl-3-(R,S)-phenylbutanenitrile; 4,4-dimethyl-5-(R,S)-phenylhexan-3-one; 1-cyclopentyl-7-methyloct-6-en-1-one; 2,2-dimethyl-3-p-tolylpropanenitrile; 3-(4-methoxy-3-methylphenyl)-3-methylbutan-2-one; 2,2,4-(R,S)-trimethyl-1-p-tolylhexan-3-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 2,2-dimethyl-1-p-tolylpentan-3-one; 3-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)heptan-3-ol; 3-cyclohexyl-2,2-dimethylpropanenitrile; 1-cyclohexyl-2,2,4-trimethylpentan-3-one; 1-(R,S)-(1-phenylethyl)-cyclobutanecarbonitrile; 1-(1-(R,S)-(1-phenylethyl)-cyclobutyl)ethanone; 2-methyl-1-(1-(R,S)-(1-phenylethyl)cyclobutyl)propan-1-one; 2-methyl-1-(R,S)-(1-(1-(R,s)-phenylethyl)cyclobutyl)propan-1-ol; 1-(1-(R,S)-phenylethyl)cyclopropanecarbonitrile; 1-(1-(1-(R,S)-phenylethyl)cyclopropyl)ethanone; 2,2-dimethyl-3-m-tolylpropanenitrile; 3-(4-tert-butylphenyl)-2,2-dimethylpropanenitrile; 1-(1-phenylcyclopropyl)but-3-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-(R,s)-ol; 4-(4-tert-butylphenyl)-3,3-dimethylbutan-2-one; 2,2-dimethyl-4-phenylbutanenitrile; 11-methyldodec-10-en-5-one; 2,9-dimethyldec-8-en-3-one; 2,10-dimethylundec-9-en-4-one; 2,2,9-trimethyldec-8-en-3-one; 2,2,3-(R,S),7-tetramethyloct-6-enenitrile; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 3,3-dimethyl-5-phenylpentan-s-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpropanenitrile; 2-((R,S)-cyclohex-2-enyl)-2,5-dimethylhexan-3-one; 3,3-dimethyl-1-phenyloctan-4-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpentan-3-one; 4,4-dimethyl-6-phenylhexan-3-one; 2,2-dimethyl-5-phenylpentanenitrile; 2,2-dimethylhept-6-enenitrile; 6,6-dimethylundec-10-en-5-one; 3,3-dimethyl-6-phenylhexan-2-one; 2,2-dimethyl-4-((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)butanenitrile.
12. The perfume delivery system of claim 11, said perfume delivery system comprising, one or more PRMs selected from 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 4-(4-methylcyclohex-3-enyl)pentan-2-ol; 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 3-methyl-4-phenylbut-3-en-2-one; 4-(4-methylphenyl)butan-2-one, 4-p-tolylbutan-2-one; 1-(3-methylphenyl)pent-1-en-3-one 1-m-tolylpent-1-en-3-one; 3-methyl-4-(4-methylphenyl)but-3-en-2-one 3-methyl-4-p-tolylbut-3-en-2-one; 4-(2-methyl-3-oxobut-1-enyl)benzonitrile; 1-phenylhex-1-en-3-one; 1-(2-methylphenyl)pent-1-en-3-one 1-o-tolylpent-1-en-3-one; 3-methyl-4-(2-methylphenyl)but-3-en-2-one 3-methyl-4-o-tolylbut-3-en-2-one; 3-methyl-4-(3-methylphenyl)but-3-en-2-one 3-methyl-4-m-tolylbut-3-en-2-one; 4-(4-methoxyphenyl)-3-methylbut-3-en-2-one; 3-(4-methylbenzylidene)pentan-2-one; 1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one; 1-(2,4,6-trimethylphenyl)hex-1-en-3-one; 1-(2,4,6-trimethylphenyl)pent-1-en-3-one; 3-methyl-4-(2,4,6-trimethylphenyl)but-3-en-2-one; 1-(2,6-dimethylphenyl)hex-1-en-3-one; 1-(2,6-dimethylphenyl)pent-1-en-3-one; 1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one; 1-cyclohexyl-2-phenylpropan-1-one; 2,2,4,7-tetramethyloct-6-en-3-one; 2,4(R,S),7-trimethyloct-6-en-3-one; 2,2,4,4,7-pentamethyloct-6-en-3-one; Ethyl 2(R,S),5-dimethyl-2-(pivaloyl)hex-4-enoate; 2,2,7-Trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclohexyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 4,4,7-trimethyloct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 3,6-dimethyl-3-(3-methylbut-2-enyl)hept-5-en-2-one; 3(R,S),6-dimethylhept-5-en-2-one; 1-(1-(3-hydroxy-3-methylbutyl)cyclohexyl)-2-methylpropan-1-one; 5-methyl-2(R,S)-(prop-1-en-2-yl)-hex-4-enoic acid; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 4,7-dimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 2,4,7-trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 3(R,S),5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)ethanone; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)pentan-1-one; 9-methyldec-8-en-3 one; 2,5-dimethyl-2-(3-methylbut-2-enyl)hex-4-enenitrile; 1-(3-methylbut-2-enyl)cyclopentanecarbonitrile; 1-(3-methylbut-2-enyl)cyclohexanecarbonitrile; 1-(3-methylbut-2-enyl)cyclopropanecarbonitrile; 1-(3-methylbut-2-enyl)cyclobutanecarbonitrile; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclobutyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)ethanone; 2-(R,S)-methyl-1-(1-phenylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)pentan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-one; 1-(1-phenylcyclopropyl)propan-1-one; 2-methyl-1-(1-phenylcyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)butan-1-one; 1-(1-p-tolylcyclopropyl)propan-1-one; 2-(R,S)-methyl-1-(1-p-tolylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)-3-methylenecyclobutyl)ethanone; 1-(1-phenylcyclobutyl)pentan-1-one; 2,2,5-trimethylhex-4-enenitrile; 6,6,9-trimethyldec-8-en-5-one; 2,5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)pentan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)butan-1-one; 2,2-dimethyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 2-methyl-1-(1-p-tolylcyclopropyl)propan-1-one; 1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)ethanone; 2-methyl-1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)butan-1-one; 2,4-dimethyl-2-m-tolylpentan-3-one; 2-methyl-2-m-tolylpropanenitrile; 3-methyl-3-m-tolylbutan-2-one; 2-methyl-2-m-tolylpentan-3-one; 1-(1-p-tolylcyclopentyl)ethanone; 7-methyl-1-phenyloct-6-en-1-one; 2,2-dimethyl-3-o-tolylpropanenitrile; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; o-methyl-benzylcyclopropanecarbonitrile; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(2-methylbenzyl)-cyclopropyl)propanone; 1-(1-(2-methylbenzyl)cyclopropyl)ethanone; 2-(R,S)-methyl-1-(1-(2-methylbenzyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(2-methylbenzyl)cyclopropyl)propan-1-one; 2,2,5-trimethyl-1-phenylhexan-3-one; 2-(1-(3-methylbut-2-enyl)cyclopropyl)propan-2-ol; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-ol; 9-methyldec-1,8-dien-3-one; 2,2-dimethyl-3-(R,S)-phenylbutanenitrile; 4,4-dimethyl-5-(R,S)-phenylhexan-3-one; 1-cyclopentyl-7-methyloct-6-en-1-one; 2,2-dimethyl-3-p-tolylpropanenitrile; 3-(4-methoxy-3-methylphenyl)-3-methylbutan-2-one; 2,2,4-(R,S)-trimethyl-1-p-tolylhexan-3-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 2,2-dimethyl-1-p-tolylpentan-3-one; 3-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)heptan-3-ol; 3-cyclohexyl-2,2-dimethylpropanenitrile; 1-cyclohexyl-2,2,4-trimethylpentan-3-one; 1-(R,S)-(1-phenylethyl)-cyclobutanecarbonitrile; 1-(1-(R,S)-(1-phenylethyl)-cyclobutyl)ethanone; 2-methyl-1-(1-(R,S)-(1-phenylethyl)cyclobutyl)propan-1-one; 2-methyl-1-(R,S)-(1-(1-(R,s)-phenylethyl)cyclobutyl)propan-1-ol; 1-(1-(R,S)-phenylethyl)cyclopropanecarbonitrile; 1-(1-(1-(R,S)-phenylethyl)cyclopropyl)ethanone; 2,2-dimethyl-3-m-tolylpropanenitrile; 3-(4-tert-butylphenyl)-2,2-dimethylpropanenitrile; 1-(1-phenylcyclopropyl)but-3-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-(R,s)-ol; 4-(4-tert-butylphenyl)-3,3-dimethylbutan-2-one; 2,2-dimethyl-4-phenylbutanenitrile; 11-methyldodec-10-en-5-one; 2,9-dimethyldec-8-en-3-one; 2,10-dimethylundec-9-en-4-one; 2,2,9-trimethyldec-8-en-3-one; 2,2,3-(R,S),7-tetramethyloct-6-enenitrile; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 3,3-dimethyl-5-phenylpentan-s-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpropanenitrile; 2-((R,S)-cyclohex-2-enyl)-2,5-dimethylhexan-3-one; 3,3-dimethyl-1-phenyloctan-4-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpentan-3-one; 4,4-dimethyl-6-phenylhexan-3-one; 2,2-dimethyl-5-phenylpentanenitrile; 2,2-dimethylhept-6-enenitrile; 6,6-dimethylundec-10-en-5-one; 3,3-dimethyl-6-phenylhexan-2-one; 2,2-dimethyl-4-((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)butanenitrile; stereoisomers of 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 4-(4-methylcyclohex-3-enyl)pentan-2-ol; 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 3-methyl-4-phenylbut-3-en-2-one; 4-(4-methylphenyl)butan-2-one, 4-p-tolylbutan-2-one; 1-(3-methylphenyl)pent-1-en-3-one 1-m-tolylpent-1-en-3-one; 3-methyl-4-(4-methylphenyl)but-3-en-2-one 3-methyl-4-p-tolylbut-3-en-2-one; 4-(2-methyl-3-oxobut-1-enyl)benzonitrile; 1-phenylhex-1-en-3-one; 1-(2-methylphenyl)pent-1-en-3-one 1-o-tolylpent-1-en-3-one; 3-methyl-4-(2-methylphenyl)but-3-en-2-one 3-methyl-4-o-tolylbut-3-en-2-one; 3-methyl-4-(3-methylphenyl)but-3-en-2-one 3-methyl-4-m-tolylbut-3-en-2-one; 4-(4-methoxyphenyl)-3-methylbut-3-en-2-one; 3-(4-methylbenzylidene)pentan-2-one; 1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one; 1-(2,4,6-trimethylphenyl)hex-1-en-3-one; 1-(2,4,6-trimethylphenyl)pent-1-en-3-one; 3-methyl-4-(2,4,6-trimethylphenyl)but-3-en-2-one; 1-(2,6-dimethylphenyl)hex-1-en-3-one; 1-(2,6-dimethylphenyl)pent-1-en-3-one; 1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one; 1-cyclohexyl-2-phenylpropan-1-one; 2,2,4,7-tetramethyloct-6-en-3-one; 2,4(R,S),7-trimethyloct-6-en-3-one; 2,2,4,4,7-pentamethyloct-6-en-3-one; Ethyl 2(R,S),5-dimethyl-2-(pivaloyl)hex-4-enoate; 2,2,7-Trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclohexyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 4,4,7-trimethyloct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 3,6-dimethyl-3-(3-methylbut-2-enyl)hept-5-en-2-one; 3 (R,S),6-dimethylhept-5-en-2-one; 1-(1-(3-hydroxy-3-methylbutyl)cyclohexyl)-2-methylpropan-1-one; 5-methyl-2(R,S)-(prop-1-en-2-yl)-hex-4-enoic acid; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 4,7-dimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 2,4,7-trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 3(R,S),5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)ethanone; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)pentan-1-one; 9-methyldec-8-en-3 one; 2,5-dimethyl-2-(3-methylbut-2-enyl)hex-4-enenitrile; 1-(3-methylbut-2-enyl)cyclopentanecarbonitrile; 1-(3-methylbut-2-enyl)cyclohexanecarbonitrile; 1-(3-methylbut-2-enyl)cyclopropanecarbonitrile; 1-(3-methylbut-2-enyl)cyclobutanecarbonitrile; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclobutyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)ethanone; 2-(R,S)-methyl-1-(1-phenylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)pentan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-one; 1-(1-phenylcyclopropyl)propan-1-one; 2-methyl-1-(1-phenylcyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)butan-1-one; 1-(1-p-tolylcyclopropyl)propan-1-one; 2-(R,S)-methyl-1-(1-p-tolylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)-3-methylenecyclobutyl)ethanone; 1-(1-phenylcyclobutyl)pentan-1-one; 2,2,5-trimethylhex-4-enenitrile; 6,6,9-trimethyldec-8-en-5-one; 2,5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)pentan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)butan-1-one; 2,2-dimethyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 2-methyl-1-(1-p-tolylcyclopropyl)propan-1-one; 1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)ethanone; 2-methyl-1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)butan-1-one; 2,4-dimethyl-2-m-tolylpentan-3-one; 2-methyl-2-m-tolylpropanenitrile; 3-methyl-3-m-tolylbutan-2-one; 2-methyl-2-m-tolylpentan-3-one; 1-(1-p-tolylcyclopentyl)ethanone; 7-methyl-1-phenyloct-6-en-1-one; 2,2-dimethyl-3-o-tolylpropanenitrile; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; o-methyl-benzylcyclopropanecarbonitrile; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(2-methylbenzyl)-cyclopropyl)propanone; 1-(1-(2-methylbenzyl)cyclopropyl)ethanone; 2-(R,S)-methyl-1-(1-(2-methylbenzyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(2-methylbenzyl)cyclopropyl)propan-1-one; 2,2,5-trimethyl-1-phenylhexan-3-one; 2-(1-(3-methylbut-2-enyl)cyclopropyl)propan-2-ol; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-ol; 9-methyldec-1,8-dien-3-one; 2,2-dimethyl-3-(R,S)-phenylbutanenitrile; 4,4-dimethyl-5-(R,S)-phenylhexan-3-one; 1-cyclopentyl-7-methyloct-6-en-1-one; 2,2-dimethyl-3-p-tolylpropanenitrile; 3-(4-methoxy-3-methylphenyl)-3-methylbutan-2-one; 2,2,4-(R,S)-trimethyl-1-p-tolylhexan-3-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 2,2-dimethyl-1-p-tolylpentan-3-one; 3-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)heptan-3-ol; 3-cyclohexyl-2,2-dimethylpropanenitrile; 1-cyclohexyl-2,2,4-trimethylpentan-3-one; 1-(R,S)-(1-phenylethyl)-cyclobutanecarbonitrile; 1-(1-(R,S)-(1-phenylethyl)-cyclobutyl)ethanone; 2-methyl-1-(1-(R,S)-(1-phenylethyl)cyclobutyl)propan-1-one; 2-methyl-1-(R,S)-(1-(1-(R,s)-phenylethyl)cyclobutyl)propan-1-ol; 1-(1-(R,S)-phenylethyl)cyclopropanecarbonitrile; 1-(1-(1-(R,S)-phenylethyl)cyclopropyl)ethanone; 2,2-dimethyl-3-m-tolylpropanenitrile; 3-(4-tert-butylphenyl)-2,2-dimethylpropanenitrile; 1-(1-phenylcyclopropyl)but-3-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-(R,s)-ol; 4-(4-tert-butylphenyl)-3,3-dimethylbutan-2-one; 2,2-dimethyl-4-phenylbutanenitrile; 11-methyldodec-10-en-5-one; 2,9-dimethyldec-8-en-3-one; 2,10-dimethylundec-9-en-4-one; 2,2,9-trimethyldec-8-en-3-one; 2,2,3-(R,S),7-tetramethyloct-6-enenitrile; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 3,3-dimethyl-5-phenylpentan-s-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpropanenitrile; 2-((R,S)-cyclohex-2-enyl)-2,5-dimethylhexan-3-one; 3,3-dimethyl-1-phenyloctan-4-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpentan-3-one; 4,4-dimethyl-6-phenylhexan-3-one; 2,2-dimethyl-5-phenylpentanenitrile; 2,2-dimethylhept-6-enenitrile; 6,6-dimethylundec-10-en-5-one; 3,3-dimethyl-6-phenylhexan-2-one; 2,2-dimethyl-4-((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)butanenitrile; and mixtures thereof.
13. A perfume delivery system according to claim 10, said perfume delivery system being a starch encapsulated accord.
14. A perfume delivery system according to claim 10, said perfume delivery system being a cyclodextrin delivery system comprising, based on total cyclodextrin delivery system weight, from 0.1% to about 99% of one or more PRMs selected from 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 4-(4-methylcyclohex-3-enyl)pentan-2-ol; 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 3-methyl-4-phenylbut-3-en-2-one; 4-(4-methylphenyl)butan-2-one, 4-p-tolylbutan-2-one; 1-(3-methylphenyl)pent-1-en-3-one 1-m-tolylpent-1-en-3-one; 3-methyl-4-(4-methylphenyl)but-3-en-2-one 3-methyl-4-p-tolylbut-3-en-2-one; 4-(2-methyl-3-oxobut-1-enyl)benzonitrile; 1-phenylhex-1-en-3-one; 1-(2-methylphenyl)pent-1-en-3-one 1-o-tolylpent-1-en-3-one; 3-methyl-4-(2-methylphenyl)but-3-en-2-one 3-methyl-4-o-tolylbut-3-en-2-one; 3-methyl-4-(3-methylphenyl)but-3-en-2-one 3-methyl-4-m-tolylbut-3-en-2-one; 4-(4-methoxyphenyl)-3-methylbut-3-en-2-one; 3-(4-methylbenzylidene)pentan-2-one; 1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one; 1-(2,4,6-trimethylphenyl)hex-1-en-3-one; 1-(2,4,6-trimethylphenyl)pent-1-en-3-one; 3-methyl-4-(2,4,6-trimethylphenyl)but-3-en-2-one; 1-(2,6-dimethylphenyl)hex-1-en-3-one; 1-(2,6-dimethylphenyl)pent-1-en-3-one; 1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one; 1-cyclohexyl-2-phenylpropan-1-one; 2,2,4,7-tetramethyloct-6-en-3-one; 2,4(R,S),7-trimethyloct-6-en-3-one; 2,2,4,4,7-pentamethyloct-6-en-3-one; Ethyl 2(R,S),5-dimethyl-2-(pivaloyl)hex-4-enoate; 2,2,7-Trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclohexyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 4,4,7-trimethyloct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 3,6-dimethyl-3-(3-methylbut-2-enyl)hept-5-en-2-one; 3(R,S),6-dimethylhept-5-en-2-one; 1-(1-(3-hydroxy-3-methylbutyl)cyclohexyl)-2-methylpropan-1-one; 5-methyl-2(R,S)-(prop-1-en-2-yl)-hex-4-enoic acid; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 4,7-dimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 2,4,7-trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 3(R,S),5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)ethanone; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)pentan-1-one; 9-methyldec-8-en-3 one; 2,5-dimethyl-2-(3-methylbut-2-enyl)hex-4-enenitrile; 1-(3-methylbut-2-enyl)cyclopentanecarbonitrile; 1-(3-methylbut-2-enyl)cyclohexanecarbonitrile; 1-(3-methylbut-2-enyl)cyclopropanecarbonitrile; 1-(3-methylbut-2-enyl)cyclobutanecarbonitrile; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclobutyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)ethanone; 2-(R,S)-methyl-1-(1-phenylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)pentan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-one; 1-(1-phenylcyclopropyl)propan-1-one; 2-methyl-1-(1-phenylcyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)butan-1-one; 1-(1-p-tolylcyclopropyl)propan-1-one; 2-(R,S)-methyl-1-(1-p-tolylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)-3-methylenecyclobutyl)ethanone; 1-(1-phenylcyclobutyl)pentan-1-one; 2,2,5-trimethylhex-4-enenitrile; 6,6,9-trimethyldec-8-en-5-one; 2,5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)pentan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)butan-1-one; 2,2-dimethyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 2-methyl-1-(1-p-tolylcyclopropyl)propan-1-one; 1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)ethanone; 2-methyl-1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)butan-1-one; 2,4-dimethyl-2-m-tolylpentan-3-one; 2-methyl-2-m-tolylpropanenitrile; 3-methyl-3-m-tolylbutan-2-one; 2-methyl-2-m-tolylpentan-3-one; 1-(1-p-tolylcyclopentyl)ethanone; 7-methyl-1-phenyloct-6-en-1-one; 2,2-dimethyl-3-o-tolylpropanenitrile; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; o-methyl-benzylcyclopropanecarbonitrile; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(2-methylbenzyl)-cyclopropyl)propanone; 1-(1-(2-methylbenzyl)cyclopropyl)ethanone; 2-(R,S)-methyl-1-(1-(2-methylbenzyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(2-methylbenzyl)cyclopropyl)propan-1-one; 2,2,5-trimethyl-1-phenylhexan-3-one; 2-(1-(3-methylbut-2-enyl)cyclopropyl)propan-2-ol; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-ol; 9-methyldec-1,8-dien-3-one; 2,2-dimethyl-3-(R,S)-phenylbutanenitrile; 4,4-dimethyl-5-(R,S)-phenylhexan-3-one; 1-cyclopentyl-7-methyloct-6-en-1-one; 2,2-dimethyl-3-p-tolylpropanenitrile; 3-(4-methoxy-3-methylphenyl)-3-methylbutan-2-one; 2,2,4-(R,S)-trimethyl-1-p-tolylhexan-3-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 2,2-dimethyl-1-p-tolylpentan-3-one; 3-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)heptan-3-ol; 3-cyclohexyl-2,2-dimethylpropanenitrile; 1-cyclohexyl-2,2,4-trimethylpentan-3-one; 1-(R,S)-(1-phenylethyl)-cyclobutanecarbonitrile; 1-(1-(R,S)-(1-phenylethyl)-cyclobutyl)ethanone; 2-methyl-1-(1-(R,S)-(1-phenylethyl)cyclobutyl)propan-1-one; 2-methyl-1-(R,S)-(1-(1-(R,s)-phenylethyl)cyclobutyl)propan-1-ol; 1-(1-(R,S)-phenylethyl)cyclopropanecarbonitrile; 1-(1-(1-(R,S)-phenylethyl)cyclopropyl)ethanone; 2,2-dimethyl-3-m-tolylpropanenitrile; 3-(4-tert-butylphenyl)-2,2-dimethylpropanenitrile; 1-(1-phenylcyclopropyl)but-3-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-(R,s)-ol; 4-(4-tert-butylphenyl)-3,3-dimethylbutan-2-one; 2,2-dimethyl-4-phenylbutanenitrile; 11-methyldodec-10-en-5-one; 2,9-dimethyldec-8-en-3-one; 2,10-dimethylundec-9-en-4-one; 2,2,9-trimethyldec-8-en-3-one; 2,2,3-(R,S),7-tetramethyloct-6-enenitrile; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 3,3-dimethyl-5-phenylpentan-s-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpropanenitrile; 2-((R,S)-cyclohex-2-enyl)-2,5-dimethylhexan-3-one; 3,3-dimethyl-1-phenyloctan-4-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpentan-3-one; 4,4-dimethyl-6-phenylhexan-3-one; 2,2-dimethyl-5-phenylpentanenitrile; 2,2-dimethylhept-6-enenitrile; 6,6-dimethylundec-10-en-5-one; 3,3-dimethyl-6-phenylhexan-2-one; 2,2-dimethyl-4-((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)butanenitrile and/or stereoisomers of 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 4-(4-methylcyclohex-3-enyl)pentan-2-ol; 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 3-methyl-4-phenylbut-3-en-2-one; 4-(4-methylphenyl)butan-2-one, 4-p-tolylbutan-2-one; 1-(3-methylphenyl)pent-1-en-3-one 1-m-tolylpent-1-en-3-one; 3-methyl-4-(4-methylphenyl)but-3-en-2-one 3-methyl-4-p-tolylbut-3-en-2-one; 4-(2-methyl-3-oxobut-1-enyl)benzonitrile; 1-phenylhex-1-en-3-one; 1-(2-methylphenyl)pent-1-en-3-one 1-o-tolylpent-1-en-3-one; 3-methyl-4-(2-methylphenyl)but-3-en-2-one 3-methyl-4-o-tolylbut-3-en-2-one; 3-methyl-4-(3-methylphenyl)but-3-en-2-one 3-methyl-4-m-tolylbut-3-en-2-one; 4-(4-methoxyphenyl)-3-methylbut-3-en-2-one; 3-(4-methylbenzylidene)pentan-2-one; 1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one; 1-(2,4,6-trimethylphenyl)hex-1-en-3-one; 1-(2,4,6-trimethylphenyl)pent-1-en-3-one; 3-methyl-4-(2,4,6-trimethylphenyl)but-3-en-2-one; 1-(2,6-dimethylphenyl)hex-1-en-3-one; 1-(2,6-dimethylphenyl)pent-1-en-3-one; 1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one; 1-cyclohexyl-2-phenylpropan-1-one; 2,2,4,7-tetramethyloct-6-en-3-one; 2,4(R,S),7-trimethyloct-6-en-3-one; 2,2,4,4,7-pentamethyloct-6-en-3-one; Ethyl 2(R,S),5-dimethyl-2-(pivaloyl)hex-4-enoate; 2,2,7-Trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclohexyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 4,4,7-trimethyloct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 3,6-dimethyl-3-(3-methylbut-2-enyl)hept-5-en-2-one; 3(R,S),6-dimethylhept-5-en-2-one; 1-(1-(3-hydroxy-3-methylbutyl)cyclohexyl)-2-methylpropan-1-one; 5-methyl-2(R,S)-(prop-1-en-2-yl)-hex-4-enoic acid; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 4,7-dimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 2,4,7-trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 3(R,S),5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)ethanone; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)pentan-1-one; 9-methyldec-8-en-3 one; 2,5-dimethyl-2-(3-methylbut-2-enyl)hex-4-enenitrile; 1-(3-methylbut-2-enyl)cyclopentanecarbonitrile; 1-(3-methylbut-2-enyl)cyclohexanecarbonitrile; 1-(3-methylbut-2-enyl)cyclopropanecarbonitrile; 1-(3-methylbut-2-enyl)cyclobutanecarbonitrile; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclobutyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)ethanone; 2-(R,S)-methyl-1-(1-phenylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)pentan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-one; 1-(1-phenylcyclopropyl)propan-1-one; 2-methyl-1-(1-phenylcyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)butan-1-one; 1-(1-p-tolylcyclopropyl)propan-1-one; 2-(R,S)-methyl-1-(1-p-tolylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)-3-methylenecyclobutyl)ethanone; 1-(1-phenylcyclobutyl)pentan-1-one; 2,2,5-trimethylhex-4-enenitrile; 6,6,9-trimethyldec-8-en-5-one; 2,5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)pentan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)butan-1-one; 2,2-dimethyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 2-methyl-1-(1-p-tolylcyclopropyl)propan-1-one; 1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)ethanone; 2-methyl-1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)butan-1-one; 2,4-dimethyl-2-m-tolylpentan-3-one; 2-methyl-2-m-tolylpropanenitrile; 3-methyl-3-m-tolylbutan-2-one; 2-methyl-2-m-tolylpentan-3-one; 1-(1-p-tolylcyclopentyl)ethanone; 7-methyl-1-phenyloct-6-en-1-one; 2,2-dimethyl-3-o-tolylpropanenitrile; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; o-methyl-benzylcyclopropanecarbonitrile; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(2-methylbenzyl)-cyclopropyl)propanone; 1-(1-(2-methylbenzyl)cyclopropyl)ethanone; 2-(R,S)-methyl-1-(1-(2-methylbenzyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(2-methylbenzyl)cyclopropyl)propan-1-one; 2,2,5-trimethyl-1-phenylhexan-3-one; 2-(1-(3-methylbut-2-enyl)cyclopropyl)propan-2-ol; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-ol; 9-methyldec-1,8-dien-3-one; 2,2-dimethyl-3-(R,S)-phenylbutanenitrile; 4,4-dimethyl-5-(R,S)-phenylhexan-3-one; 1-cyclopentyl-7-methyloct-6-en-1-one; 2,2-dimethyl-3-p-tolylpropanenitrile; 3-(4-methoxy-3-methylphenyl)-3-methylbutan-2-one; 2,2,4-(R,S)-trimethyl-1-p-tolylhexan-3-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 2,2-dimethyl-1-p-tolylpentan-3-one; 3-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)heptan-3-ol; 3-cyclohexyl-2,2-dimethylpropanenitrile; 1-cyclohexyl-2,2,4-trimethylpentan-3-one; 1-(R,S)-(1-phenylethyl)-cyclobutanecarbonitrile; 1-(1-(R,S)-(1-phenylethyl)-cyclobutyl)ethanone; 2-methyl-1-(1-(R,S)-(1-phenylethyl)cyclobutyl)propan-1-one; 2-methyl-1-(R,S)-(1-(1-(R,s)-phenylethyl)cyclobutyl)propan-1-ol; 1-(1-(R,S)-phenylethyl)cyclopropanecarbonitrile; 1-(1-(1-(R,S)-phenylethyl)cyclopropyl)ethanone; 2,2-dimethyl-3-m-tolylpropanenitrile; 3-(4-tert-butylphenyl)-2,2-dimethylpropanenitrile; 1-(1-phenylcyclopropyl)but-3-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-(R,s)-ol; 4-(4-tert-butylphenyl)-3,3-dimethylbutan-2-one; 2,2-dimethyl-4-phenylbutanenitrile; 11-methyldodec-10-en-5-one; 2,9-dimethyldec-8-en-3-one; 2,10-dimethylundec-9-en-4-one; 2,2,9-trimethyldec-8-en-3-one; 2,2,3-(R,S),7-tetramethyloct-6-enenitrile; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 3,3-dimethyl-5-phenylpentan-s-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpropanenitrile; 2-((R,S)-cyclohex-2-enyl)-2,5-dimethylhexan-3-one; 3,3-dimethyl-1-phenyloctan-4-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpentan-3-one; 4,4-dimethyl-6-phenylhexan-3-one; 2,2-dimethyl-5-phenylpentanenitrile; 2,2-dimethylhept-6-enenitrile; 6,6-dimethylundec-10-en-5-one; 3,3-dimethyl-6-phenylhexan-2-one; 2,2-dimethyl-4-((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)butanenitrile.
15. A perfume delivery system according to claim 10, said perfume delivery system being a polymer assisted delivery matrix system comprising, based on total polymer assisted delivery matrix system weight, from 0.1% to about 99% of one or more PRMs selected from 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 4-(4-methylcyclohex-3-enyl)pentan-2-ol; 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 3-methyl-4-phenylbut-3-en-2-one; 4-(4-methylphenyl)butan-2-one, 4-p-tolylbutan-2-one; 1-(3-methylphenyl)pent-1-en-3-one 1-m-tolylpent-1-en-3-one; 3-methyl-4-(4-methylphenyl)but-3-en-2-one 3-methyl-4-p-tolylbut-3-en-2-one; 4-(2-methyl-3-oxobut-1-enyl)benzonitrile; 1-phenylhex-1-en-3-one; 1-(2-methylphenyl)pent-1-en-3-one 1-o-tolylpent-1-en-3-one; 3-methyl-4-(2-methylphenyl)but-3-en-2-one 3-methyl-4-o-tolylbut-3-en-2-one; 3-methyl-4-(3-methylphenyl)but-3-en-2-one 3-methyl-4-m-tolylbut-3-en-2-one; 4-(4-methoxyphenyl)-3-methylbut-3-en-2-one; 3-(4-methylbenzylidene)pentan-2-one; 1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one; 1-(2,4,6-trimethylphenyl)hex-1-en-3-one; 1-(2,4,6-trimethylphenyl)pent-1-en-3-one; 3-methyl-4-(2,4,6-trimethylphenyl)but-3-en-2-one; 1-(2,6-dimethylphenyl)hex-1-en-3-one; 1-(2,6-dimethylphenyl)pent-1-en-3-one; 1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one; 1-cyclohexyl-2-phenylpropan-1-one; 2,2,4,7-tetramethyloct-6-en-3-one; 2,4(R,S),7-trimethyloct-6-en-3-one; 2,2,4,4,7-pentamethyloct-6-en-3-one; Ethyl 2(R,S),5-dimethyl-2-(pivaloyl)hex-4-enoate; 2,2,7-Trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclohexyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 4,4,7-trimethyloct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 3,6-dimethyl-3-(3-methylbut-2-enyl)hept-5-en-2-one; 3(R,S),6-dimethylhept-5-en-2-one; 1-(1-(3-hydroxy-3-methylbutyl)cyclohexyl)-2-methylpropan-1-one; 5-methyl-2(R,S)-(prop-1-en-2-yl)-hex-4-enoic acid; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 4,7-dimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 2,4,7-trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 3(R,S),5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)ethanone; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)pentan-1-one; 9-methyldec-8-en-3 one; 2,5-dimethyl-2-(3-methylbut-2-enyl)hex-4-enenitrile; 1-(3-methylbut-2-enyl)cyclopentanecarbonitrile; 1-(3-methylbut-2-enyl)cyclohexanecarbonitrile; 1-(3-methylbut-2-enyl)cyclopropanecarbonitrile; 1-(3-methylbut-2-enyl)cyclobutanecarbonitrile; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclobutyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)ethanone; 2-(R,S)-methyl-1-(1-phenylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)pentan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-one; 1-(1-phenylcyclopropyl)propan-1-one; 2-methyl-1-(1-phenylcyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)butan-1-one; 1-(1-p-tolylcyclopropyl)propan-1-one; 2-(R,S)-methyl-1-(1-p-tolylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)-3-methylenecyclobutyl)ethanone; 1-(1-phenylcyclobutyl)pentan-1-one; 2,2,5-trimethylhex-4-enenitrile; 6,6,9-trimethyldec-8-en-5-one; 2,5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)pentan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)butan-1-one; 2,2-dimethyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 2-methyl-1-(1-p-tolylcyclopropyl)propan-1-one; 1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)ethanone; 2-methyl-1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)butan-1-one; 2,4-dimethyl-2-m-tolylpentan-3-one; 2-methyl-2-m-tolylpropanenitrile; 3-methyl-3-m-tolylbutan-2-one; 2-methyl-2-m-tolylpentan-3-one; 1-(1-p-tolylcyclopentyl)ethanone; 7-methyl-1-phenyloct-6-en-1-one; 2,2-dimethyl-3-o-tolylpropanenitrile; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; o-methyl-benzylcyclopropanecarbonitrile; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(2-methylbenzyl)-cyclopropyl)propanone; 1-(1-(2-methylbenzyl)cyclopropyl)ethanone; 2-(R,S)-methyl-1-(1-(2-methylbenzyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(2-methylbenzyl)cyclopropyl)propan-1-one; 2,2,5-trimethyl-1-phenylhexan-3-one; 2-(1-(3-methylbut-2-enyl)cyclopropyl)propan-2-ol; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-ol; 9-methyldec-1,8-dien-3-one; 2,2-dimethyl-3-(R,S)-phenylbutanenitrile; 4,4-dimethyl-5-(R,S)-phenylhexan-3-one; 1-cyclopentyl-7-methyloct-6-en-1-one; 2,2-dimethyl-3-p-tolylpropanenitrile; 3-(4-methoxy-3-methylphenyl)-3-methylbutan-2-one; 2,2,4-(R,S)-trimethyl-1-p-tolylhexan-3-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 2,2-dimethyl-1-p-tolylpentan-3-one; 3-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)heptan-3-ol; 3-cyclohexyl-2,2-dimethylpropanenitrile; 1-cyclohexyl-2,2,4-trimethylpentan-3-one; 1-(R,S)-(1-phenylethyl)-cyclobutanecarbonitrile; 1-(1-(R,S)-(1-phenylethyl)-cyclobutyl)ethanone; 2-methyl-1-(1-(R,S)-(1-phenylethyl)cyclobutyl)propan-1-one; 2-methyl-1-(R,S)-(1-(1-(R,s)-phenylethyl)cyclobutyl)propan-1-ol; 1-(1-(R,S)-phenylethyl)cyclopropanecarbonitrile; 1-(1-(1-(R,S)-phenylethyl)cyclopropyl)ethanone; 2,2-dimethyl-3-m-tolylpropanenitrile; 3-(4-tert-butylphenyl)-2,2-dimethylpropanenitrile; 1-(1-phenylcyclopropyl)but-3-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-(R,s)-ol; 4-(4-tert-butylphenyl)-3,3-dimethylbutan-2-one; 2,2-dimethyl-4-phenylbutanenitrile; 11-methyldodec-10-en-5-one; 2,9-dimethyldec-8-en-3-one; 2,10-dimethylundec-9-en-4-one; 2,2,9-trimethyldec-8-en-3-one; 2,2,3-(R,S),7-tetramethyloct-6-enenitrile; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 3,3-dimethyl-5-phenylpentan-s-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpropanenitrile; 2-((R,S)-cyclohex-2-enyl)-2,5-dimethylhexan-3-one; 3,3-dimethyl-1-phenyloctan-4-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpentan-3-one; 4,4-dimethyl-6-phenylhexan-3-one; 2,2-dimethyl-5-phenylpentanenitrile; 2,2-dimethylhept-6-enenitrile; 6,6-dimethylundec-10-en-5-one; 3,3-dimethyl-6-phenylhexan-2-one; 2,2-dimethyl-4-((1R,5S)-6,6-dimethylbicyclo [3.1.1]hept-2-en-2-yl)butanenitrile and/or stereoisomers of 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 4-(4-methylcyclohex-3-enyl)pentan-2-ol; 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 3-methyl-4-phenylbut-3-en-2-one; 4-(4-methylphenyl)butan-2-one, 4-p-tolylbutan-2-one; 1-(3-methylphenyl)pent-1-en-3-one 1-m-tolylpent-1-en-3-one; 3-methyl-4-(4-methylphenyl)but-3-en-2-one 3-methyl-4-p-tolylbut-3-en-2-one; 4-(2-methyl-3-oxobut-1-enyl)benzonitrile; 1-phenylhex-1-en-3-one; 1-(2-methylphenyl)pent-1-en-3-one 1-o-tolylpent-1-en-3-one; 3-methyl-4-(2-methylphenyl)but-3-en-2-one 3-methyl-4-o-tolylbut-3-en-2-one; 3-methyl-4-(3-methylphenyl)but-3-en-2-one 3-methyl-4-m-tolylbut-3-en-2-one; 4-(4-methoxyphenyl)-3-methylbut-3-en-2-one; 3-(4-methylbenzylidene)pentan-2-one; 1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one; 1-(2,4,6-trimethylphenyl)hex-1-en-3-one; 1-(2,4,6-trimethylphenyl)pent-1-en-3-one; 3-methyl-4-(2,4,6-trimethylphenyl)but-3-en-2-one; 1-(2,6-dimethylphenyl)hex-1-en-3-one; 1-(2,6-dimethylphenyl)pent-1-en-3-one; 1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one; 1-cyclohexyl-2-phenylpropan-1-one; 2,2,4,7-tetramethyloct-6-en-3-one; 2,4(R,S),7-trimethyloct-6-en-3-one; 2,2,4,4,7-pentamethyloct-6-en-3-one; Ethyl 2(R,S),5-dimethyl-2-(pivaloyl)hex-4-enoate; 2,2,7-Trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclohexyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 4,4,7-trimethyloct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 3,6-dimethyl-3-(3-methylbut-2-enyl)hept-5-en-2-one; 3(R,S),6-dimethylhept-5-en-2-one; 1-(1-(3-hydroxy-3-methylbutyl)cyclohexyl)-2-methylpropan-1-one; 5-methyl-2(R,S)-(prop-1-en-2-yl)-hex-4-enoic acid; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 4,7-dimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 2,4,7-trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 3(R,S),5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)ethanone; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)pentan-1-one; 9-methyldec-8-en-3 one; 2,5-dimethyl-2-(3-methylbut-2-enyl)hex-4-enenitrile; 1-(3-methylbut-2-enyl)cyclopentanecarbonitrile; 1-(3-methylbut-2-enyl)cyclohexanecarbonitrile; 1-(3-methylbut-2-enyl)cyclopropanecarbonitrile; 1-(3-methylbut-2-enyl)cyclobutanecarbonitrile; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclobutyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)ethanone; 2-(R,S)-methyl-1-(1-phenylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)pentan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-one; 1-(1-phenylcyclopropyl)propan-1-one; 2-methyl-1-(1-phenylcyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)butan-1-one; 1-(1-p-tolylcyclopropyl)propan-1-one; 2-(R,S)-methyl-1-(1-p-tolylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)-3-methylenecyclobutyl)ethanone; 1-(1-phenylcyclobutyl)pentan-1-one; 2,2,5-trimethylhex-4-enenitrile; 6,6,9-trimethyldec-8-en-5-one; 2,5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)pentan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)butan-1-one; 2,2-dimethyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 2-methyl-1-(1-p-tolylcyclopropyl)propan-1-one; 1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)ethanone; 2-methyl-1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)butan-1-one; 2,4-dimethyl-2-m-tolylpentan-3-one; 2-methyl-2-m-tolylpropanenitrile; 3-methyl-3-m-tolylbutan-2-one; 2-methyl-2-m-tolylpentan-3-one; 1-(1-p-tolylcyclopentyl)ethanone; 7-methyl-1-phenyloct-6-en-1-one; 2,2-dimethyl-3-o-tolylpropanenitrile; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; o-methyl-benzylcyclopropanecarbonitrile; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(2-methylbenzyl)-cyclopropyl)propanone; 1-(1-(2-methylbenzyl)cyclopropyl)ethanone; 2-(R,S)-methyl-1-(1-(2-methylbenzyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(2-methylbenzyl)cyclopropyl)propan-1-one; 2,2,5-trimethyl-1-phenylhexan-3-one; 2-(1-(3-methylbut-2-enyl)cyclopropyl)propan-2-ol; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-ol; 9-methyldec-1,8-dien-3-one; 2,2-dimethyl-3-(R,S)-phenylbutanenitrile; 4,4-dimethyl-5-(R,S)-phenylhexan-3-one; 1-cyclopentyl-7-methyloct-6-en-1-one; 2,2-dimethyl-3-p-tolylpropanenitrile; 3-(4-methoxy-3-methylphenyl)-3-methylbutan-2-one; 2,2,4-(R,S)-trimethyl-1-p-tolylhexan-3-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 2,2-dimethyl-1-p-tolylpentan-3-one; 3-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)heptan-3-ol; 3-cyclohexyl-2,2-dimethylpropanenitrile; 1-cyclohexyl-2,2,4-trimethylpentan-3-one; 1-(R,S)-(1-phenylethyl)-cyclobutanecarbonitrile; 1-(1-(R,S)-(1-phenylethyl)-cyclobutyl)ethanone; 2-methyl-1-(1-(R,S)-(1-phenylethyl)cyclobutyl)propan-1-one; 2-methyl-1-(R,S)-(1-(1-(R,s)-phenylethyl)cyclobutyl)propan-1-ol; 1-(1-(R,S)-phenylethyl)cyclopropanecarbonitrile; 1-(1-(1-(R,S)-phenylethyl)cyclopropyl)ethanone; 2,2-dimethyl-3-m-tolylpropanenitrile; 3-(4-tert-butylphenyl)-2,2-dimethylpropanenitrile; 1-(1-phenylcyclopropyl)but-3-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-(R,s)-ol; 4-(4-tert-butylphenyl)-3,3-dimethylbutan-2-one; 2,2-dimethyl-4-phenylbutanenitrile; 11-methyldodec-10-en-5-one; 2,9-dimethyldec-8-en-3-one; 2,10-dimethylundec-9-en-4-one; 2,2,9-trimethyldec-8-en-3-one; 2,2,3-(R,S),7-tetramethyloct-6-enenitrile; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 3,3-dimethyl-5-phenylpentan-s-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpropanenitrile; 2-((R,S)-cyclohex-2-enyl)-2,5-dimethylhexan-3-one; 3,3-dimethyl-1-phenyloctan-4-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpentan-3-one; 4,4-dimethyl-6-phenylhexan-3-one; 2,2-dimethyl-5-phenylpentanenitrile; 2,2-dimethylhept-6-enenitrile; 6,6-dimethylundec-10-en-5-one; 3,3-dimethyl-6-phenylhexan-2-one; 2,2-dimethyl-4-((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)butanenitrile.
16. A perfume delivery system according to claim 10, said perfume delivery system being a amine assisted delivery system, said amine assisted delivery system comprising, based on total amine assisted delivery system weight, from 1% to about 99% of one or more PRMs selected from 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 4-(4-methylcyclohex-3-enyl)pentan-2-ol; 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 3-methyl-4-phenylbut-3-en-2-one; 4-(4-methylphenyl)butan-2-one, 4-p-tolylbutan-2-one; 1-(3-methylphenyl)pent-1-en-3-one 1-m-tolylpent-1-en-3-one; 3-methyl-4-(4-methylphenyl)but-3-en-2-one 3-methyl-4-p-tolylbut-3-en-2-one; 4-(2-methyl-3-oxobut-1-enyl)benzonitrile; 1-phenylhex-1-en-3-one; 1-(2-methylphenyl)pent-1-en-3-one 1-o-tolylpent-1-en-3-one; 3-methyl-4-(2-methylphenyl)but-3-en-2-one 3-methyl-4-o-tolylbut-3-en-2-one; 3-methyl-4-(3-methylphenyl)but-3-en-2-one 3-methyl-4-m-tolylbut-3-en-2-one; 4-(4-methoxyphenyl)-3-methylbut-3-en-2-one; 3-(4-methylbenzylidene)pentan-2-one; 1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one; 1-(2,4,6-trimethylphenyl)hex-1-en-3-one; 1-(2,4,6-trimethylphenyl)pent-1-en-3-one; 3-methyl-4-(2,4,6-trimethylphenyl)but-3-en-2-one; 1-(2,6-dimethylphenyl)hex-1-en-3-one; 1-(2,6-dimethylphenyl)pent-1-en-3-one; 1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one; 1-cyclohexyl-2-phenylpropan-1-one; 2,2,4,7-tetramethyloct-6-en-3-one; 2,4(R,S),7-trimethyloct-6-en-3-one; 2,2,4,4,7-pentamethyloct-6-en-3-one; Ethyl 2(R,S),5-dimethyl-2-(pivaloyl)hex-4-enoate; 2,2,7-Trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclohexyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 4,4,7-trimethyloct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 3,6-dimethyl-3-(3-methylbut-2-enyl)hept-5-en-2-one; 3 (R,S),6-dimethylhept-5-en-2-one; 1-(1-(3-hydroxy-3-methylbutyl)cyclohexyl)-2-methylpropan-1-one; 5-methyl-2(R,S)-(prop-1-en-2-yl)-hex-4-enoic acid; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 4,7-dimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 2,4,7-trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 3 (R,S),5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)ethanone; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)pentan-1-one; 9-methyldec-8-en-3 one; 2,5-dimethyl-2-(3-methylbut-2-enyl)hex-4-enenitrile; 1-(3-methylbut-2-enyl)cyclopentanecarbonitrile; 1-(3-methylbut-2-enyl)cyclohexanecarbonitrile; 1-(3-methylbut-2-enyl)cyclopropanecarbonitrile; 1-(3-methylbut-2-enyl)cyclobutanecarbonitrile; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclobutyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)ethanone; 2-(R,S)-methyl-1-(1-phenylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)pentan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-one; 1-(1-phenylcyclopropyl)propan-1-one; 2-methyl-1-(1-phenylcyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)butan-1-one; 1-(1-p-tolylcyclopropyl)propan-1-one; 2-(R,S)-methyl-1-(1-p-tolylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)-3-methylenecyclobutyl)ethanone; 1-(1-phenylcyclobutyl)pentan-1-one; 2,2,5-trimethylhex-4-enenitrile; 6,6,9-trimethyldec-8-en-5-one; 2,5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)pentan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)butan-1-one; 2,2-dimethyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 2-methyl-1-(1-p-tolylcyclopropyl)propan-1-one; 1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)ethanone; 2-methyl-1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)butan-1-one; 2,4-dimethyl-2-m-tolylpentan-3-one; 2-methyl-2-m-tolylpropanenitrile; 3-methyl-3-m-tolylbutan-2-one; 2-methyl-2-m-tolylpentan-3-one; 1-(1-p-tolylcyclopentyl)ethanone; 7-methyl-1-phenyloct-6-en-1-one; 2,2-dimethyl-3-o-tolylpropanenitrile; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; omethyl-benzylcyclopropanecarbonitrile; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(2-methylbenzyl)-cyclopropyl)propanone; 1-(1-(2-methylbenzyl)cyclopropyl)ethanone; 2-(R,S)-methyl-1-(1-(2-methylbenzyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(2-methylbenzyl)cyclopropyl)propan-1-one; 2,2,5-trimethyl-1-phenylhexan-3-one; 2-(1-(3-methylbut-2-enyl)cyclopropyl)propan-2-ol; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-ol; 9-methyldec-1,8-dien-3-one; 2,2-dimethyl-3-(R,S)-phenylbutanenitrile; 4,4-dimethyl-5-(R,S)-phenylhexan-3-one; 1-cyclopentyl-7-methyloct-6-en-1-one; 2,2-dimethyl-3-p-tolylpropanenitrile; 3-(4-methoxy-3-methylphenyl)-3-methylbutan-2-one; 2,2,4-(R,S)-trimethyl-1-p-tolylhexan-3-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 2,2-dimethyl-1-p-tolylpentan-3-one; 3-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)heptan-3-ol; 3-cyclohexyl-2,2-dimethylpropanenitrile; 1-cyclohexyl-2,2,4-trimethylpentan-3-one; 1-(R,S)-(1-phenylethyl)-cyclobutanecarbonitrile; 1-(1-(R,S)-(1-phenylethyl)-cyclobutyl)ethanone; 2-methyl-1-(1-(R,S)-(1-phenylethyl)cyclobutyl)propan-1-one; 2-methyl-1-(R,S)-(1-(1-(R,s)-phenylethyl)cyclobutyl)propan-1-ol; 1-(1-(R,S)-phenylethyl)cyclopropanecarbonitrile; 1-(1-(1-(R,S)-phenylethyl)cyclopropyl)ethanone; 2,2-dimethyl-3-m-tolylpropanenitrile; 3-(4-tert-butylphenyl)-2,2-dimethylpropanenitrile; 1-(1-phenylcyclopropyl)but-3-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-(R,s)-ol; 4-(4-tert-butylphenyl)-3,3-dimethylbutan-2-one; 2,2-dimethyl-4-phenylbutanenitrile; 11-methyldodec-10-en-5-one; 2,9-dimethyldec-8-en-3-one; 2,10-dimethylundec-9-en-4-one; 2,2,9-trimethyldec-8-en-3-one; 2,2,3-(R,S),7-tetramethyloct-6-enenitrile; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 3,3-dimethyl-5-phenylpentan-s-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpropanenitrile; 2-((R,S)-cyclohex-2-enyl)-2,5-dimethylhexan-3-one; 3,3-dimethyl-1-phenyloctan-4-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpentan-3-one; 4,4-dimethyl-6-phenylhexan-3-one; 2,2-dimethyl-5-phenylpentanenitrile; 2,2-dimethylhept-6-enenitrile; 6,6-dimethylundec-10-en-5-one; 3,3-dimethyl-6-phenylhexan-2-one; 2,2-dimethyl-4-((1R,5S)-6,6-dimethylbicyclo [3.1.1]hept-2-en-2-yl)butanenitrile; stereoisomers of 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 4-(4-methylcyclohex-3-enyl)pentan-2-ol; 5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-methyl-4-(4-methylcyclohex-3-enyl)pentan-2-ol; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-ol; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-ol; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 5-(4-methylcyclohex-3-enyl)hexan-3-yl acetate; 3-methyl-4-phenylbut-3-en-2-one; 4-(4-methylphenyl)butan-2-one, 4-p-tolylbutan-2-one; 1-(3-methylphenyl)pent-1-en-3-one 1-m-tolylpent-1-en-3-one; 3-methyl-4-(4-methylphenyl)but-3-en-2-one 3-methyl-4-p-tolylbut-3-en-2-one; 4-(2-methyl-3-oxobut-1-enyl)benzonitrile; 1-phenylhex-1-en-3-one; 1-(2-methylphenyl)pent-1-en-3-one 1-o-tolylpent-1-en-3-one; 3-methyl-4-(2-methylphenyl)but-3-en-2-one 3-methyl-4-o-tolylbut-3-en-2-one; 3-methyl-4-(3-methylphenyl)but-3-en-2-one 3-methyl-4-m-tolylbut-3-en-2-one; 4-(4-methoxyphenyl)-3-methylbut-3-en-2-one; 3-(4-methylbenzylidene)pentan-2-one; 1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one; 1-(2,4,6-trimethylphenyl)hex-1-en-3-one; 1-(2,4,6-trimethylphenyl)pent-1-en-3-one; 3-methyl-4-(2,4,6-trimethylphenyl)but-3-en-2-one; 1-(2,6-dimethylphenyl)hex-1-en-3-one; 1-(2,6-dimethylphenyl)pent-1-en-3-one; 1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one; 1-cyclohexyl-2-phenylpropan-1-one; 2,2,4,7-tetramethyloct-6-en-3-one; 2,4(R,S),7-trimethyloct-6-en-3-one; 2,2,4,4,7-pentamethyloct-6-en-3-one; Ethyl 2(R,S),5-dimethyl-2-(pivaloyl)hex-4-enoate; 2,2,7-Trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclohexyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 4,4,7-trimethyloct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 3,6-dimethyl-3-(3-methylbut-2-enyl)hept-5-en-2-one; 3(R,S),6-dimethylhept-5-en-2-one; 1-(1-(3-hydroxy-3-methylbutyl)cyclohexyl)-2-methylpropan-1-one; 5-methyl-2(R,S)-(prop-1-en-2-yl)-hex-4-enoic acid; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 4,7-dimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 2,4,7-trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 3(R,S),5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)ethanone; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)pentan-1-one; 9-methyldec-8-en-3 one; 2,5-dimethyl-2-(3-methylbut-2-enyl)hex-4-enenitrile; 1-(3-methylbut-2-enyl)cyclopentanecarbonitrile; 1-(3-methylbut-2-enyl)cyclohexanecarbonitrile; 1-(3-methylbut-2-enyl)cyclopropanecarbonitrile; 1-(3-methylbut-2-enyl)cyclobutanecarbonitrile; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclobutyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)ethanone; 2-(R,S)-methyl-1-(1-phenylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)pentan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-one; 1-(1-phenylcyclopropyl)propan-1-one; 2-methyl-1-(1-phenylcyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)butan-1-one; 1-(1-p-tolylcyclopropyl)propan-1-one; 2-(R,S)-methyl-1-(1-p-tolylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)-3-methylenecyclobutyl)ethanone; 1-(1-phenylcyclobutyl)pentan-1-one; 2,2,5-trimethylhex-4-enenitrile; 6,6,9-trimethyldec-8-en-5-one; 2,5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)pentan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)butan-1-one; 2,2-dimethyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 2-methyl-1-(1-p-tolylcyclopropyl)propan-1-one; 1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)ethanone; 2-methyl-1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)butan-1-one; 2,4-dimethyl-2-m-tolylpentan-3-one; 2-methyl-2-m-tolylpropanenitrile; 3-methyl-3-m-tolylbutan-2-one; 2-methyl-2-m-tolylpentan-3-one; 1-(1-p-tolylcyclopentyl)ethanone; 7-methyl-1-phenyloct-6-en-1-one; 2,2-dimethyl-3-o-tolylpropanenitrile; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; o-methyl-benzylcyclopropanecarbonitrile; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(2-methylbenzyl)-cyclopropyl)propanone; 1-(1-(2-methylbenzyl)cyclopropyl)ethanone; 2-(R,S)-methyl-1-(1-(2-methylbenzyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(2-methylbenzyl)cyclopropyl)propan-1-one; 2,2,5-trimethyl-1-phenylhexan-3-one; 2-(1-(3-methylbut-2-enyl)cyclopropyl)propan-2-ol; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 2-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)butan-2-ol; 1-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-ol; 9-methyldec-1,8-dien-3-one; 2,2-dimethyl-3-(R,S)-phenylbutanenitrile; 4,4-dimethyl-5-(R,S)-phenylhexan-3-one; 1-cyclopentyl-7-methyloct-6-en-1-one; 2,2-dimethyl-3-p-tolylpropanenitrile; 3-(4-methoxy-3-methylphenyl)-3-methylbutan-2-one; 2,2,4-(R,S)-trimethyl-1-p-tolylhexan-3-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 2,2-dimethyl-1-p-tolylpentan-3-one; 3-(R,S)-(1-(3-methylbut-2-enyl)cyclobutyl)heptan-3-ol; 3-cyclohexyl-2,2-dimethylpropanenitrile; 1-cyclohexyl-2,2,4-trimethylpentan-3-one; 1-(R,S)-(1-phenylethyl)-cyclobutanecarbonitrile; 1-(1-(R,S)-(1-phenylethyl)-cyclobutyl)ethanone; 2-methyl-1-(1-(R,S)-(1-phenylethyl)cyclobutyl)propan-1-one; 2-methyl-1-(R,S)-(1-(1-(R,s)-phenylethyl)cyclobutyl)propan-1-ol; 1-(1-(R,S)-phenylethyl)cyclopropanecarbonitrile; 1-(1-(1-(R,S)-phenylethyl)cyclopropyl)ethanone; 2,2-dimethyl-3-m-tolylpropanenitrile; 3-(4-tert-butylphenyl)-2,2-dimethylpropanenitrile; 1-(1-phenylcyclopropyl)but-3-en-1-one; 1-(1-phenylcyclopropyl)but-3-en-1-(R,s)-ol; 4-(4-tert-butylphenyl)-3,3-dimethylbutan-2-one; 2,2-dimethyl-4-phenylbutanenitrile; 11-methyldodec-10-en-5-one; 2,9-dimethyldec-8-en-3-one; 2,10-dimethylundec-9-en-4-one; 2,2,9-trimethyldec-8-en-3-one; 2,2,3-(R,S),7-tetramethyloct-6-enenitrile; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 3,3-dimethyl-5-phenylpentan-s-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpropanenitrile; 2-((R,S)-cyclohex-2-enyl)-2,5-dimethylhexan-3-one; 3,3-dimethyl-1-phenyloctan-4-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpentan-3-one; 4,4-dimethyl-6-phenylhexan-3-one; 2,2-dimethyl-5-phenylpentanenitrile; 2,2-dimethylhept-6-enenitrile; 6,6-dimethylundec-10-en-5-one; 3,3-dimethyl-6-phenylhexan-2-one; 2,2-dimethyl-4-((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)butanenitrile; and mixtures thereof.
17. A perfume delivery system according to claim 10, said perfume delivery system being a pro-perfume amine reaction product, said pro-perfume amine reaction product comprising, based on total pro-perfume amine reaction product weight, from 0.1% to about 99% of one or more PRMs selected from 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 3-methyl-4-phenylbut-3-en-2-one; 4-(4-methylphenyl)butan-2-one, 4-p-tolylbutan-2-one; 1-(3-methylphenyl)pent-1-en-3-one 1-m-tolylpent-1-en-3-one; 3-methyl-4-(4-methylphenyl)but-3-en-2-one 3-methyl-4-p-tolylbut-3-en-2-one; 1-phenylhex-1-en-3-one; 1-(2-methylphenyl)pent-1-en-3-one 1-o-tolylpent-1-en-3-one; 3-methyl-4-(2-methylphenyl)but-3-en-2-one 3-methyl-4-o-tolylbut-3-en-2-one; 3-methyl-4-(3-methylphenyl)but-3-en-2-one 3-methyl-4-m-tolylbut-3-en-2-one; 4-(4-methoxyphenyl)-3-methylbut-3-en-2-one; 3-(4-methylbenzylidene)pentan-2-one; 1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one; 1-(2,4,6-trimethylphenyl)hex-1-en-3-one; 1-(2,4,6-trimethylphenyl)pent-1-en-3-one; 3-methyl-4-(2,4,6-trimethylphenyl)but-3-en-2-one; 1-(2,6-dimethylphenyl)hex-1-en-3-one; 1-(2,6-dimethylphenyl)pent-1-en-3-one; 1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one; 1-cyclohexyl-2-phenylpropan-1-one; 2,2,4,7-tetramethyloct-6-en-3-one; 2,4(R,S),7-trimethyloct-6-en-3-one; 2,2,4,4,7-pentamethyloct-6-en-3-one; 2,2,7-Trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclohexyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 4,4,7-trimethyloct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 3,6-dimethyl-3-(3-methylbut-2-enyl)hept-5-en-2-one; 3 (R,S),6-dimethylhept-5-en-2-one; 1-(1-(3-hydroxy-3-methylbutyl)cyclohexyl)-2-methylpropan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 4,7-dimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 2,4,7-trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 3 (R,S),5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)ethanone; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)pentan-1-one; 9-methyldec-8-en-3 one; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclobutyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)ethanone; 2-(R,S)-methyl-1-(1-phenylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)pentan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-one; 1-(1-phenylcyclopropyl)propan-1-one; 2-methyl-1-(1-phenylcyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)butan-1-one; 1-(1-p-tolylcyclopropyl)propan-1-one; 2-(R,S)-methyl-1-(1-p-tolylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)-3-methylenecyclobutyl)ethanone; 1-(1-phenylcyclobutyl)pentan-1-one; 6,6,9-trimethyldec-8-en-5-one; 2,5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)pentan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)butan-1-one; 2,2-dimethyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 2-methyl-1-(1-p-tolylcyclopropyl)propan-1-one; 1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)ethanone; 2-methyl-1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)butan-1-one; 2,4-dimethyl-2-m-tolylpentan-3-one; 3-methyl-3-m-tolylbutan-2-one; 2-methyl-2-m-tolylpentan-3-one; 1-(1-p-tolylcyclopentyl)ethanone; 7-methyl-1-phenyloct-6-en-1-one; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(2-methylbenzyl)-cyclopropyl)propanone; 1-(1-(2-methylbenzyl)cyclopropyl)ethanone; 2-(R,S)-methyl-1-(1-(2-methylbenzyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(2-methylbenzyl)cyclopropyl)propan-1-one; 2,2,5-trimethyl-1-phenylhexan-3-one; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 9-methyldec-1,8-dien-3-one; 4,4-dimethyl-5-(R,S)-phenylhexan-3-one; 1-cyclopentyl-7-methyloct-6-en-1-one; 3-(4-methoxy-3-methylphenyl)-3-methylbutan-2-one; 2,2,4-(R,S)-trimethyl-1-p-tolylhexan-3-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 2,2-dimethyl-1-p-tolylpentan-3-one; 1-cyclohexyl-2,2,4-trimethylpentan-3-one; 1-(1-(R,S)-(1-phenylethyl)-cyclobutyl)ethanone; 2-methyl-1-(1-(R,S)-(1-phenylethyl)cyclobutyl)propan-1-one; 1-(1-(1-(R,S)-phenylethyl)cyclopropyl)ethanone; 1-(1-phenylcyclopropyl)but-3-en-1-one; 4-(4-tert-butylphenyl)-3,3-dimethylbutan-2-one; 11-methyldodec-10-en-5-one; 2,9-dimethyldec-8-en-3-one; 2,10-dimethylundec-9-en-4-one; 2,2,9-trimethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 3,3-dimethyl-5-phenylpentan-s-one; 2-((R,S)-cyclohex-2-enyl)-2,5-dimethylhexan-3-one; 3,3-dimethyl-1-phenyloctan-4-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpentan-3-one; 4,4-dimethyl-6-phenylhexan-3-one; 6,6-dimethylundec-10-en-5-one; and 3,3-dimethyl-6-phenylhexan-2-one; stereoisomers of 2-cyclohexyl-1-phenylethanone; 2-methyl-4-phenyloctan-3-one; 2,5-dimethyl-4-phenylhexan-3-one; 2-methyl-4-phenylhexan-3-one; 2-cyclohexyl-1-(4-methylphenyl)ethanone 2-cyclohexyl-1-p-tolylethanone; 2-cycloheptyl-1-phenylethanone; 2-cyclopentyl-1-p-tolylethanone; 2-cyclopentyl-1-(4-ethylphenyl)ethanone; 2-cyclopentyl-1-(2,4,6-trimethylphenyl)ethanone; 2-cyclopentyl-1-phenylethanone; 3-cyclohexyl-1-phenylpropan-1-one; 3-cyclohexyl-1-(4-ethylphenyl)propan-1-one; 3-cyclohexyl-1-(4-methylphenyl)propan-1-one 3-cyclohexyl-1-p-tolylpropan-1-one; 3-cyclohexyl-1-(2,4,6-trimethylphenyl)propan-1-one; 2-(4-methylcyclohex-3-enyl)nonan-4-one; 4-(4-methylcyclohex-3-enyl)pentan-2-one; 5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-methyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 2-(4-methylcyclohex-3-enyl)heptan-4-one; 6-(4-methylcyclohex-3-enyl)hept-1-en-4-one; 2,2-dimethyl-5-(4-methylcyclohex-3-enyl)hexan-3-one; 3-methyl-4-phenylbut-3-en-2-one; 4-(4-methylphenyl)butan-2-one, 4-p-tolylbutan-2-one; 1-(3-methylphenyl)pent-1-en-3-one 1-m-tolylpent-1-en-3-one; 3-methyl-4-(4-methylphenyl)but-3-en-2-one 3-methyl-4-p-tolylbut-3-en-2-one; 1-phenylhex-1-en-3-one; 1-(2-methylphenyl)pent-1-en-3-one 1-o-tolylpent-1-en-3-one; 3-methyl-4-(2-methylphenyl)but-3-en-2-one 3-methyl-4-o-tolylbut-3-en-2-one; 3-methyl-4-(3-methylphenyl)but-3-en-2-one 3-methyl-4-m-tolylbut-3-en-2-one; 4-(4-methoxyphenyl)-3-methylbut-3-en-2-one; 3-(4-methylbenzylidene)pentan-2-one; 1-(2-methylphenyl)hex-1-en-3-one 1-o-tolylhex-1-en-3-one; 1-(2,4,6-trimethylphenyl)hex-1-en-3-one; 1-(2,4,6-trimethylphenyl)pent-1-en-3-one; 3-methyl-4-(2,4,6-trimethylphenyl)but-3-en-2-one; 1-(2,6-dimethylphenyl)hex-1-en-3-one; 1-(2,6-dimethylphenyl)pent-1-en-3-one; 1-(3-methylphenyl)hex-1-en-3-one 1-m-tolylhex-1-en-3-one; 1-cyclohexyl-2-phenylpropan-1-one; 2,2,4,7-tetramethyloct-6-en-3-one; 2,4(R,S),7-trimethyloct-6-en-3-one; 2,2,4,4,7-pentamethyloct-6-en-3-one; 2,2,7-Trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclohexyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclohexyl)propan-1-one; 4,4,7-trimethyloct-6-en-3-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)ethanone; 1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 3,6-dimethyl-3-(3-methylbut-2-enyl)hept-5-en-2-one; 3 (R,S),6-dimethylhept-5-en-2-one; 1-(1-(3-hydroxy-3-methylbutyl)cyclohexyl)-2-methylpropan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)propan-1-one; 4,7-dimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 2,4,7-trimethyl-4-(3-methylbut-2-enyl)oct-6-en-3-one; 3 (R,S),5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)ethanone; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)pentan-1-one; 9-methyldec-8-en-3 one; 2-methyl-1-(1-(3-(R,S)-methylbut-2-enyl)cyclobutyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)ethanone; 2-(R,S)-methyl-1-(1-phenylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)cyclobutyl)pentan-1-one; 2-methyl-1-(1-(3-methylbut-2-enyl)cyclobutyl)propan-1-one; 1-(1-phenylcyclopropyl)propan-1-one; 2-methyl-1-(1-phenylcyclopropyl)propan-1-one; 1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)butan-1-one; 1-(1-p-tolylcyclopropyl)propan-1-one; 2-(R,S)-methyl-1-(1-p-tolylcyclopropyl)butan-1-one; 1-(1-(3-methylbut-2-enyl)-3-methylenecyclobutyl)ethanone; 1-(1-phenylcyclobutyl)pentan-1-one; 6,6,9-trimethyldec-8-en-5-one; 2,5,5,8-tetramethylnon-7-en-4-one; 1-(1-(3-methylbut-2-enyl)cyclopentyl)pentan-1-one; 3-methyl-1-(1-(3-methylbut-2-enyl)cyclopentyl)butan-1-one; 2,2-dimethyl-1-(1-(3-methylbut-2-enyl)cyclopropyl)propan-1-one; 2-methyl-1-(1-p-tolylcyclopropyl)propan-1-one; 1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)ethanone; 2-methyl-1-(1-((E)-3,7-dimethylocta-2,6-dienyl)cyclopropyl)butan-1-one; 2,4-dimethyl-2-m-tolylpentan-3-one; 3-methyl-3-m-tolylbutan-2-one; 2-methyl-2-m-tolylpentan-3-one; 1-(1-p-tolylcyclopentyl)ethanone; 7-methyl-1-phenyloct-6-en-1-one; 3,3-dimethyl-4-o-tolylbutan-2-one; 2,2-dimethyl-1-o-tolylpentan-3-one; 2,2,4-trimethyl-1-o-tolylhexan-3-one; 1-(1-(2-methylbenzyl)-cyclopropyl)propanone; 1-(1-(2-methylbenzyl)cyclopropyl)ethanone; 2-(R,S)-methyl-1-(1-(2-methylbenzyl)cyclopropyl)butan-1-one; 2-methyl-1-(1-(2-methylbenzyl)cyclopropyl)propan-1-one; 2,2,5-trimethyl-1-phenylhexan-3-one; 1-(1-(3-methylbut-2-enyl)cyclopbutyl)propan-1-one; 9-methyldec-1,8-dien-3-one; 4,4-dimethyl-5-(R,S)-phenylhexan-3-one; 1-cyclopentyl-7-methyloct-6-en-1-one; 3-(4-methoxy-3-methylphenyl)-3-methylbutan-2-one; 2,2,4-(R,S)-trimethyl-1-p-tolylhexan-3-one; 3,3-dimethyl-4-(R,S)-phenylpentan-2-one; 2,2-dimethyl-1-p-tolylpentan-3-one; 1-cyclohexyl-2,2,4-trimethylpentan-3-one; 1-(1-(R,S)-(1-phenylethyl)-cyclobutyl)ethanone; 2-methyl-1-(1-(R,S)-(1-phenylethyl)cyclobutyl)propan-1-one; 1-(1-(1-(R,S)-phenylethyl)cyclopropyl)ethanone; 1-(1-phenylcyclopropyl)but-3-en-1-one; 4-(4-tert-butylphenyl)-3,3-dimethylbutan-2-one; 11-methyldodec-10-en-5-one; 2,9-dimethyldec-8-en-3-one; 2,10-dimethylundec-9-en-4-one; 2,2,9-trimethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 4,4,5-(R,S),9-tetramethyldec-8-en-3-one; 3,3-dimethyl-5-phenylpentan-s-one; 2-((R,S)-cyclohex-2-enyl)-2,5-dimethylhexan-3-one; 3,3-dimethyl-1-phenyloctan-4-one; 2-((R,S)-cyclohex-2-enyl)-2-methylpentan-3-one; 4,4-dimethyl-6-phenylhexan-3-one; 6,6-dimethylundec-10-en-5-one; and 3,3-dimethyl-6-phenylhexan-2-one; and mixtures thereof.
18. A consumer product comprising, based on total consumer product weight, from about 0.001% to about 20% of a perfume delivery system selected from the perfume delivery systems of claims 10-17.
19. A method of cleaning or treating a situs comprising optionally washing and/or rinsing said situs, contacting said situs with the composition selected from the compositions of claims 1-18 and mixtures thereof and optionally washing and/or rinsing said situs.
US12/628,255 2008-12-01 2009-12-01 Perfume systems Abandoned US20100137178A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US12/628,255 US20100137178A1 (en) 2008-12-01 2009-12-01 Perfume systems
US13/616,766 US8431520B2 (en) 2008-12-01 2012-09-14 Perfume systems

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11872008P 2008-12-01 2008-12-01
US12/628,255 US20100137178A1 (en) 2008-12-01 2009-12-01 Perfume systems

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/616,766 Continuation US8431520B2 (en) 2008-12-01 2012-09-14 Perfume systems

Publications (1)

Publication Number Publication Date
US20100137178A1 true US20100137178A1 (en) 2010-06-03

Family

ID=42223365

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/628,255 Abandoned US20100137178A1 (en) 2008-12-01 2009-12-01 Perfume systems
US13/616,766 Active US8431520B2 (en) 2008-12-01 2012-09-14 Perfume systems

Family Applications After (1)

Application Number Title Priority Date Filing Date
US13/616,766 Active US8431520B2 (en) 2008-12-01 2012-09-14 Perfume systems

Country Status (9)

Country Link
US (2) US20100137178A1 (en)
EP (1) EP2362765B1 (en)
JP (1) JP5567029B2 (en)
CN (1) CN102300550B (en)
BR (1) BRPI0922770A2 (en)
CA (1) CA2744033A1 (en)
MX (1) MX2011005801A (en)
RU (1) RU2588972C2 (en)
WO (1) WO2010065446A2 (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100180386A1 (en) * 2009-01-16 2010-07-22 The Procter & Gamble Company Bleaching compositions containing perfume microcapsules
US20110160112A1 (en) * 2009-12-25 2011-06-30 Uwiz Technology Co., Ltd. Cleaning composition
US20110308555A1 (en) * 2010-06-22 2011-12-22 Johan Smets Perfume systems
US20110308556A1 (en) * 2010-06-22 2011-12-22 Johan Smets Perfume systems
US20140021270A1 (en) * 2012-07-19 2014-01-23 National Institute Of Standards And Technology Vapor capture and release systems
WO2013142654A3 (en) * 2012-03-23 2014-05-08 The Procter & Gamble Company Compositions for delivering perfume to the skin
EP2746259A1 (en) 2012-12-21 2014-06-25 Basf Se Substituted [1,2,4]triazole and imidazole compounds
EP2746260A1 (en) 2012-12-21 2014-06-25 Basf Se Substituted [1,2,4]triazole and imidazole compounds
WO2014191256A1 (en) * 2013-05-29 2014-12-04 Henkel Ag & Co. Kgaa Photolabile pro-fragrances
EP2993221A1 (en) * 2014-09-08 2016-03-09 Symrise AG Encapsulated fragrance mixtures
US9447362B2 (en) 2012-12-26 2016-09-20 Kao Corporation Nitrile compound
WO2017004343A1 (en) * 2015-06-30 2017-01-05 The Procter & Gamble Company Feedstock compositions containing multiple populations of microcapsules and methods for making
US10264783B2 (en) * 2016-07-14 2019-04-23 Arcus Hunting, Llc Sprayable gelling animal attractant

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR086558A1 (en) * 2011-06-23 2014-01-08 Procter & Gamble PERFUME SYSTEM
WO2014142025A1 (en) * 2013-03-12 2014-09-18 高砂香料工業株式会社 Compound having cyclopropane ring, and flavor composition containing same
MX2016012467A (en) * 2014-03-26 2016-12-20 Procter & Gamble Perfume systems.
CN104031742B (en) * 2014-06-26 2016-02-10 上海应用技术学院 A kind of slow-release solid perfume compound and preparation method thereof
US10748272B2 (en) * 2017-05-18 2020-08-18 Applied Materials Israel Ltd. Measuring height difference in patterns on semiconductor wafers

Citations (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3594328A (en) * 1965-08-02 1971-07-20 Ciba Ltd Process for the encapsulation of dispersible materials
US3812011A (en) * 1971-09-30 1974-05-21 Hayashibara Biochem Lab Method of converting starch to beta-cyclodextrin
US4317881A (en) * 1979-04-07 1982-03-02 Sanraku-Ocean Co., Ltd. Process for producing cyclodextrins
US4378923A (en) * 1981-07-09 1983-04-05 Nippon Kokan Kabushiki Kaisha Binding device for elongated pipes
US4430243A (en) * 1981-08-08 1984-02-07 The Procter & Gamble Company Bleach catalyst compositions and use thereof in laundry bleaching and detergent compositions
US4514461A (en) * 1981-08-10 1985-04-30 Woo Yen Kong Fragrance impregnated fabric
US4515705A (en) * 1983-11-14 1985-05-07 The Procter & Gamble Company Compositions containing odor purified proteolytic enzymes and perfumes
US4537706A (en) * 1984-05-14 1985-08-27 The Procter & Gamble Company Liquid detergents containing boric acid to stabilize enzymes
US4537707A (en) * 1984-05-14 1985-08-27 The Procter & Gamble Company Liquid detergents containing boric acid and formate to stabilize enzymes
US4539135A (en) * 1983-06-01 1985-09-03 Colgate Palmolive Co. Perfume-containing carrier for laundry compositions
US4540721A (en) * 1983-03-10 1985-09-10 The Procter & Gamble Company Method of providing odor to product container
US4597898A (en) * 1982-12-23 1986-07-01 The Proctor & Gamble Company Detergent compositions containing ethoxylated amines having clay soil removal/anti-redeposition properties
USRE32713E (en) * 1980-03-17 1988-07-12 Capsule impregnated fabric
US4911852A (en) * 1988-10-07 1990-03-27 The Procter & Gamble Company Liquid laundry detergent with curable amine functional silicone for fabric wrinkle reduction
US4917920A (en) * 1988-02-02 1990-04-17 Kanebo, Ltd. Fibrous structures having a durable fragrance and a process for preparing the same
US5112688A (en) * 1989-02-27 1992-05-12 The Procter & Gamble Company Microcapsules containing hydrophobic liquid core
US5300305A (en) * 1991-09-12 1994-04-05 The Procter & Gamble Company Breath protection microcapsules
US5486303A (en) * 1993-08-27 1996-01-23 The Procter & Gamble Company Process for making high density detergent agglomerates using an anhydrous powder additive
US5489392A (en) * 1994-09-20 1996-02-06 The Procter & Gamble Company Process for making a high density detergent composition in a single mixer/densifier with selected recycle streams for improved agglomerate properties
US5506201A (en) * 1994-04-29 1996-04-09 International Flavors & Fragrances Inc. Formulation of a fat surfactant vehicle containing a fragrance
US5516448A (en) * 1994-09-20 1996-05-14 The Procter & Gamble Company Process for making a high density detergent composition which includes selected recycle streams for improved agglomerate
US5552378A (en) * 1990-03-06 1996-09-03 The Procter & Gamble Company Solid consumer product compositions containing small particle cyclodextrin complexes
US5565422A (en) * 1995-06-23 1996-10-15 The Procter & Gamble Company Process for preparing a free-flowing particulate detergent composition having improved solubility
US5565145A (en) * 1994-05-25 1996-10-15 The Procter & Gamble Company Compositions comprising ethoxylated/propoxylated polyalkyleneamine polymers as soil dispersing agents
US5569645A (en) * 1995-04-24 1996-10-29 The Procter & Gamble Company Low dosage detergent composition containing optimum proportions of agglomerates and spray dried granules for improved flow properties
US5595967A (en) * 1995-02-03 1997-01-21 The Procter & Gamble Company Detergent compositions comprising multiperacid-forming bleach activators
US5597936A (en) * 1995-06-16 1997-01-28 The Procter & Gamble Company Method for manufacturing cobalt catalysts
US5651976A (en) * 1993-06-17 1997-07-29 The United States Of America As Represented By The Secretary Of The Navy Controlled release of active agents using inorganic tubules
US5858959A (en) * 1997-02-28 1999-01-12 Procter & Gamble Company Delivery systems comprising zeolites and a starch hydrolysate glass
US5879584A (en) * 1994-09-10 1999-03-09 The Procter & Gamble Company Process for manufacturing aqueous compositions comprising peracids
US5929022A (en) * 1996-08-01 1999-07-27 The Procter & Gamble Company Detergent compositions containing amine and specially selected perfumes
US5958870A (en) * 1996-04-01 1999-09-28 The Procter & Gamble Company Betaine ester compounds of active alcohols
US6024943A (en) * 1996-12-23 2000-02-15 Ness; Jeremy Nicholas Particles containing absorbed liquids and methods of making them
US6042792A (en) * 1997-09-18 2000-03-28 International Flavors & Fragrances Inc. Apparatus for preparing a solid phase microparticulate composition
US6048830A (en) * 1996-03-22 2000-04-11 The Procter & Gamble Company Delivery system having release barrier loaded zeolite
US6051540A (en) * 1998-11-05 2000-04-18 International Flavors & Fragrances Inc. Method employing drum chilling and apparatus therefor for producing fragrance-containing long lasting solid particle
US6093691A (en) * 1996-08-19 2000-07-25 The Procter & Gamble Company Rinse added fabric softening compositions and method of use for the delivery of fragrance derivatives
US6096918A (en) * 1998-02-13 2000-08-01 Givaudan Roure (International) Sa Aryl-acrylic acid esters
US6103678A (en) * 1996-11-07 2000-08-15 The Procter & Gamble Company Compositions comprising a perfume and an amino-functional polymer
US6106875A (en) * 1997-10-08 2000-08-22 Givaudan Roure (International) Sa Method of encapsulating flavors and fragrances by controlled water transport into microcapsules
US6200949B1 (en) * 1999-12-21 2001-03-13 International Flavors And Fragrances Inc. Process for forming solid phase controllably releasable fragrance-containing consumable articles
US6218355B1 (en) * 1998-05-28 2001-04-17 Firmenich Sa Slow release of fragrant compounds in perfumery using a keto esters
US6225464B1 (en) * 1997-03-07 2001-05-01 The Procter & Gamble Company Methods of making cross-bridged macropolycycles
US6245732B1 (en) * 1996-03-22 2001-06-12 The Procter Gamble Co. Delivery system having release inhibitor loaded zeolite and method for making same
US6277796B1 (en) * 1996-12-19 2001-08-21 The Procter & Gamble Company Dryer-activated fabric conditioning and antistatic compositions with improved perfume longevity
US6294514B1 (en) * 1998-11-24 2001-09-25 The Procter & Gamble Company Process for preparing mono-long chain amine oxide surfactants with low nitrite, nitrosamine and low residual peroxide
US6376445B1 (en) * 1997-08-14 2002-04-23 Procter & Gamble Company Detergent compositions comprising a mannanase and a protease
US6413920B1 (en) * 1998-07-10 2002-07-02 Procter & Gamble Company Amine reaction compounds comprising one or more active ingredient
US6437150B1 (en) * 1998-04-20 2002-08-20 Givaudan Sa Compounds having protected hydroxy groups
US20030036489A1 (en) * 2001-05-04 2003-02-20 The Procter & Gamble Company Consumable composition comprising perfumed particles and article containing the same
US6531444B1 (en) * 2000-11-09 2003-03-11 Salvona, Llc Controlled delivery system for fabric care products
US6544945B1 (en) * 1998-02-24 2003-04-08 The Procter & Gamble Company Cyclic pro-perfumes having modifiable fragrance raw material alcohol release rates
US6544926B1 (en) * 2001-10-11 2003-04-08 Appleton Papers Inc. Microcapsules having improved printing and efficiency
US6548467B2 (en) * 1999-09-02 2003-04-15 The Procter & Gamble Company Sanitizing compositions and methods
US20030125222A1 (en) * 2000-01-05 2003-07-03 Ekkehard Jahns Microcapsule preparations and detergents and cleaning agents containing microcapsules
US6592990B2 (en) * 2000-09-06 2003-07-15 Appleton Papers Inc. In situ microencapsulated adhesive
US20030158344A1 (en) * 2002-02-08 2003-08-21 Rodriques Klein A. Hydrophobe-amine graft copolymer
US6610646B2 (en) * 2000-06-01 2003-08-26 The Procter & Gamble Company Enhanced duration fragrance delivery system having a non-distorted initial fragrance impression
US20030165692A1 (en) * 2002-01-24 2003-09-04 Friedrich Koch Coagulates containing microcapsules
US20040058845A1 (en) * 2002-09-05 2004-03-25 Metrot Veronique Sylvie Structured liquid fabric treatment compositions
US20040071746A1 (en) * 2002-10-10 2004-04-15 Popplewell Lewis Michael Encapsulated fragrance chemicals
US20040071742A1 (en) * 2002-10-10 2004-04-15 Popplewell Lewis Michael Encapsulated fragrance chemicals
US20040072719A1 (en) * 2002-10-10 2004-04-15 Bennett Sydney William Encapsulated fragrance chemicals
US20040087476A1 (en) * 2002-11-01 2004-05-06 Dykstra Robert Richard Polymeric assisted delivery using separate addition
US20040087477A1 (en) * 2001-03-16 2004-05-06 Ness Jeremy Nicholas Perfume encapsulates
US20040092425A1 (en) * 2002-11-04 2004-05-13 The Procter & Gamble Company Liquid laundry detergent
US20040091445A1 (en) * 2002-11-01 2004-05-13 The Procter & Gamble Company Rinse-off personal care compositions comprising cationic perfume polymeric particles
US20040092414A1 (en) * 2002-11-01 2004-05-13 Clapp Mannie Lee Rinse-off personal care compositions comprising anionic and/or nonionic perfume polymeric particles
US20040106536A1 (en) * 2000-03-20 2004-06-03 Jean Mane Solid perfumed preparation in the form of microbeads and the use thereof
US20040110648A1 (en) * 2002-11-01 2004-06-10 Jordan Glenn Thomas Perfume polymeric particles
US20050003980A1 (en) * 2003-06-27 2005-01-06 The Procter & Gamble Company Lipophilic fluid cleaning compositions capable of delivering scent
US6861402B1 (en) * 1999-06-01 2005-03-01 The Procter & Gamble Company Pro-fragrances
US6869923B1 (en) * 1998-06-15 2005-03-22 Procter & Gamble Company Perfume compositions
US20050124530A1 (en) * 2002-04-03 2005-06-09 Serge Creutz Fragrance compositions
US20060003913A1 (en) * 2004-06-30 2006-01-05 The Procter & Gamble Company Perfumed liquid laundry detergent compositions with functionalized silicone fabric care agents
US6984617B2 (en) * 2002-04-26 2006-01-10 The Procter & Gamble Company Fragrance release
US20060005333A1 (en) * 2004-07-09 2006-01-12 Vincenzo Catalfamo Roller for providing benefits to fabric
US6987084B2 (en) * 2000-11-08 2006-01-17 The Procter & Gamble Co. Photo-labile pro-fragrance conjugates
US20060020459A1 (en) * 2004-07-21 2006-01-26 Carter John A System and method for immigration tracking and intelligence
US20060039934A1 (en) * 2002-08-14 2006-02-23 Ness Jeremy N Compositions comprising encapsulated material
US7018978B2 (en) * 1998-10-23 2006-03-28 Procter & Gamble Company Fragrance pro-accords and aldehyde and ketone fragrance libraries
US7071151B2 (en) * 2001-09-11 2006-07-04 Procter & Gamble Company Compositions comprising photo-labile perfume delivery
US20070082829A1 (en) * 2005-09-27 2007-04-12 Johan Smets Microcapsule and method of producing same
US7208463B2 (en) * 2000-06-02 2007-04-24 The Procter & Gamble Company Fragrance compositions
US7208462B2 (en) * 2000-06-02 2007-04-24 The Procter & Gamble Company Fragrance compositions
US7208464B2 (en) * 2000-06-02 2007-04-24 The Procter & Gamble Company Fragrance compositions
US20070191256A1 (en) * 2006-02-10 2007-08-16 Fossum Renae D Fabric care compositions comprising formaldehyde scavengers
US20070202063A1 (en) * 2006-02-28 2007-08-30 Dihora Jiten O Benefit agent containing delivery particle
US20070207942A1 (en) * 2004-03-26 2007-09-06 Serge Creutz Controlled Release Compositions
US20080031961A1 (en) * 2006-08-01 2008-02-07 Philip Andrew Cunningham Benefit agent containing delivery particle
US20080118568A1 (en) * 2006-11-22 2008-05-22 Johan Smets Benefit agent containing delivery particle
US7407650B2 (en) * 2000-10-27 2008-08-05 The Procter & Gamble Company Fragrance compositions
US20080187596A1 (en) * 2004-06-10 2008-08-07 Jiten Odhavji Dihora Benefit agent containing delivery particle
US7413731B2 (en) * 2000-10-27 2008-08-19 The Procter And Gamble Company Fragrance compositions
US20090209661A1 (en) * 2008-02-15 2009-08-20 Nigel Patrick Somerville Roberts Delivery particle
US20100029539A1 (en) * 2008-07-30 2010-02-04 Jiten Odhavji Dihora Delivery particle
US7659239B2 (en) * 2006-05-24 2010-02-09 The Procter & Gamble Company Process of incorporating microcapsules into dryer-added fabric care articles

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3453317A (en) * 1962-07-11 1969-07-01 Hoffmann La Roche Unsaturated carbonyl compounds and processes
US4226892A (en) * 1967-11-09 1980-10-07 Firmenich Sa Flavoring with cycloaliphatic unsaturated ketones
CH559517A5 (en) * 1972-07-25 1975-03-14 Firmenich & Cie 4-(2,2-Dimethyl-cyclobutyl)but-3-ene-2 one - as ingredient in perfumes and foodstuffs for imparting or modifying flavour
US4234627A (en) 1977-02-04 1980-11-18 The Procter & Gamble Company Fabric conditioning compositions
JPS57146600A (en) 1981-03-06 1982-09-10 Japan Maize Prod Recovery of gamma-cyclodextrin
US4561998A (en) 1982-05-24 1985-12-31 The Procter & Gamble Company Near-neutral pH detergents containing anionic surfactant, cosurfactant and fatty acid
US4550862A (en) 1982-11-17 1985-11-05 The Procter & Gamble Company Liquid product pouring and measuring package with self draining feature
US4582634A (en) * 1983-04-21 1986-04-15 International Flavors & Fragrances Inc. Use in augmenting or enhancing the aroma of perfume compositions, colognes and perfumed articles of 1-phenylpenten-4-one-1 and methyl homologues thereof
US4968451A (en) 1988-08-26 1990-11-06 The Procter & Gamble Company Soil release agents having allyl-derived sulfonated end caps
US4973422A (en) 1989-01-17 1990-11-27 The Procter & Gamble Company Perfume particles for use in cleaning and conditioning compositions
US5321031A (en) * 1992-09-23 1994-06-14 Schering Corporation 1,2-disubstituted ethyl amides as inhibitors of ACAT
ES2144515T5 (en) 1993-03-01 2006-03-16 THE PROCTER & GAMBLE COMPANY BIODEGRADABLE CONCENTRATED COMPOSITIONS OF SUBSTITUTING FABRIC AMMONIUM OF FABRICS, AND COMPOUNDS CONTAINING CHAINS OF Unsaturated FATTY ACIDS OF MIDDLE IODINE INDEX.
US5451458A (en) * 1993-03-19 1995-09-19 Xerox Corporation Recording sheets
TR28670A (en) * 1993-06-02 1996-12-17 Procter & Gamble Perfume release system containing zeolites.
US5691297A (en) 1994-09-20 1997-11-25 The Procter & Gamble Company Process for making a high density detergent composition by controlling agglomeration within a dispersion index
US5574005A (en) 1995-03-07 1996-11-12 The Procter & Gamble Company Process for producing detergent agglomerates from high active surfactant pastes having non-linear viscoelastic properties
US5576282A (en) 1995-09-11 1996-11-19 The Procter & Gamble Company Color-safe bleach boosters, compositions and laundry methods employing same
MA24136A1 (en) 1996-04-16 1997-12-31 Procter & Gamble MANUFACTURE OF SURFACE AGENTS.
US6147037A (en) 1996-08-19 2000-11-14 The Procter & Gamble Company Fragrance delivery systems
ZA9711269B (en) 1996-12-19 1998-06-23 Procter & Gamble Dryer added fabric softening compositions and method of use for the delivery of fragrance derivatives.
AU730047B2 (en) * 1997-01-31 2001-02-22 Monsanto Company Process and compositions for enhancing reliability of exogenous chemical substances applied to plants
CN1262632C (en) 1997-03-07 2006-07-05 普罗格特-甘布尔公司 Bleach compositions containing metal bleach catalyst, and bleach activators and/or organic percarboxylic acids
CN1268107A (en) 1997-06-27 2000-09-27 普罗格特-甘布尔公司 Pro-fragrance linear acetals and ketals
US6645479B1 (en) 1997-09-18 2003-11-11 International Flavors & Fragrances Inc. Targeted delivery of active/bioactive and perfuming compositions
UA66370C2 (en) * 1997-12-16 2004-05-17 Lilly Co Eli Arylpiperazines having activity to setotonin 1 receptors
US6479682B1 (en) 1998-04-20 2002-11-12 Givaudan Sa Compounds having protected hydroxy groups
CA2329331C (en) 1998-04-23 2005-06-14 The Procter & Gamble Company Encapsulated perfume particles and detergent compositions containing said particles
AU2026100A (en) 1998-11-30 2000-06-19 Procter & Gamble Company, The Process for preparing cross-bridged tetraaza macrocycles
US7129204B2 (en) 2000-06-02 2006-10-31 Quest International Services B.V. Perfumes
US6956013B2 (en) 2001-04-10 2005-10-18 The Procter & Gamble Company Photo-activated pro-fragrances
JP2002327193A (en) * 2001-04-27 2002-11-15 Kiyomitsu Kawasaki Compound perfume and washing-softening agent composition containing the compound perfume
GB0119935D0 (en) 2001-08-16 2001-10-10 Quest Int Perfume containing composition
BRPI0214515B1 (en) 2001-12-13 2016-03-22 Firmenich & Cie perfume composition or perfumed article, method for enhancing, intensifying or modifying the odor of a fragrant article or perfume composition, method for perfuming a surface, method for intensifying or prolonging the diffusion effect of an odorous ingredient on a surface, and, compound
US7053034B2 (en) 2002-04-10 2006-05-30 Salvona, Llc Targeted controlled delivery compositions activated by changes in pH or salt concentration
US20030215417A1 (en) 2002-04-18 2003-11-20 The Procter & Gamble Company Malodor-controlling compositions comprising odor control agents and microcapsules containing an active material
US20030216488A1 (en) 2002-04-18 2003-11-20 The Procter & Gamble Company Compositions comprising a dispersant and microcapsules containing an active material
US6740631B2 (en) 2002-04-26 2004-05-25 Adi Shefer Multi component controlled delivery system for fabric care products
ATE365766T1 (en) * 2003-11-14 2007-07-15 Procter & Gamble POLYMERIC COMPOSITIONS FOR SUSTAINED RELEASE OF VOLATILE MATERIALS
HUE028490T2 (en) * 2003-12-02 2016-12-28 Univ Ohio State Res Found Zn 2+ -chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors
US20050181969A1 (en) 2004-02-13 2005-08-18 Mort Paul R.Iii Active containing delivery particle
DK1720836T3 (en) * 2004-02-25 2014-05-05 Lilly Co Eli 6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO [D] AZEPINES AS 5-HT2C RECEPTOR AGONISTS
US7947086B2 (en) 2004-09-01 2011-05-24 The Procter & Gamble Company Method for cleaning household fabric-based surface with premoistened wipe
EP1661977A1 (en) * 2004-11-29 2006-05-31 The Procter & Gamble Company Detergent compositions
US20060292098A1 (en) 2005-05-19 2006-12-28 Scavone Timothy A Consumer noticeable improvement in wetness protection
JP4948813B2 (en) * 2005-09-22 2012-06-06 東レ・ダウコーニング株式会社 Method for producing ketimine structure-containing alkoxysilane
BRPI0603808A2 (en) 2006-04-20 2009-03-10 Procter & Gamble release particle containing active
WO2007130685A1 (en) 2006-05-05 2007-11-15 The Procter & Gamble Company Films with microcapsules
US20070270327A1 (en) 2006-05-22 2007-11-22 The Procter & Gamble Company Dryer-added fabric care articles imparting fabric feel benefits
US20070275866A1 (en) 2006-05-23 2007-11-29 Robert Richard Dykstra Perfume delivery systems for consumer goods
SG139587A1 (en) * 2006-07-28 2008-02-29 Givaudan Sa Method of using organic compounds
EP2155844B1 (en) 2007-06-05 2012-11-21 The Procter & Gamble Company Perfume systems
EP2160176B1 (en) 2007-06-11 2017-07-26 The Procter and Gamble Company Benefit agent containing delivery particle
WO2010053940A1 (en) 2008-11-07 2010-05-14 The Procter & Gamble Company Benefit agent containing delivery particle
US20100190674A1 (en) 2009-01-29 2010-07-29 Johan Smets Encapsulates
US20100190673A1 (en) 2009-01-29 2010-07-29 Johan Smets Encapsulates

Patent Citations (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3594328A (en) * 1965-08-02 1971-07-20 Ciba Ltd Process for the encapsulation of dispersible materials
US3812011A (en) * 1971-09-30 1974-05-21 Hayashibara Biochem Lab Method of converting starch to beta-cyclodextrin
US4317881A (en) * 1979-04-07 1982-03-02 Sanraku-Ocean Co., Ltd. Process for producing cyclodextrins
USRE32713E (en) * 1980-03-17 1988-07-12 Capsule impregnated fabric
US4378923A (en) * 1981-07-09 1983-04-05 Nippon Kokan Kabushiki Kaisha Binding device for elongated pipes
US4430243A (en) * 1981-08-08 1984-02-07 The Procter & Gamble Company Bleach catalyst compositions and use thereof in laundry bleaching and detergent compositions
US4514461A (en) * 1981-08-10 1985-04-30 Woo Yen Kong Fragrance impregnated fabric
US4597898A (en) * 1982-12-23 1986-07-01 The Proctor & Gamble Company Detergent compositions containing ethoxylated amines having clay soil removal/anti-redeposition properties
US4540721A (en) * 1983-03-10 1985-09-10 The Procter & Gamble Company Method of providing odor to product container
US4539135A (en) * 1983-06-01 1985-09-03 Colgate Palmolive Co. Perfume-containing carrier for laundry compositions
US4515705A (en) * 1983-11-14 1985-05-07 The Procter & Gamble Company Compositions containing odor purified proteolytic enzymes and perfumes
US4537707A (en) * 1984-05-14 1985-08-27 The Procter & Gamble Company Liquid detergents containing boric acid and formate to stabilize enzymes
US4537706A (en) * 1984-05-14 1985-08-27 The Procter & Gamble Company Liquid detergents containing boric acid to stabilize enzymes
US4917920A (en) * 1988-02-02 1990-04-17 Kanebo, Ltd. Fibrous structures having a durable fragrance and a process for preparing the same
US4911852A (en) * 1988-10-07 1990-03-27 The Procter & Gamble Company Liquid laundry detergent with curable amine functional silicone for fabric wrinkle reduction
US5112688A (en) * 1989-02-27 1992-05-12 The Procter & Gamble Company Microcapsules containing hydrophobic liquid core
US5552378A (en) * 1990-03-06 1996-09-03 The Procter & Gamble Company Solid consumer product compositions containing small particle cyclodextrin complexes
US5300305A (en) * 1991-09-12 1994-04-05 The Procter & Gamble Company Breath protection microcapsules
US5651976A (en) * 1993-06-17 1997-07-29 The United States Of America As Represented By The Secretary Of The Navy Controlled release of active agents using inorganic tubules
US5486303A (en) * 1993-08-27 1996-01-23 The Procter & Gamble Company Process for making high density detergent agglomerates using an anhydrous powder additive
US5506201A (en) * 1994-04-29 1996-04-09 International Flavors & Fragrances Inc. Formulation of a fat surfactant vehicle containing a fragrance
US5565145A (en) * 1994-05-25 1996-10-15 The Procter & Gamble Company Compositions comprising ethoxylated/propoxylated polyalkyleneamine polymers as soil dispersing agents
US5879584A (en) * 1994-09-10 1999-03-09 The Procter & Gamble Company Process for manufacturing aqueous compositions comprising peracids
US5516448A (en) * 1994-09-20 1996-05-14 The Procter & Gamble Company Process for making a high density detergent composition which includes selected recycle streams for improved agglomerate
US5489392A (en) * 1994-09-20 1996-02-06 The Procter & Gamble Company Process for making a high density detergent composition in a single mixer/densifier with selected recycle streams for improved agglomerate properties
US5595967A (en) * 1995-02-03 1997-01-21 The Procter & Gamble Company Detergent compositions comprising multiperacid-forming bleach activators
US5569645A (en) * 1995-04-24 1996-10-29 The Procter & Gamble Company Low dosage detergent composition containing optimum proportions of agglomerates and spray dried granules for improved flow properties
US5597936A (en) * 1995-06-16 1997-01-28 The Procter & Gamble Company Method for manufacturing cobalt catalysts
US5565422A (en) * 1995-06-23 1996-10-15 The Procter & Gamble Company Process for preparing a free-flowing particulate detergent composition having improved solubility
US6245732B1 (en) * 1996-03-22 2001-06-12 The Procter Gamble Co. Delivery system having release inhibitor loaded zeolite and method for making same
US6048830A (en) * 1996-03-22 2000-04-11 The Procter & Gamble Company Delivery system having release barrier loaded zeolite
US5958870A (en) * 1996-04-01 1999-09-28 The Procter & Gamble Company Betaine ester compounds of active alcohols
US5929022A (en) * 1996-08-01 1999-07-27 The Procter & Gamble Company Detergent compositions containing amine and specially selected perfumes
US6093691A (en) * 1996-08-19 2000-07-25 The Procter & Gamble Company Rinse added fabric softening compositions and method of use for the delivery of fragrance derivatives
US6103678A (en) * 1996-11-07 2000-08-15 The Procter & Gamble Company Compositions comprising a perfume and an amino-functional polymer
US6277796B1 (en) * 1996-12-19 2001-08-21 The Procter & Gamble Company Dryer-activated fabric conditioning and antistatic compositions with improved perfume longevity
US6024943A (en) * 1996-12-23 2000-02-15 Ness; Jeremy Nicholas Particles containing absorbed liquids and methods of making them
US5858959A (en) * 1997-02-28 1999-01-12 Procter & Gamble Company Delivery systems comprising zeolites and a starch hydrolysate glass
US6225464B1 (en) * 1997-03-07 2001-05-01 The Procter & Gamble Company Methods of making cross-bridged macropolycycles
US6376445B1 (en) * 1997-08-14 2002-04-23 Procter & Gamble Company Detergent compositions comprising a mannanase and a protease
US6042792A (en) * 1997-09-18 2000-03-28 International Flavors & Fragrances Inc. Apparatus for preparing a solid phase microparticulate composition
US6106875A (en) * 1997-10-08 2000-08-22 Givaudan Roure (International) Sa Method of encapsulating flavors and fragrances by controlled water transport into microcapsules
US6096918A (en) * 1998-02-13 2000-08-01 Givaudan Roure (International) Sa Aryl-acrylic acid esters
US6544945B1 (en) * 1998-02-24 2003-04-08 The Procter & Gamble Company Cyclic pro-perfumes having modifiable fragrance raw material alcohol release rates
US6437150B1 (en) * 1998-04-20 2002-08-20 Givaudan Sa Compounds having protected hydroxy groups
US6218355B1 (en) * 1998-05-28 2001-04-17 Firmenich Sa Slow release of fragrant compounds in perfumery using a keto esters
US6869923B1 (en) * 1998-06-15 2005-03-22 Procter & Gamble Company Perfume compositions
US6413920B1 (en) * 1998-07-10 2002-07-02 Procter & Gamble Company Amine reaction compounds comprising one or more active ingredient
US7018978B2 (en) * 1998-10-23 2006-03-28 Procter & Gamble Company Fragrance pro-accords and aldehyde and ketone fragrance libraries
US6051540A (en) * 1998-11-05 2000-04-18 International Flavors & Fragrances Inc. Method employing drum chilling and apparatus therefor for producing fragrance-containing long lasting solid particle
US6294514B1 (en) * 1998-11-24 2001-09-25 The Procter & Gamble Company Process for preparing mono-long chain amine oxide surfactants with low nitrite, nitrosamine and low residual peroxide
US6861402B1 (en) * 1999-06-01 2005-03-01 The Procter & Gamble Company Pro-fragrances
US6548467B2 (en) * 1999-09-02 2003-04-15 The Procter & Gamble Company Sanitizing compositions and methods
US6200949B1 (en) * 1999-12-21 2001-03-13 International Flavors And Fragrances Inc. Process for forming solid phase controllably releasable fragrance-containing consumable articles
US20030125222A1 (en) * 2000-01-05 2003-07-03 Ekkehard Jahns Microcapsule preparations and detergents and cleaning agents containing microcapsules
US20040106536A1 (en) * 2000-03-20 2004-06-03 Jean Mane Solid perfumed preparation in the form of microbeads and the use thereof
US6610646B2 (en) * 2000-06-01 2003-08-26 The Procter & Gamble Company Enhanced duration fragrance delivery system having a non-distorted initial fragrance impression
US7208464B2 (en) * 2000-06-02 2007-04-24 The Procter & Gamble Company Fragrance compositions
US7208462B2 (en) * 2000-06-02 2007-04-24 The Procter & Gamble Company Fragrance compositions
US7208463B2 (en) * 2000-06-02 2007-04-24 The Procter & Gamble Company Fragrance compositions
US6592990B2 (en) * 2000-09-06 2003-07-15 Appleton Papers Inc. In situ microencapsulated adhesive
US7413731B2 (en) * 2000-10-27 2008-08-19 The Procter And Gamble Company Fragrance compositions
US7407650B2 (en) * 2000-10-27 2008-08-05 The Procter & Gamble Company Fragrance compositions
US6987084B2 (en) * 2000-11-08 2006-01-17 The Procter & Gamble Co. Photo-labile pro-fragrance conjugates
US6531444B1 (en) * 2000-11-09 2003-03-11 Salvona, Llc Controlled delivery system for fabric care products
US20040087477A1 (en) * 2001-03-16 2004-05-06 Ness Jeremy Nicholas Perfume encapsulates
US20030036489A1 (en) * 2001-05-04 2003-02-20 The Procter & Gamble Company Consumable composition comprising perfumed particles and article containing the same
US7071151B2 (en) * 2001-09-11 2006-07-04 Procter & Gamble Company Compositions comprising photo-labile perfume delivery
US6544926B1 (en) * 2001-10-11 2003-04-08 Appleton Papers Inc. Microcapsules having improved printing and efficiency
US20030165692A1 (en) * 2002-01-24 2003-09-04 Friedrich Koch Coagulates containing microcapsules
US20030158344A1 (en) * 2002-02-08 2003-08-21 Rodriques Klein A. Hydrophobe-amine graft copolymer
US20050124530A1 (en) * 2002-04-03 2005-06-09 Serge Creutz Fragrance compositions
US20050143282A1 (en) * 2002-04-03 2005-06-30 Serge Creutz Emulsions
US6984617B2 (en) * 2002-04-26 2006-01-10 The Procter & Gamble Company Fragrance release
US20060039934A1 (en) * 2002-08-14 2006-02-23 Ness Jeremy N Compositions comprising encapsulated material
US20040058845A1 (en) * 2002-09-05 2004-03-25 Metrot Veronique Sylvie Structured liquid fabric treatment compositions
US20040072719A1 (en) * 2002-10-10 2004-04-15 Bennett Sydney William Encapsulated fragrance chemicals
US20040071746A1 (en) * 2002-10-10 2004-04-15 Popplewell Lewis Michael Encapsulated fragrance chemicals
US20040072720A1 (en) * 2002-10-10 2004-04-15 Joseph Brain Encapsulated fragrance chemicals
US20040071742A1 (en) * 2002-10-10 2004-04-15 Popplewell Lewis Michael Encapsulated fragrance chemicals
US20040091445A1 (en) * 2002-11-01 2004-05-13 The Procter & Gamble Company Rinse-off personal care compositions comprising cationic perfume polymeric particles
US20040110648A1 (en) * 2002-11-01 2004-06-10 Jordan Glenn Thomas Perfume polymeric particles
US20040087476A1 (en) * 2002-11-01 2004-05-06 Dykstra Robert Richard Polymeric assisted delivery using separate addition
US20040092414A1 (en) * 2002-11-01 2004-05-13 Clapp Mannie Lee Rinse-off personal care compositions comprising anionic and/or nonionic perfume polymeric particles
US20040092425A1 (en) * 2002-11-04 2004-05-13 The Procter & Gamble Company Liquid laundry detergent
US20050003980A1 (en) * 2003-06-27 2005-01-06 The Procter & Gamble Company Lipophilic fluid cleaning compositions capable of delivering scent
US20070207942A1 (en) * 2004-03-26 2007-09-06 Serge Creutz Controlled Release Compositions
US20080187596A1 (en) * 2004-06-10 2008-08-07 Jiten Odhavji Dihora Benefit agent containing delivery particle
US20060003913A1 (en) * 2004-06-30 2006-01-05 The Procter & Gamble Company Perfumed liquid laundry detergent compositions with functionalized silicone fabric care agents
US20060005333A1 (en) * 2004-07-09 2006-01-12 Vincenzo Catalfamo Roller for providing benefits to fabric
US20060020459A1 (en) * 2004-07-21 2006-01-26 Carter John A System and method for immigration tracking and intelligence
US20070082829A1 (en) * 2005-09-27 2007-04-12 Johan Smets Microcapsule and method of producing same
US20070191256A1 (en) * 2006-02-10 2007-08-16 Fossum Renae D Fabric care compositions comprising formaldehyde scavengers
US20070202063A1 (en) * 2006-02-28 2007-08-30 Dihora Jiten O Benefit agent containing delivery particle
US7659239B2 (en) * 2006-05-24 2010-02-09 The Procter & Gamble Company Process of incorporating microcapsules into dryer-added fabric care articles
US20080031961A1 (en) * 2006-08-01 2008-02-07 Philip Andrew Cunningham Benefit agent containing delivery particle
US20080118568A1 (en) * 2006-11-22 2008-05-22 Johan Smets Benefit agent containing delivery particle
US20090209661A1 (en) * 2008-02-15 2009-08-20 Nigel Patrick Somerville Roberts Delivery particle
US20100029539A1 (en) * 2008-07-30 2010-02-04 Jiten Odhavji Dihora Delivery particle

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100180386A1 (en) * 2009-01-16 2010-07-22 The Procter & Gamble Company Bleaching compositions containing perfume microcapsules
US20110160112A1 (en) * 2009-12-25 2011-06-30 Uwiz Technology Co., Ltd. Cleaning composition
US9994793B2 (en) 2010-06-22 2018-06-12 The Procter & Gamble Company Perfume systems
US8987187B2 (en) * 2010-06-22 2015-03-24 The Procter & Gamble Company Perfume systems
US8609603B2 (en) * 2010-06-22 2013-12-17 The Procter & Gamble Company Perfume systems
EP3085759A3 (en) * 2010-06-22 2016-12-21 The Procter and Gamble Company Perfume systems
US20110308556A1 (en) * 2010-06-22 2011-12-22 Johan Smets Perfume systems
US20110308555A1 (en) * 2010-06-22 2011-12-22 Johan Smets Perfume systems
EP3121255A1 (en) * 2010-06-22 2017-01-25 The Procter and Gamble Company Perfume systems
US20150141310A1 (en) * 2010-06-22 2015-05-21 The Procter & Gamble Company Perfume systems
EP3121256A1 (en) * 2010-06-22 2017-01-25 The Procter and Gamble Company Perfume systems
WO2013142654A3 (en) * 2012-03-23 2014-05-08 The Procter & Gamble Company Compositions for delivering perfume to the skin
US8895041B2 (en) 2012-03-23 2014-11-25 The Procter & Gamble Company Compositions for delivering perfume to the skin
US9161899B2 (en) 2012-03-23 2015-10-20 The Procter & Gamble Company Compositions for delivering perfume to the skin
US9364417B2 (en) 2012-03-23 2016-06-14 The Procter & Gamble Company Compositions for delivering perfume to the skin
US20140021270A1 (en) * 2012-07-19 2014-01-23 National Institute Of Standards And Technology Vapor capture and release systems
EP2746259A1 (en) 2012-12-21 2014-06-25 Basf Se Substituted [1,2,4]triazole and imidazole compounds
EP2746260A1 (en) 2012-12-21 2014-06-25 Basf Se Substituted [1,2,4]triazole and imidazole compounds
US9447362B2 (en) 2012-12-26 2016-09-20 Kao Corporation Nitrile compound
AU2014273342B2 (en) * 2013-05-29 2017-11-23 Henkel Ag & Co. Kgaa Photolabile pro-fragrances
WO2014191256A1 (en) * 2013-05-29 2014-12-04 Henkel Ag & Co. Kgaa Photolabile pro-fragrances
US9593063B2 (en) 2013-05-29 2017-03-14 Henkel Ag & Co. Kgaa Photolabile pro-fragrances
JP2016526041A (en) * 2013-05-29 2016-09-01 ヘンケル・アクチェンゲゼルシャフト・ウント・コムパニー・コマンディットゲゼルシャフト・アウフ・アクチェンＨｅｎｋｅｌ ＡＧ ＆ Ｃｏ． ＫＧａＡ Photosensitive professional fragrance
EP2993221A1 (en) * 2014-09-08 2016-03-09 Symrise AG Encapsulated fragrance mixtures
CN106795451A (en) * 2014-09-08 2017-05-31 西姆莱斯股份公司 The fragrance material mixture of encapsulation
US20170247645A1 (en) * 2014-09-08 2017-08-31 Symrise Ag Encapsulated fragrance mixtures
WO2016037948A1 (en) * 2014-09-08 2016-03-17 Symrise Ag Encapsulated fragrance mixtures
WO2017004343A1 (en) * 2015-06-30 2017-01-05 The Procter & Gamble Company Feedstock compositions containing multiple populations of microcapsules and methods for making
US10264783B2 (en) * 2016-07-14 2019-04-23 Arcus Hunting, Llc Sprayable gelling animal attractant
US11071298B2 (en) 2016-07-14 2021-07-27 Arcus Hunting, Llc Sprayable gelling animal attractant

Also Published As

Publication number Publication date
CA2744033A1 (en) 2010-06-10
US20130012422A1 (en) 2013-01-10
WO2010065446A3 (en) 2011-05-26
CN102300550A (en) 2011-12-28
EP2362765B1 (en) 2020-04-08
JP2012510561A (en) 2012-05-10
RU2588972C2 (en) 2016-07-10
RU2011120488A (en) 2013-01-10
WO2010065446A2 (en) 2010-06-10
JP5567029B2 (en) 2014-08-06
US8431520B2 (en) 2013-04-30
BRPI0922770A2 (en) 2019-09-24
EP2362765A2 (en) 2011-09-07
MX2011005801A (en) 2011-06-20
CN102300550B (en) 2014-04-23

Similar Documents

Publication Publication Date Title
US8431520B2 (en) Perfume systems
US9994793B2 (en) Perfume systems
US9822327B2 (en) Perfume systems
US10144903B2 (en) Perfume systems
CA2799582C (en) Perfume systems
EP3521409A2 (en) Perfume systems
CA2879563C (en) Perfume systems

Legal Events

Date Code Title Description
AS Assignment

Owner name: THE PROCTER & GAMBLE COMPANY,OHIO

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SMETS, JOHAN (NMN);DENUTTE, HUGO ROBERT GERMAIN;PINTENS, AN (NMN);AND OTHERS;SIGNING DATES FROM 20091120 TO 20091204;REEL/FRAME:023648/0763

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION